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Abstract 
 
RNA-binding proteins (RBPs) are central players in cell biology and respond to 
a multitude of cellular cues and environmental stimuli. Identification of RBPs 
associated with specific transcripts in a cell is a challenging task; and the 
available strategies to purify specific transcripts and their bound proteome face 
numerous limitations. Thus, methods to determine the composition of proteins 
on a given RNA are required to further understand the regulation and biological 
function of any given RNA.  
Therefore, the focus of my PhD project was to develop a highly specific and 
selective method, “specific Ribonucleoprotein (RNP) capture”, to isolate a 
specific RNA species together with its bound proteome. Following irradiation 
with ultraviolet (UV) light that creates a covalent bond between RNA and 
protein, RNAs are captured using short LNA (locked nucleic acid)/DNA mixmer 
antisense probes coupled to a solid support.The proteins covalently linked to 
the isolated RNA are then identified by quantitative mass spectrometry. First, I 
successfully established the method for this application in vitro. Mass 
spectrometry data revealed that the protein Sister of Sex lethal (Ssx) has similar 
binding preferences to a mRNA derived from male-specific lethal (msl)2 mRNA 
as its paralog Sxl in Drosophila melanogaster embryo extracts. This 
demonstrated the specificity and selectivity of the method and provided direct 
experimental evidence for Ssx-RNA binding.  
Following these experiments, I extended the protocol to in-cell applications, 
focusing on the 18S and 28S ribosomal RNA (rRNA) of HeLa cells. Compared 
to bacteria, eukaryotic rRNAs possess “expansion segments” with much to be 
learnt about their bound RBPs and function. The high specificity of the method 
allowed me to generate distinct proteomic datasets for these two rRNAs. The 
method’s excellent biochemical performance is reflected by the overlap of these 
datasets with previous literature information on the cytoplasmic ribosome and 
system-wide screens of ribosomal biogenesis. Notably, my data revealed a 
strong connection between heterogeneous ribonucleoproteins (HNRNPs) and 
ribosomal RNA biogenesis, which is an unexplored area of research. In 
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summary, “specific RNP capture” allows identification of a given RNAs 
proteome and can be applied to both in vitro and cultured cells systems.  
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Zusammenfassung 
 
Erforschung der Biologie von Ribonukleoprotein Komplexen: spezifische 
Aufreinigung von Ribonukleoproteinkomplexen mit komplementären 
modifizierten Oligonukleotiden (Locked Nucleic Acids) 
 
RNA-Bindeproteine (RBPs) sind wichtige und zentrale Moleküle in der 
Zellbiologie, da sie dynamisch auf verschiedene Stimuli und zelluläre 
Stresssituation reagieren können. Die Aufreinigung von einem spezifischen 
Transkript mit den gebunden RBPs unterliegt vielerlei Limitierungen, sodass zu 
Beginn meiner Doktorarbeit ein Bedarf an Methoden bestand, um neue 
biologische Fragestellen zu einer spezifischen RNA zu beantworten. Der Fokus 
dieser Doktorarbeit lag daher in der Entwicklung einer spezifischen und 
selektiven Aufreinigungsstrategie von Ribonukleoproteinen („specific 
Ribonuleoprotein capture“, „specific RNP capture“).  
Diese neu entwickelte Methode erlaubt eine Aufreinigung einer spezifischen 
RNA zusammen mit den gebundenen Protein-Interaktionspartnern. Direkte 
RNA-Protein Interaktionen werden durch Bestrahlung mit ultravioletten Licht 
fixiert. Die RNA mit den direkt daran gebunden Proteinen wird dann mit Hilfe 
von kurzen komplementären Oligonukleotidsequenzen, welche kovalent an 
magnetische Partikel gekoppelt sind und aus einer Mixtur von Locked Nucleic 
Acids (LNA) und DNA bestehen, herausgezogen. Proteine, welche an der 
spezifischen RNA gebunden sind, können schließlich über quantitative 
Massenspektrometrie analysiert und identifiziert werden. 
Zunächst habe ich „specific RNP capture“ für die in vitro Anwendung etabliert. 
Mit der massenspektrometrischen Analyse konnte ich dabei aufdecken, dass 
das Protein Sister of Sex lethal (Ssx) in Drosophila melanogaster Embryo 
Extrakten ähnliche Sequenzbindungspräferenzen, kommend aus der mRNA 
von male-specific lethal (msl)2 mRNA, wie dessen Paralog Sxl besitzt. Mit den 
Ergebnissen dieses Experiments konnte ich die Spezifität und Selektivität der 
Methode demonstrieren und zugleich experimentellen Beweis für die Ssx-RNA 
Bindung liefern. 
Danach erweiterte ich die Anwendung der Methode auf die Aufreinigung von 
spezifischen endogenen RNA Spezies in humanen Zellen. Ich fokussierte mich 
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auf die spezifische Aufreinigung der 18S und 28S ribosomalen RNA (rRNA) von 
HeLa Zellen. In Vergleich zu Bakterien besitzt eukaryotische rRNA sogenannte 
„Expansion Segments“ (interne Einlagerung und Evolution von Nukleotiden in 
die konservierte rRNA Sequenz). Da noch wenig über diese „Expansion 
Segments“ und deren gebundenen RNA-Bindeproteine bekannt ist, ist eine 
generelle Studie Bindepartner von rRNA interessant und ermöglicht eine 
zukünftige Erweiterung der Methode auf Region-spezifische Anreicherung von 
den rRNA „Expansion Segments“ und deren gebunden Proteinen. Die 
spezifische Isolation der 18S und 28S rRNA erlaubte mir die Generierung von 
spezifischen Proteindatensätzen der jeweiligen rRNA. Die exzellente 
biochemische Leistung der Methode zeigte sich insbesondere in der Re-
Identifizierung von Proteinen des zytoplasmatischen Ribosoms und Proteinen, 
welche in der Biogenese des Ribosoms involviert sind. Darüber hinaus konnte 
ich neue Proteine identifizieren, welche eine mögliche Rolle in der  ribosomalen 
Funktion oder Biogenese haben könnten. Beachtenswert war die Anreicherung 
von HNRNP Proteinen (heterogenous ribonucleoproteins) als größere 
Gruppierung in den rRNA Interaktionsdatensätzen. HNRNP Proteine wurden als 
RNA Bindeproteine bisher hauptsächlich mit der Reifung von mRNA in 
Verbindung gebracht.  
Zusammengefasst beschreibt meine Arbeit die Etablierung der neuen Methode 
„specific RNP capture“ (spezifische Aufreinigung von Ribonukleoprotein 
Komplexen), welche eine Aufreinigung von einer spezifischen RNA Spezies 
zusammen mit den direkt gebundenen Proteinen erlaubt. Ich konnte zeigen, 
dass diese Methode sowohl für den in vitro Gebrauch als auch für den 
Gebrauch in Zellen geeignet ist. In den Experimenten in humanen Zellen konnte 
ich neben bekannten rRNA Interaktionspartnern, Proteine identifizieren, welche 
eine mögliche neue Funktion in der Biologie der rRNA oder des Ribosoms 
einnehmen könnten. 
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1 Introduction 
1.1 The discovery of RNA as a central player in Biology 
In the 1950s, after the discovery of the DNA structure (Watson & Crick, 1953), 
the interest for RNA and its connection to DNA emerged. The central dogma, 
the first time postulated by Francis Crick in 1956 (Crick, 1958), states that DNA 
is transcribed into RNA which is translated into proteins. RNA was in those days 
rather seen as a supporting player of DNA, which mediates the information 
transfer from DNA. Therefore, the research focus was limited to the three types 
of RNA involved in protein synthesis: the mRNA, the transfer RNA (tRNA) and 
the ribosomal RNA (rRNA). During these early days, RNA was not an easy 
object of research. Its short-lived and unstable nature and the complexity and 
variety of mRNAs represented a challenge for RNA biologists. First, the so 
called “microsomes” could be isolated (Claude, 1944). These “microsomes” 
turned out later to be the ribosomes, the cellular machinery of protein 
translation, which associate in multiple copies to mRNA forming polysomes 
(Slayter et al., 1963). The discovery of the first phages with a RNA genome 
(f2/MS2/R17) (Loeb & Zinder, 1961; Davis et al., 1963; Parenchynch & Graham, 
1962) exemplified that RNA can exhibit multitude of functions, even 
independent of DNA. With every new finding of novel functions of RNA and 
novel RNA types, it became clearer that the RNA biology is more complex than 
previously anticipated and RNA was not just a mediator of the genetic 
information, but a central player in cell biology.  
1.2 The functional diversity of RNA 
Discovery of many different RNA types (Figure 1.1) spurred further 
experimentation and resulted in the establishment of RNA biology as a research 
field of its own. 
After the discovery that the ribosome consists of ribosomal RNA and proteins, 
the highly structured transfer RNA (tRNA) (Hoagland et al., 1958), with its 
cloverleaf like structure, was identified as the molecule needed to bring the right 
amino acids to the ribosome. The mRNA on the other hand was described to be 
the central molecule for the translation of the genetic code into a protein. The 
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mRNA molecule is capped at the 5’end and polyadenylated at the 3’ end. These 
modifications allow recognition by translation initiation factors and are 
determinants of mRNA stability. 
 
Figure 1.1; The diversity of the RNA world. Besides the coding mRNA there are many types of RNA that 
are non-coding. Just some examples of the multitude of existing RNA types are displayed here and 
explained in the text. Other RNAs include e.g. vault RNAs (Stadler et al., 2009) from the vault particle, the 
7SL RNA (Pool., 2004) in the signal recognition particle (SRP), viral RNAs (Poltronieri et al., 2015) and 
tRNA derived small RNAs (tsRNAs) (Haussecker et al., 2010). The non-coding tRNA and rRNA are 
involved in the translation process. rRNA catalyzes the peptidyl-transferase reaction within the ribosome 
during translation; The various non-coding RNAs in the cell serve  a multitude of different functions within 
the cell. 
After transcription, the mRNA contains intron and exons and is referred to as 
pre-mRNA. Upon intron removal, alternative exon usage allows variations of the 
primary mRNA sequence expanding the potential protein sequence outcomes 
that an mRNA can encode. The responsible process for the variation of the 
mRNA pool is called splicing. With the discovery of small nuclear RNAs 
(snRNAs) (Lerner & Steitz, 1979), a novel function of RNA in splicing was 
described. Deep sequencing revealed that 90% of all transcription units are 
spliced in more than one pattern (Pan et al., 2008). Different proteins can be 
translated from these differentially spliced RNAs, including non-functional 
products (Delaney et al., 1993). Thereby, splicing allows an additional level of 
regulation in a cell.  
The discovery of RNA interference (RNAi) (Ecker & Davis, 1986; Napoli et al., 
1990; Van Blockland et al., 1994; Fire et al., 1998) and microRNAs (miRNAs) 
Introduction  
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(Lee et al., 1993; Wightman et al., 1993) demonstrated that another type of 
small RNAs can have regulatory function in mRNA fate. Small RNAs can 
silence gene expression by interacting with a target mRNA and either trigger its 
degradation or regulating its translation (Jonas & Izaurralde, 2015). Another 
type of small RNAs, the piwi interacting RNAs (piRNAs), are found in the 
germline of many animals and are the adaptive defense against transposons in 
the genome. This involves silencing mechanisms that act on multiple levels, 
including epigenetic control of the mobile elements (Iwasaki et al., 2015).  
Advances in RNA sequencing technologies lead to the discovery of other new 
types of RNA species, which were initially considered to be rather 
transcriptional noise or sequencing artefacts. This included the long non coding 
RNAs (lncRNAs) (Kapranov et al., 2007) and circular RNAs (circRNAs) 
(Salzman et al., 2012). However, shortly after it could be demonstrated that 
gene regulation can be controlled by lncRNAs as exemplified by Xist, which 
associates with one copy of the X-chromosome and mediates its silencing in 
female mammals in a process called dosage compensation (Wutz, 2011). To 
date, biological roles of numerous lncRNAs are described, but the function of 
other members of the family is still poorly understood. Furthermore, it remains 
unclear, whether all members of the family are truly non-coding, as many 
lncRNAs can be found associated with ribosomes (Quinn & Chang, 2016). 
Similarly, the role of circRNAs in biology initially was enigmatic. Circularization 
of these RNAs occurs co-transcriptionally and it is still unclear, whether 
numerous circRNAs are non-functional products of aberrant splicing (Chen, 
2016). However, recently proteins were identified, which can actively promote 
circularization of RNA (Conn et al., 2015).This might be a first indication that 
circularization is a regulated process of biological relevance. CircRNAs carrying 
a multitude of miRNA binding sites have already been shown to act as miRNA 
sponges (Hansen et al., 2013; Memczak et al., 2013). circRNAs do not have 5’ 
or 3’ ends and are therefore resistant to exonuclease mediated degradation; 
circRNAs are hence more stable than most linear RNAs. Based on the stability 
and the possibility to carry several interaction sites, it is possible to envision a 
role as scavenger complexes targeting molecules such as miRNAs or RNA-
binding proteins (Hentze & Preiss, 2013).  
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There are additional RNA species described, and the repertoire of RNA 
molecules is still growing, placing this molecule in the epicenter of cellular 
biology. The complexity of the RNA world with its biological diversity implies that 
a broad variety of trans-acting protein factors are required to enable RNA 
functions, the RNA binding proteins (RBPs). 
1.3 From RNA-binding proteins to ribonucleoprotein 
complexes 
Proteins associate with RNA from the transcription to the decay of RNA. RNA- 
binding proteins (RBPs) interact in a very dynamic manner with RNA to form 
ribonucleoprotein (RNP) complexes. RBPs execute regulatory functions at 
specific stages of RNA metabolism (e.g. during splicing, processing, transport, 
translation) (Dreyfuss et al., 2002). Further functions of RBPs can include 
structure modulation of the RNA by acting as RNA chaperones or helicases 
(Mohr et al., 2002; Semrad, 2011). Interaction with RNA is mediated by the 
RNA-binding domains (RBDs). Classical RBPs follow a modular design 
combining a limited scope of RBDs, including the RNA recognition motif (RRM), 
the zinc finger motif (Znf), the hnrnp K homology motif (KH), the S1 domain, 
double stranded RNA-binding motif (dsRBM) and others (see Lunde et al., 2007 
for the complete repertoire). Some of these domains can bind also DNA or 
proteins (Clery & Allain, 2011). RRM is the most common RBD that can be 
found in about 0.5-1% of human genes (Finn et al., 2005). Several RRMs are 
often combined in tandem to increase binding affinity and specificity, as in the 
case of Poly-(A) binding protein (PABP), Sex lethal (Sxl) or Nucleolin (Ncl). 
Having several RRMs in tandem enables higher RNA binding affinity and 
sequence specificity (Chen & Varani, 2014).  
The broad family of Znf motifs was initially described as DNA binding (Hanas et 
al., 1983). The Znf domains are classified by the combination of cysteines (C) 
and histidines (H), which are the amino acids that chelate the Zn2+ ion (e.g. 
CCHH, CCCH, CCCC) (Clery & Allain, 2011). 
dsRBMs are often found in multiple copies in RBPs (e.g. Drosophila protein 
Staufen with 5 copies). dsRBMs recognize the RNA structure but they can also 
bind sequences specifically by projecting amino acids to the Watson-Crick 
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paired bases, like Adar2 that converts adenosine to inosine (Barraud & Allain, 
2011). 
The repertoire of RBPs has substantially grown due to recent genome-wide 
studies that enabled the identification of novel RBPs. With the increasing 
knowledge about RBPs many more non classical RBDs have been described 
(see later). 
1.4 The central role of RBPs in post transcriptional gene 
regulation  
Gene expression is a tightly regulated process, because the timely and spatial 
expression of a protein is important for the survival and adaptation of the 
organism. The numerous cues and stresses that affect an organism require a 
highly versatile, fast and flexible toolset of gene expression regulation (Figure 
1.2). The extent of gene regulation increases with the complexity of the 
organism. In prokaryotes, transcription and translation are coupled processes. 
However, in eukaryotes, these two processes are separated into different 
compartments, the nucleus and the cytoplasm. The compartmentalization of 
processes allows regulation based on differential localization. In addition, 
eukaryotic mRNAs undergo a multitude of processing events including splicing, 
editing, capping with 7-methylguanosin (m7G) at the 5’end and polyadenylation 
at the 3’ end. These events start already co-transcriptionally and are mediated 
by RBPs (Moore, 2005; Glisovic et al., 2008.) 
 
Figure 1.2; Different modes of gene expression control in eukaryotes. From transcription to decay.  
Gene expression can be controlled through transcriptional regulation or post-
transcriptional regulation. Transcriptional control is more economic, as this early 
control checkpoint saves energy resources like the nucleotides that are used 
during transcription. Nevertheless, post-transcriptional control is a favorable 
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process when it comes to fast responses to stimuli and stresses (Holcic & 
Sonenberg, 2005; Hershey et al., 2012). Post-transcriptional control is fast 
because it operates on already transcribed RNA. Translational control is 
conceptually the fastest way of post-transcriptional control because it bypasses 
all upstream time consuming processes of RNA production and processing.  
RBPs are key players in post-transcriptional regulation and their differential 
binding specificities, combinatorial binding abilities and differential localizations 
allow a highly specific and diverse regulatory control of post-transcriptional 
events (Moore, 2005; Glisovic et al., 2008). One level of post-transcriptional 
control affects mRNA levels by altering the stability of the transcript. Abundance 
of an mRNA in the cytoplasm is dependent on its synthesis rate, processing, its 
nuclear export rates and degradation rate. The interaction of proteins on cis-
acting elements to the RNA can fine tune all these processes, for example 
determining the mRNA degradation rate by recruiting mRNA degradation 
machineries. These cis-acting elements can be often found in the 3’UTR of 
mRNAs (Matoulkova et al., 2012). One prominent example is the iron 
responsive element (IRE), which is found in 5 copies in the 3’UTR of transferrin 
receptor mRNA. In iron-replete cells, the iron regulatory proteins 1/2 (IRP1/2) 
(also described later) do not bind the IREs and therefore the transcript becomes 
a target of endonuclease attack and subsequent degradation. In iron-deficient 
cells IRP1/IRP2 bind to the IREs and thereby protect the mRNA from 
degradation by a not further understood mechanism (Casey et al., 1988; 
Müllner & Kühn, 1988; Binder et al., 1994). Other examples are the AU rich 
elements (AREs) present in in the 3’UTR of mRNA (Gardiner et al. 2015) of a 
number of mRNAs encoding cytokines and chemokines. AREs can be bound by 
trans-acting factors like ARE- binding proteins causing mRNA decay and 
translational repression. There are also other factors like Hu-antigen D (HuD) 
that bind AREs and stabilize targeted mRNA (Bolognani et al. 2010; Gardiner et 
al. 2015).  
Another way to control gene expression is on the level of mRNA splicing. 
Splicing of a pre-mRNA removes the introns, which are noncoding regions of 
the RNA. Splicing events on one pre-mRNA can then also lead to varying 
mRNA products that are translated into different proteins (Pan et al., 2008). This 
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process is in large extent regulated by differential association of RBPs that 
increase selection or occlude a given splicing donor or acceptor.  
Another mechanism to expand or change the protein repertoire relies on RNA 
editing (Nishikura, 2016). RNA editing involves the conversion of adenosine to 
inosine catalyzed by the ADAR proteins. RNA editing can alter the protein 
product and also affect RNA secondary structure, stability and splicing. C to U 
editing by Apobec1 on apolipoprotein (apoB) mRNA creates a UAA termination 
codon and thereby results in a shorter protein product encoded by the apoB 
gene. The apoB gene thereby encodes for two apolipoproteins, the shorter 
ApoB48 and the longer ApoB100, that both have specific functions in the fatty 
acid transport in mammals (Davidson & Shelness, 2000). 
The spatial control of RNA abundance by locating proteins to particular 
subcellular regions is an additional important element of gene expression 
regulation (Gonsalvez & Long, 2012). Localization of transcripts to a destined 
region of the cell or the organism has been well studied in different systems, 
including prominently Drosophila (Berleth et al., 1988; Ephrussi et al., 1991; 
Lécuyer et al., 2007) and yeast (Andoh et al., 2006; Schmid et al., 2006; Aronov 
et al., 2007). Cell polarization requires asymmetric localization of proteins. For 
this purpose specific mRNAs are often differentially localized.  Localization of 
oskar (osk), nanos (nos), bicoid (bcd), and gurken (grk) mRNA is crucial for 
Drosophila embryonic axis specification (Lasko, 2012). The involvement of the 
cytoskeleton and the interaction with cis acting factors that associate the target 
mRNAs to molecular motors and microtubules is necessary for the localization 
of these mRNAs. Other cis acting factors prevent translation during transport of 
these RNPs. 
mRNA levels do not always correlate with the protein levels in a cell. Correlation 
of mRNA levels and protein levels decreases with the complexity of the 
organism. The correlation of mRNA and protein levels for E.coli is R2 ~0.8 
(Taniguchi et al., 2010) whereas it is ~0.7 for yeast (Ghaemmaghami et al., 
2003) and 0.4 in human (Schwanhäusser et al., 2011). Translational control is 
one explanation for the decreased correlation between mRNA and protein 
levels in the cell. Translational control is a post-transcriptional control 
mechanism that does not affect mRNA abundance but allows rapid changes of 
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protein levels in response to environmental cues (Hershey et al., 2012). 
Translation can be subdivided into initiation, elongation, termination and 
ribosome recycling. Many translational control mechanisms target the first step, 
the translational initiation (see below). Some eukaryotic mRNAs (~5-10% of all 
mRNAs) (Le & Maizel, 1997) or viral RNAs (Kieft et al., 2008) with internal 
ribosomal entry sites (IRESs) can often be translated by a mechanisms that 
differ from the canonical cap-dependent translation initiation through direct 
recruitment of the RNA to the 40S subunit. This makes IRES-containing 
transcripts less sensitive to downregulation of initiation factors under cellular 
stresses such as starvation (Gilbert et al., 2007; Riley et al., 2010) or infection 
(Bonnneau & Sonenberg, 1987; Irurzun et al., 1995). Length and structure of 
the 5’ UTR of an mRNA can affect the efficiency of scanning, acting as a 
regulatory element. Specific translational regulation at the initiation step occurs 
often by binding of RBPs to specific sites in the 3’-UTR of an mRNA, often 
modulating the interactions between the 5’ and 3’ end of the RNA (closed loop) 
or altering the activity of initiation factors (Gray & Hentze, 1994). This is 
exemplified by the action of the Drosophila protein sex lethal (Sxl) on the mRNA 
of male specific lethal 2 (msl2), as described below (Duncan et al., 2006; 
Gebauer et al., 2003; Abaza et al., 2006; Beckmann et al., 2005; Duncan et al., 
2009; Medenbach et al., 2011).  
Besides silencing of their targets by induction of RNA degradation, miRNAs can 
regulate target RNAs at the translation step. Translational repression through 
miRNA can occur by shortening of the poly(A) tail (deadenylation), which 
hampers the closed loop formation and slows down initiation and the re-
initiation event by post-terminating ribosomes. There is still no full 
understanding of how miRNAs regulate translation but they might act by 
targeting eIF4A, an RNA helicase needed to unwind the secondary structure 
nearby the start codon during translation initiation (Meijer et al., 2013; Ricci et 
al., 2013; Fukao et al., 2014; Fukaya et al., 2014). A recent study suggests an 
additional mechanism independent of eIF4AI activity and 43S scanning 
mechanism (Kuzuoğlu-Öztürk et al., 2016) that involves CCR4-NOT and DDX6. 
However, the molecular basis of this mechanism remains obscure. 
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Translational control events that affect the elongation phase are less frequently 
observed. Most of the time elongation works at maximal speed and efficiency. It 
is known that rare codons can slow down this process and thereby affect 
translational efficiency (Irwin et al., 1995; Yu et al., 2015). During translation of 
proteins resident in the endoplasmic reticulum the elongation is paused by the 
signal recognition particle (Wolin & Walter, 1989). 
1.4.1 Sxl, a paradigmatic RBP involved in posttranscriptional control 
during Drosophila development 
In Drosophila, the protein Sxl plays a pivotal role at the top of a sex 
determination and dosage compensation regulation cascade. Dosage 
compensation is a mechanism that ensures females and males to have equal 
levels of gene product despite having different number of chromosome X (Cline 
& Meyer, 1996).  Sex determination ensures the correct development of sex 
characteristics in an organism. The Sxl gene is present on the X-chromosome; 
its sex specific transcription is regulated by transcription factors that also reside 
on the X-chromosome (Keyes et al., 1992). Just embryos that harbor 2 X-
chromosomes can initiate the Sxl expression. Shortly after the sex specific 
transcription of Sxl from the early promoter, Sxl transcription starts from a 
second, “late”, promoter that is present and active in both males and females. 
The early sex specific Sxl directs then splicing of the late Sxl transcript to 
generate a translatable version of Sxl (Cline, 1984; Bell et al., 1991). It thereby 
creates a sex specific activation pulse of active Sxl. The autoregulative loop of 
splicing by the Sxl protein allows then Sxl production from the late transcript 
throughout life.  
Sxl is a RBP with two conserved RRMs and an N-terminal glycine-rich region 
(Wang & Bell, 1994). The interaction of Sxl to target RNA works in a 
cooperative fashion. The glycine-rich region promotes this cooperativity and 
also allows co-recruitment of proteins with similar glycine-rich regions such as 
the HNRNP A/B homolog Hrb87F (Wang et al., 1997). The region of Sxl 
containing residues 122–301 (called dRBD4) shows full biological activity but 
the two RRMs alone (residues 123–294, called dRBD3) are sufficient for the 
RNA-binding activity (Grskovic et al., 2003).  
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Sxl binds to poly(U) stretches of target mRNAs (Inoue et al., 1990; Valcárcel et 
al., 1993). Target mRNAs include for example Sxl itself (Cline, 1984; Bell et al., 
1991), transformer mRNA (tra) (Boggs et al., 1987) and male specific lethal-2 
(msl-2) (Bashaw & Baker, 1995). On these target mRNAs Sxl functions as a 
translational repressor and/or as a regulator of alternative splicing. Tra is 
downstream of Sxl in the sex determination cascade and its sex specific 
expression is controlled by splicing regulation by Sxl. The transcription factor 
msl-2 is part of the male specific lethal complex consisting of four proteins that 
bind specifically to the X chromosome in the male to upregulate its expression 
for dosage compensation (Conrad & Akhtar, 2012). The msl-2 transcript carries 
three U-rich binding sites targeted by Sxl that could be defined to be 70 nt in the 
5′ UTR (site B) (Gebauer et al., 1999) and 46 nt in the 3′ UTR (sites E and F) 
(Gebauer et al., 2003). For effective msl-2 silencing, Sxl acts via several 
mechanisms. At the level of splicing, Sxl promotes the retention of an intron that 
is necessary for downstream translational repression steps through Sxl 
(Gebauer et al., 1998). Binding of Sxl to its binding site displaces the large 
subunit of the U2 auxiliary factor (U2AF), diverting it to a distal low-affinity 
poly(Y) tract and inhibits thereby recognition of the 5' splice by the U2 small 
nuclear recognition particle (U2 snRNP) (Merendino et al., 1999).   
Translational repression through Sxl is promoted by a dual-mechanism 
(Beckmann et al., 2005) (Figure 1.3). When Sxl binds to the 3’ UTR, it co-
recruits Upstream of N-ras (UNR) (Duncan et al., 2006) and inhibits ribosome 
recruitment (Duncan et al., 2009) and thereby translational initiation. Sxl bound 
to the 5’ binding site interferes with ribosomal scanning (Gebauer et al., 2003) 
by a mechanism that involves redirecting the ribosome to an upstream AUG 
(Medenbach et al., 2011). Sxl is an enthralling RBP because of its strong RNA 
interaction and the multitude of functions it has on its target mRNAs. It also 
exemplifies the diversity of post transcriptional control mechanisms. 
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Figure 1.3; Mechanisms of translational control of msl2 mRNA promoted by Sxl. In female 
Drosophila cells, SXL is expressed and it can associate with U rich binding sites, which reside in the 5' and 
3' UTRs of msl-2 mRNA. Bound to the 3' UTR, Sxl can recruit UNR. The SXL–UNR complex then blocks 
the association of the 43S ribosomal preinitiation complex at the 5' end of msl-2 mRNA, thereby repressing 
translation initiation. Sxl bound to the 5’UTR inhibits translation by redirecting the ribosome to an upstream 
AUG. Male Drosophila cells do not express SXL, the translation inhibitory complex is not formed and msl2 
can be translated. (Figure kindly provided by Jan Medenbach, University of Regensburg; adapted from 
Duncan et al., 2006) 
1.5 The Ribosome 
1.5.1 Ribosomes –macromolecular complexes made of rRNAs and 
proteins 
In all living cells the mRNA derived synthesis of proteins is carried out by a 
macromolecular machine, the ribosome. The ribosome was first discovered via 
electron microscopy of plant cells 1953 (Robinson & Brown, 1953). Later it was 
isolated from animal cells and at this time referred to as RNP particles or 
microsomes (Palade, 1955). The ribosome (termed 70S in prokaryotes and 80S 
in eukaryotes based on its Svedberg sedimentation coefficient) is composed of 
two subunits that have different functions during translation. The small subunit 
(30S in prokaryotes and 40S in eukaryotes) is the decoding center, where 
interactions between codons in the mRNA and the anticodons of tRNAs are 
monitored. Based on these interactions the right order of amino acids will be 
added to the nascent polypeptide. The large subunit (50S in prokaryotes and 
60S in eukaryotes) carries the catalytic active center in which the formation of 
the peptide bonds is catalyzed. Both subunits consist of ribosomal RNA (rRNA) 
and ribosomal proteins. In eubacteria, the small subunit contains one 16S 
ribosomal RNA (rRNA) molecule and 21 small subunit ribosomal proteins (Rps 
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proteins), the large subunit contains 5S and 23S rRNAs and 33 large subunit 
ribosomal proteins (Rpl proteins) (Melnikov et al., 2012). In eukaryotes, the 
small subunit contains 18S rRNA and 32 Rps proteins, the large subunit 
consists of 28S, 5.8S and 5S rRNA and contains 47 Rpl proteins. Mitochondria 
also possess ribosomes for the synthesis of highly hydrophobic proteins (13 in 
human) involved in oxidative phosphorylation. Mitochondrial ribosomes (55S) 
have diverged from the prokaryotic ribosomes by having reduced RNA content 
and increased protein content (O’Brien, 2003).  
Crystallographic analyses of ribosomes have been very challenging because of 
their size, complexity and the lack of symmetry, the presence of several flexible 
components and the instability of rRNA. Therefore it was a breakthrough in the 
field, when the first high resolution (2.4 Å) crystal structure of the prokaryotic 
50S subunit was resolved (Ban et al., 2000) and could give first structural 
insights into protein synthesis. The peptidyl-transferase center directly attracted 
attention because of the absence of proteins. It was therefore observed in the 
structure what was already speculated, that the ribosome is a ribozyme in which 
the RNA acts as the catalyst (Cech, 2000).  
Soon after first structural insights of the ribosome were given by the prokaryotic 
50S subunit structure, other structures were resolved by cryo-electron 
microscopy and crystallography including eukaryotic, prokaryotic and the 
mitochondrial ribosome (Wimberley et al., 2000; Spahn et al., 2001; Spahn et 
al., 2004; Boehringer et al., 2005; Chandramouli et al., 2008 Taylor et al., 2009; 
Armache et al., 2010; Klinge et al., 2011; Rabl et al., 2011; Ben-Shem et al., 
2011; Jenner et al., 2012; Anger et al., 2013; Greber et al., 2014; Amunts et al., 
2015; Khatter et al., 2015).  
The collection of structural data from different organisms in the tree of life 
allowed studies about structural conservations and differences (Figure 1.4). 
Bacterial and eukaryotic ribosomes share a common structural core, which 
includes 34 conserved proteins (15 in the small and 19 in the large subunit) and 
a core of 4400 nt rRNA. The conserved core harbors the functional centers of 
the ribosome, the A (Aminoacyl), the P (Peptidyl) and E (Exit) site (Spahn et al., 
2001; Ramakrishnan, 2002; Smith et al., 2008). These sites are formed 
between the small and big subunit of the ribosome. The mRNA interacts with 
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the small subunit and moves in a step-wise manner from codon to codon during 
the translation, the catalytic function of the ribosome.  
1.5.2 Expansions of rRNA in eukaryotes – the ribosomal expansion 
segments 
Eukaryotes exhibit multiple extensions of the 18S and 28S rRNA in comparison 
to the prokaryotic rRNA; these insertions are referred to as expansion segments 
(Gerbi, 1996). Within eukaryotes the ribosomes also differ in their protein and 
RNA mass, which increases with the complexity of the organism (Melnikov et 
al., 2012; Anger et al., 2013). The increase of protein mass associated to 
protein size increase (protein extensions) appears to be modest, whereas the 
increase of rRNA mass is significant (Figure 1.4).  
 
Figure 1.4; Expansion and evolution of the ribosome. Surface representations (a, c, e) and schematics 
(b, d, f) of the bacterial (T. thermophiles) ribosome (Jenner et al. 2010), the S. cerevisiae ribosome (Ben-
Shem et al. 2011) and the human ribosome (Anger et al. 2013). TE, tunnel exit.(Figure modified from 
Anger et al. 2013; reprinted with permission; license number 3920180057435 provided by Copyright 
Clearance Center) 
The 30 rRNA expansion elements (28 in yeast and tetrahymena), often 
protruding out of the ribosomal core, are involved in inter-subunit bridge 
formation (Armache et al., 2010; Anger et al., 2013; Khatter et al., 2015) and 
could serve as interaction platform of factors that might regulate translation or 
interact with the nascent peptide chain (Beckmann et al., 2001). Deletion of 
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rRNA expansion segments showed a role of some expansion segments in 
ribosomal biogenesis (Ramesh & Woolford, 2016). The longest expansion 
segment in humans is ES27L in the 28S rRNA. It builds a strong stem loop 
structure and might link the ribosome with the ER membrane (Pfeffer et al., 
2012). ES27L is also involved in inter-subunit bridge formation and is suggested 
to recruit chaperones or modifying enzymes to the nascent peptide chain close 
at the peptide exit channel (Beckmann et al., 2001). In yeast, structural data 
showed that the biogenesis factor Arx1 (human ortholog Pa2G4/EBP1) interacts 
with the expansion segment ES27L (Greber et al., 2012) in the premature 60S 
subunit where it associates close to the polypeptide tunnel exit. Arx1 might 
thereby lock the premature 60S subunit to prevent premature association of 
nascent chain processing factors. The expansion segment ES6S is the longest 
in the human 18S rRNA and is involved in inter-subunit bridge formation. 
Nevertheless, there is still a lack of knowledge about the different functions of 
the expansion segments and why the complexity of these expansion segments 
increases with complexity of the organism. The expansion segments might 
associate with many translational and maturation regulators and can thereby 
contribute to the increasing layer of regulation in organisms with increasing 
complexity. 
1.5.3 The ribosome – a molecular machine 
The ribosome is required to translate the mRNA into protein. It reads the 
genetic code, i.e. nucleotide base triplet in the mRNA, and catalyzes the peptide 
bond formation between amino acids. The mechanism of translation by the 
ribosome comprises three phases, the initiation, the elongation and the 
termination and recycling phase (Dever & Green, 2012).  
In eukaryotic translation (Hershey et al., 2012), cap-dependent translational 
initiation is the most frequent initiation mechanism (Figure 1.5) and involves 
scanning of the 43S pre-initiation complex from the 5’ cap of the mRNA to the 
start codon. Eukaryotic translation initiation factors (eIF1-6) are involved in the 
different steps of translation initiation. The GTP binding protein eIF2 specifically 
recognizes the initiator tRNA, which is loaded with the initiator amino acid 
Methionine (Met). This ternary complex binds to the small subunit and forms the 
43S complex. The cap structure is recognized by the initiation factor complex 
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eIF4F (composed by eIF4A, E, and G), guiding the 43S complex to the 5’ end of 
the mRNA. Supported by the eIFs and consuming ATP, the 40S ribosome 
subunit starts the scanning of the mRNA until it reaches the first start codon. 
Upon reaching the start codon, the 60S subunit binds to the 40S subunit in a 
process known as “joining”. The initiator Met-tRNA then positions to the 
ribosomal P-site and eIF5 hydrolyzes the eiF2-bound GTP and thereby releases 
the initiation factors to finish the initiation phase.  
 
Figure 1.5; Cap dependent translation initiation mechanism in eukaryotes. (Figure from Klann & 
Dever, 2004; reprinted with permission; license number 3920190031575 provided by Copyright Clearance 
Center) 
The elongation phase of translation (Dever & Green, 2012) involves the action 
of eukaryotic elongation factors (eEFs). When the first codon resides at the P 
site of the ribosome, the second codon is present at the A site and is awaiting 
the respective aminoacyl-tRNA. The elongation factor eEF1A binds the 
aminoacyl-tRNA in a GTP dependent manner and guides the tRNA to the A site 
of the ribosome, where the tRNA anticodon base pairs with the mRNA codon. 
Upon codon recognition and GTP hydrolysis by eEF1A, the aminoacyl-tRNA is 
positioned into the A site. Peptide bond formation with the P-site aminoacyl-
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tRNA or peptidyl-tRNA is a rapid process catalyzed by the large subunit rRNA in 
the peptidyl transferase center. Conformational changes of the ribosome trigger 
the movement of the tRNAs into hybrid P/E and A/P states. GTP hydrolysis 
through eEF2 leads to the conformational changes that allow movement of the 
mRNA and tRNA. In this post-translocation state a free tRNA resides in the E 
site and the peptidyl-tRNA in the P site. The A site is free for the arrival of the 
next tRNA.  
By reaching the stop codon during translation, the translational termination 
mechanism is initiated (Dever & Green, 2012). Translational termination 
involves the eukaryotic release factors (eRFs). eRF1 has a tRNA shape and 
can recognize the stop codon. eRF3 is a GTP binding protein that triggers upon 
GTP hydrolysis the deposition of a domain of eRF1 into the peptidyl transferase 
center, a process that results in peptide release from the ribosome.  
1.5.4 The birth of the ribosome – ribosomal biogenesis 
 
Figure 1.6; Ribosome Biogenesis at a glance. (from Lafontaine, 2015; reprinted with permission; license 
number 3920240959172 provided by Copyright Clearance Center) 
Introduction  
 
25 
 
Biogenesis of the ribosomes starts in the nucleolus and ends with the formation 
of the catalytic ribosome in the cytoplasm (Olson & Dundr, 2001). The process 
of ribosome biogenesis is a complex and energy demanding mechanism that 
includes rRNA processing and protein assembly steps (Figure 1.6). The 18S, 
5.8S and 28S rRNAs are co-transcribed by Polymerase I (Pol I) as a long 
primary transcript (35S in yeast, 47S in human) from head to tail tandem 
repeats of rDNA (~150 in haploid yeast cells and 300-400 in diploid human 
cells) (Worton et al., 1988). In S.cerevisiae, the rDNA repeat also encodes for 
the 5S rRNA, which is transcribed by Pol III in reverse direction (Srivastasa & 
Schlesinger, 1991). In human and other eukaryotes, the 5S rRNA is 
synthesized by Pol III from multiple genes in close proximity to the nucleolus 
(Fedoriw et al., 2012). In the primary transcript, rRNAs are separated by spacer 
sequences, the internal transcribed spacers 1 and 2 (ITS1, ITS2) and the 
external transcribed spacers (5’ETS, 3’ETS). After transcription, a cascade of 
processing steps follows that include exonucleolytic and endonucleolytic 
cleavages (Henras et al., 2015). The order of some of the nucleolytic steps can 
differ between organisms but also from cell type to cell type (Bowman et al., 
1983; Savino & Gerbi, 1990; Hadjiolova et al., 1993;). The first cleavage occurs 
at ITS1 and downstream to this cleavage the pathways for the small and big 
subunit biogenesis diverge. For biogenesis steps that include base 
modifications and folding, the primary transcripts associate with ribosomal 
proteins, pre-ribosomal factors and nucleolar ribonucleoprotein particles 
(snRNPs). More than 200 factors in addition to ribosomal proteins are involved 
in the ribosomal biogenesis (Thomson et al., 2013). snRNPs like U17, U14 or 
U8 function as RNA chaperones and assist the early cleavages (Reichow et al., 
2007). Ribose methylation and uridine isomerization to pseudouridine is 
catalyzed boxC/D and box H/ACA RNPs respectively (Watkins & Bohnsack, 
2012). The snoRNAs in these complexes hybridize to the specific positions in 
the ribosomal RNA and guide the modifications by the core proteins, the 
methyltransferase Fibrillarin and the pseudouridine synthase Dyskerin. 
Modification of rRNA is mostly found on functionally relevant positions of the 
ribosome (Liang et al., 2009). Many helicases of the AAA ATPase family are 
involved in ribosome biogenesis; they might modulate the RNA interactions 
within the pre-rRNA (Martin et al., 2013).  
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Most of the processing steps occur still in the nucleolus but additional 
processing take place in the nucleoplasm and the cytoplasm. The export to the 
cytoplasm appears to be specific for each subunit by interaction with specific 
export receptors. The karyopherin Crm1 mediates export of 40S and 60S 
particles in a Ran-GTP dependent manner. Adapter proteins that are distinct for 
40S and 60S regulate the interaction with Crm1 via a nuclear export signal 
(NES). Nmd3 was identified to be the adapter protein specific for 60S export 
(Matsuo et al., 2014), whereas Slx9 was recently discovered to be the adapter 
protein for 40S export (Fischer et al., 2015 ). In the cytoplasm, the assembly of 
the ribosomal subunits is finalized and the translation inhibited till the maturation 
of the ribosome is complete. An example is the already mentioned binding of 
the protein Arx1 (human ortholog Pa2G4 or EBP1) to the peptide exit tunnel 
where it inhibits the association of translation factors in yeast (Greber et al., 
2012).  
Defective Ribosomes can be problematic for the function of the cell; therefore, 
surveillance mechanisms exist to eliminate dysfunctional ribosomal subunits. 
The multi-protein TRAMP complex, a cofactor of the exosomes, specifically 
targets misprocessed nuclear pre-rRNA and marks it for degradation by adding 
a 3’ oligo-A-tail (Dez et al., 2006). If the nuclear surveillance mechanism is 
bypassed, the non-functional rRNA decay (NRD), in which rRNAs that are fully 
maturated but harbor point mutation at sites important for translation in mature 
ribosomes are detected and degraded (Séraphin & Graille, 2012). NRD acts co-
translationally and involves factors of the “No go” decay (NGD) machinery, 
which targets mRNAs that lead to stalling of ribosomes during translation. The 
mechanism of NRD is less clear than the NGD mechanism but one assumes 
that additional ubiquitination of ribosomal proteins and the additional action of 
the proteasome is required. 
If biogenesis of the ribosome is affected by mutations of genes involved in 
biogenesis, a group of diseases is caused. The group of diseases associated 
with ribosome biogenesis is collectively called ribosomopathy (Freed et al., 
2010). The most studied ribosomopathy disease is Diamond-Blackfan anemia 
(DBA) caused by mutation of ribosomal proteins. The phenotype of 
ribosomopathies is complex because a defect in ribosome biogenesis causes 
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ribosomal stress, which also involves p53 dependent pathways. DBA patients 
have malformations of limbs, an abnormal red blood cell physiology, and have 
an increased risk of cancer. The complexity of the ribosomopathies phenotypes 
illustrates the central role of ribosomes for cellular function and are not yet fully 
understood at the molecular level. 
1.6 RBP analysis 
1.6.1 Genome wide discovery of RBPs  
Global RNA centric methods to identify RBPs have substantially expanded the 
diversity of RNA-protein interactions in the last years. First attempts to identify 
novel RBP were performed in vitro. Proteome-wide microarrays were incubated 
with fluorescence labeled RNA (Scherrer et al., 2010). After the washing steps, 
the arrays were scanned and analyzed for proteins that bound labeled RNAs. 
Unexpectedly, a number of metabolic enzymes were identified in these studies. 
In vitro studies are nevertheless prone to non-specific interactions with basic 
proteins through interaction with the negative charges at the RNA phosphate 
backbone. To circumvent this limitation, RNA interactome capture was 
developed in two independent laboratories to capture native protein-RNA 
interactions of living cells (Castello et al., 2012; Baltz et al., 2012). Both studies 
were based on UV crosslinking with 254 nm UV light, or with 365 nm UV using 
photoactivatable ribonucleotides (PAR), to covalently link the proteins to RNA 
placed at zero distances in living cells. Poly(A)+ RNA was capture by 
hybridization with oligod(T) beads . Stringent washes allowed the removal of 
proteins that were not covalently bound to the captured RNA. Proteins were 
released by RNase digestion and then analyzed by quantitative mass 
spectrometry (MS).  
For human cells, the study lead to the identification of 1218 high probability 
RBPs in HeLa, HEK293 and Huh-7 cells (Beckmann et al., 2016). RNA 
interactome capture opened a new chapter for RBP biology and promoted the 
discovery of additional RBPs in other cellular systems and species, that were 
different human cell types (Castello et al., 2012; Baltz et al., 2012; Beckmann et 
al., 2015), murine ES cells (Kwon et al., 2013), murine macrophages (Liepelt et 
al., 2016), murine cardiomyocytes (Liao et al., 2016); C.elegans (Matia-
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Gonzalez et al., 2015), parasites (Plasmodium, Trypanosoma) (Bunnik et al., 
2016; Lueong et al., 2016), D. melanogaster (Wessels et al., 2016; Sysoev et 
al., 2016) A. thaliana  (Marondedze et al., 2016) and S.cerevisiae (Mitchell et 
al., 2012; Matia-Gonzalez et al., 2015; Beckmann et al., 2015). Data from even 
more species are expected to become available in the near future. Knowing the 
repertoire of RBPs of different organisms will offer unprecedented opportunities 
to study the evolution of RBPs across species. 
 
 
 
 
 
 
 
 
 
Figure 1.7; Schematic of the (m)RNA interactome capture protocol. Proteins bound to RNA are 
crosslinked in living cells by either conventional crosslinking at 254 nm (cCL) (top) or via PAR crosslinking 
at 365 nm (bottom). The mRNA together with the crosslinked proteins are captured on oligo(dT) magnetic 
beads. After stringent washes, the proteins are released by RNase treatment and analyzed via mass 
spectrometry (Mass Spec). (from Castello et al. 2013; figure reprinted with permission; license number 
3920180833736 provided by Copyright Clearance Center) 
The RNA interactome turned out to be more complex than previously expected, 
with 1218 high probability RBPs identified in HeLa (Castello et al., 2012). 
Interestingly, the majority of the newly identified RBPs do not contain a classical 
RBD (~55%) (Beckmann et al. 2016) (Figure 1.8). The proteins that do not 
contain a known RBD often harbor other motifs or domains associated to other 
functions. For example, the WD40 domain was previously described to be 
involved in protein-protein interactions and has now also been experimentally 
confirmed to also interact specifically with RNA (Lau et al., 2009).  
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Figure 1.8; Novel RBDs account for majority of RNA binding. RNA interactome capture discovers 
many RNA-binding proteins that lack identifiable RNA-binding domains. (taken from Beckmann et  al., 
2016; Open Source, used under the terms of the Creative Commons Attribution 4.0) 
To shed light on the possible new RNA-binding motifs or domains, a new 
method combining RNA interactome capture with differential (partial) protease 
digestion was developed. This method, named RBDmap (Castello et al., 2016), 
can define in a global scale the exact region with which the identified protein 
interacts with RNA. As in RNA interactome capture, RBPs crosslinked to 
polyadenylated RNA after UV irradiation are isolated using oligo(dT) beads. 
After elution, the RNA-protein complexes are treated with a protease that 
digests the proteins at positions that occur less frequently than thos for trypsin. 
The subsequent tryptic digestion step allowed, after a second round of oligo(dT) 
selection, the identification of the high-confidence RNA-binding region by MS 
measurements and bioinformatics analysis. RBDmap allowed the identification 
of 1174 high-confidence RNA binding sites in 529 RBPs, re-identifying classical 
RBDs but also discovering as RNA partners domains that have been previously 
known to be involved in other functions like enzymatic catalysis (e.g. 
thioredoxin, chaperones), involved in protein-protein interactions (e.g. 14-3-3), 
mediator of protein localization (cytoskeleton binding protein) or metabolic 
enzymes (e.g dinucleotide-binding, mononucleotide binding). Interestingly, half 
of the identified regions that interacted with RNA are disordered protein regions 
of intrinsically disordered proteins. Intrinsically disordered regions provide the 
highest flexibility to the interaction potential of a protein sequence allowing 
association with multitude of binding partners (Järvelin et al., 2016). These 
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regions are often of low amino acid complexity and specific amino acid 
combinations are readily identified, including the RGG-box. Previous NMR 
studies of FMR1 confirmed that the RGG boxes are important for the interaction 
with RNA (Phan et al., 2011). The arginines of RGG boxes can form 
electrostatic interactions with the RNA bases; the flexible glycine backbone 
allows spatial adaptation of to the polypeptide to the RNA shape.  
Intriguing among newly discovered RBPs is the presence of metabolic enzymes 
(Castello et al., 2015). These RNA-binding metabolic enzymes often share 
mononucleotide or dinucleotide binding domains, which were also confirmed by 
RBDmap to be the probable docking sites for the interaction with RNA. The 
previously proposed REM (RNA, enzyme, metabolite) hypothesis describes the 
existence of a functional link between metabolism and gene expression that is 
driven by a group of metabolic enzymes with capacity to bind RNA (Hentze & 
Preiss, 2010). A well-studied example of such a network is the already 
mentioned Aconitase/ Iron responsive protein 1 (IRP1) function, which loses its 
cofactor under iron-deficient conditions and switches its enzymatic activity to 
binding of specific hairpin structures, Iron responsive elements (IREs), in the 5’ 
or 3’ of mRNA encoding iron homeostasis factors (Hentze et al., 1987; Casey et 
al., 1988; Müllner & Kühn, 1988). It thereby controls the translation or stability of 
RNAs involved in iron metabolism. A more recent example is the role of 
Glyceraldehyde phosphate Dehydrogenase (GAPDH) during the metabolic 
switch to aerobic glycolysis in T cell activation (Chang et al., 2013) (Figure 1.9). 
In inactive T cells GAPDH represses Interferon γ (IFNγ) expression by binding 
to an AU rich element (ARE) in the 3′ UTR of the IFNγ mRNA. Following T cell 
activation and the switch to aerobic glycolysis, GAPDH fully engages in its 
metabolic role allowing expression of IFNγ mRNA. As metabolic enzymes are 
highly susceptible to metabolic changes resulting from different cellular or 
environmental changes, they represent an attractive choice to regulate gene 
expression under these conditions. The exact mechanisms by which metabolic 
enzymes can switch their activities from metabolism to RNA binding remain 
poorly understood. 
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Figure 1.9; A metabolic switch during T cell activation transforms the glycolytic enzyme GAPDH to 
a RBP. After T cell activation, oxidative phosphorylation (OXPHOS) is active and glycolysis disengaged. 
After disengaging of glycolysis, GAPDH binds to AU rich elements within the 3’UTR of IFN-y-mRNA and 
regulates its translation. (Redrawn and adapted with permission from Chang et al. 2013; license number 
3920181256777 provided by Copyright Clearance Center) 
Protein-RNA studies were mostly studied from a protein-centric perspective, 
assuming that binding affinity and specificity is promoted by the protein and the 
RNA acts as a passive entity in the interaction. As the RNA interactome studies 
revealed many high confidence RBPs without any known RBD, one can 
hypothesize that the RNA could also mediate the binding through 3D shape-
complementarity (Beckmann et al., 2016). Specific binding mediated by an RNA 
molecule is well established for RNA aptamers and viral internal ribosomal entry 
sites (IRESs) (Pelletier & Sonenberg, 1988; Jang et al., 1988; Hashem et al., 
2013). It is then possible that many RNAs evolved to specifically interact with a 
given protein. With increasing knowledge on RNA modifications coming from 
epitranscriptomics data (Saletore et al., 2012) one can speculate that 
posttranscriptional modifications on RNA also regulate protein-RNA 
interactions. One example for an epitranscriptomic switch was recently 
described for the interaction between HNRNPC and mRNA, where an N6-
Methyladenosine (m6A) modification increases the binding (Liu et al., 2015). 
In summary, the nature of most RNPs is highly dynamic and versatile. RBPs are 
therefore the key players of RNA fate through regulation of gene expression 
upon environmental cues, cellular stresses and signaling.  
Introduction 
 
32 
 
1.6.2 Studying the posttranscriptional networks of RBPs  
Protein centric methods to examine the interaction of a given protein with RNA 
are often based on protein immunoprecipitation. The RNAs associated with the 
protein of interest are then identified by sequencing or microarray analysis. RNA 
immunoprecipitation (RIP) (Steitz, 1989; Tenenbaum et al., 2002; Gilbert & 
Svejstrup, 2006) and cross-linking immunoprecipitation (CLIP) (Ule et al., 2003; 
Licatalosi et al., 2008) are the two fundamental protein-centric approaches 
extensively used in the RNA field (Figure 1.10). The difference between these 
techniques is the use of UV crosslinking step at 254 nm in the CLIP protocol or 
365 nm in the PAR-CLIP protocol (see below) to perform site specific 
crosslinking. UV crosslinking is analogous to the formaldehyde fixation step for 
the analysis of chromatin in the chromatin immunoprecipitation (CHIP) protocol 
(Orlando, 2000). UV light produces an irreversible cross-link of proteins 
interacting with RNA in “zero” distance (Pashev et al., 1991; Hafner et al., 
2010). UV crosslinking has the advantage to allow more stringent washes and 
thereby addresses possible issues with post-lysis associations of binding 
partners, which appears to be a major problem in RIP based approaches 
(Darnell, 2010). Stringent conditions in RIP still have to be mild enough to allow 
RNA-protein interactions to be maintained. RNA can be sticky and thereby one 
can get significant backgrounds in RIP experiments. The validation of noisy 
data can be challenging.  
In CLIP, downstream identification of the binding site can be achieved with 
single nucleotide resolution, whereas using RIP only a low resolution 
identification of the binding site can be made. Single nucleotide resolution 
identification was improved with the revised protocol of individual-nucleotide 
resolution CLIP (iCLIP) (König et al. 2010).  
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Figure 1.10; Comparison of immunoprecipitation based protein centric methods.  
Another protocol based on site specific crosslinking uses photoactivatable 
ribonucleotides like 4-thiouridine or 6-thioguanosine. These photoactivatable 
ribonucleotides (PAR) allow crosslinking at a wavelength of 365 nm, the 
corresponding method is called PAR-CLIP (Hafner et al., 2010; Figure 1.10). 
Enhanced CLIP (eCLIP) represents a recent improvement of iCLIP, which 
allows mid-throughput library generation through a highly optimized workflow. 
This allowed the generation of large initial datasets including 102 eCLIP 
experiments for 73 diverse RBPs in two human cell lines (van Nostrand et al., 
2016). The number of generated eCLIP datasets of RBPs is continuously 
growing. 
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1.6.3 RBP identification of specific RNA species 
For the specific enrichment of a transcript together with its protein binding 
partners different strategies have been developed. Current techniques involve 
the use of different affinity tags inserted into the target RNA or hybridization with 
antisense oligonucleotides. Tags can be biotin (Lamond et al., 1988; Srisawat & 
Engelke, 2001), aptamers (Bachler et al., 1999; Leppek & Stoecklin, 2013) or 
specific protein binding sequences (Youngman & Green, 2005). The biotin tag 
is widely used because of its high affinity to streptavidin (Kd = 10−14 M) (Green, 
1975) that is almost as stable as covalent linkage. As there are also biotinylated 
proteins in a cell, streptavidin-biotin based pull-down of protein complexes have 
the risk of trapping many contaminants (Wilchek & Bayer, 1988). Insertion of 
sequences (e.g. MS2 loops) in target RNAs has the disadvantage that the tag 
can alter the structural properties of the RNA affecting its lifecycle. An early 
approach used biotin tagged pre-mRNA immobilized via avidin to a solid 
support to pull-down proteins involved in splicing from HeLa cell nuclear 
extracts (Lamond et al., 1988).  
Bacteriophage-derived tethering systems like the interaction between the MS2 
motif with the MS2 coat protein (MCP) and the interaction between the boxB 
RNA element with the lambda N protein are often used for RNA pull-down 
experiments. Especially the MS2/MCP system was utilized for several 
purifications of RNP complexes (Das et al., 2000; Leonov et al., 2003). In MS2-
BioTRAP (Tsai et al., 2011) the MS2 system was also applied for the isolation 
of in vivo assembled RNPs. One disadvantage of RNA capture through 
tethering systems is the incompatibility with highly stringent denaturing and high 
salt conditions, which does not allow the removal of indirect binders. To limit 
contaminations due to resin interaction, tandem RNA affinity methods like TRAP 
(Krause & Simmonds, 2004) or RAT (Hogg & Collins, 2007) make use of two 
different tags on the RNA to remove unspecific contaminants that are 
interacting with the resin.  
Another possibility to target specific RNAs is the use of aptamers. Aptamers are 
highly structured RNA motifs that were designed and selected in vitro to bind 
specific proteins or molecules. One example is an aptamer that was modeled to 
bind streptomycin (Bachler et al., 1999) and was used to purify U1 snRNPs. 
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Another example is a streptavidin binding aptamer that was termed S1. S1 
enabled the purification of RNaseP associated RNPs. Later the S1 aptamer was 
further improved to have higher affinity than S1 or the MS2 and PP7 system 
(Leppek & Stoecklin, 2013). An advantage is that the aptamer can be directly 
immobilized on a resin during the pull-down protocol and no co-expression or in 
vitro expression of tagged protein is necessary.  
As already mentioned, the application of tags has its advantages to target 
specific RNAs, but the required modifications on the RNA structure or the usage 
of genetic engineering to express a tagged RNA in cells can produce biases in 
the analysis of the RNA interactome. Structural elements of the RNA that are 
involved in RNA-protein interactions might not form when the endogenous RNA 
structure is affected by the tag. In addition, the processing steps, intracellular 
localization and translation might be changed by the introduced tag. Therefore, 
also other approaches were developed to target the RNA of interest with its 
bound RBPs specifically. These approaches are based on CRISPR technology, 
or antisense oligonucleotide hybridization.  
With the discovery of the biological function and mechanism of the clustered 
interspaced short palindromic repeats (CRISPR) and CRISPR associated 
protein (CAS) in prokaryotic immunity, the research toolbox could be widely 
extended (Wright et al., 2016). For the RNA-pulldown the protein Cas9 is biotin 
tagged and a specially designed protospacer adjacent motif (PAM) present in 
oligonucleotides (PAMmers) is used to direct Cas9 to the RNA of interest. The 
complex can then be pulled down via the Biotin tag of Cas9 (O’Connell et al., 
2014). The drawback of this elegant pulldown strategy is its complexity, the 
incompatibility with highly stringent denaturing conditions (due to its dependent 
on folded Cas protein) and the dependence on genetic engineering. 
One early example of the use of antisense oligonucleotides is the isolation of 
snRNP complexes (Lamond et al., 1989) and the telomerase (Lingner & Cech, 
1996) with antisense oligonucleotides made of 2′-O-alkyl RNA. The alkylation 
makes RNA resistant to nucleases and enable it to form specific and stable 
hybrids with the target RNA. The hybridization of 2′-O-alkyl RNA 
oligonucleotides to the target RNA is more specific and stable than with DNA 
oligonucleotides. The coupling of biotin residues to the used oligonucleotides 
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enables affinity purification of the RNP complexes. Another example for an 
antisense oligonucleotide based protocol is the peptide nucleic acid (PNA) 
assisted identification of RBPs (PAIR) (Zielinski et al., 2006). PNAs enable the 
oligonucleotide to penetrate cell membranes of living cells and to hybridize to 
their targets. The PNA used in PAIR also contains the photoactivatable amino 
acid adduct p-benzophenylalanine. This adduct covalently crosslinks to proteins 
after exposure to UV light. The crosslinking has just an effect over a short 
distance (<4.5 Å), hence a large number of oligonucleotides has to be used for 
a comprehensive characterization of the binding partners. Another drawback is 
the fact that the protocol is dependent on two hybridization steps, one within the 
cell between the PNA and the target mRNA, one for the isolation between biotin 
tagged oligonucleotides and the target mRNA. Two sequential hybridization 
steps might limit the efficiency of the protocol. 
For the characterization of proteins bound to lncRNAs several labs established 
a protocol that uses a multitude of biotinylated DNA oligonucleotides hybridizing 
to the RNA of interest (referred to as “tiling approach”) (West et al., 2014; Chu 
et al., 2015; McHugh et al., 2015) (Figure 1.11). This protocol is exemplified by 
the recent determination of the Xist RNA-bound proteome by the methods 
named CHIRP-MS (Chromatin Isolation by RNA Purification) (Chu et al., 2015) 
and RAP-MS (RNA Antisense Purification) (McHugh et al., 2015). The 
advantage is that for the “tiling approach” RNA integrity is not crucial. 
Nevertheless, the disadvantage of using a broad number of oligonucleotides is 
that it is impossible to estimate the contribution to noise and signal of each 
individual probe. Moreover, it would be difficult to target distinct transcript 
isoforms or particular regions of the RNA of interest, since the probes cover the 
whole transcript. In addition, some of the “tiling approaches” make use of 
extensive formaldehyde crosslinking (West et al., 2014; Chu et al., 2015), which 
leads to the detection of many indirect interacting proteins. The high percentage 
of formaldehyde (3%) used in these approaches might even lead to a fixation of 
the whole cell.  
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Figure 1.11; Two recent „tiling approaches“ for specific RNP capture. (CHIRP MS from Chu et al. 
2015; RAP-MS from McHugh et al. 2015); Both methods make use a pool of biotinylated DNA probes 
complementary to the RNA of interest. RNA-protein interactions are preserved by UV crosslinking or 
fixation with formaldehyde. After hybridization, the complexes are captured with streptavidin beads that 
bind the biotinylated DNA probes. The proteins are finally released and analyzed via mass spectrometry. 
(Figure redrawn and adapted with permission (Roth & Diederich 2015); license number 3920181058057 
provided by Copyright Clearance Center) FA Xlink = Formaldehyde Crosslinking 
My PhD thesis project is based on the antisense hybridization strategy and 
involves UV crosslinking. The difference to other methods is the use of locked 
nucleic acids (LNAs) that allow stabilization of the oligonucleotide and also 
increases the hybridization efficiency by forcing the oligonucleotide in a 
hybridization friendly conformation (Kauppinen et al., 2005) (Figure 1.12) , even 
better than the already mentioned 2′-O-alkyl RNA oligonucleotides. The 
conformation of the furanose ring of DNA and RNA exists in equilibrium 
between two conformations, the C2′-endo and C3′-endo conformation. In 
contrast to DNA, RNA forms the most stable hybrids in the C3’endo 
conformation. The methylene bridge in the LNA molecule is locking the 
conformation of the furanose ring to an extreme C3′-endo conformation, thereby 
promotes the stable RNA-RNA hybrid formation. LNA oligonucleotides were 
used before for poly(A) RNA enrichment from guanidinium thiocyanate 
(Jacobsen et al., 2004) containing cell lysate and a kit for LNA poly(A) mRNA 
sample preparation is available from the supplier Exiqon. Another difference to 
the other protocols is the use of covalent linkage of the oligonucleotide to solid 
support, which allows stringent conditions and avoids contaminations by 
interaction with resin proteins as it is known for the biotin-streptavidin 
immobilization (Wilchek & Bayer, 1988). 
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Figure 1.12; Comparison between conformations of nucleotides. A) Conformations of furanose ring in 
RNA, DNA and LNA (pictures taken and modified from Elmen et al. 2014; Wahlestedt et al. 2000) B) Helix 
formations of RNA in C3’ endo (A-form helix) and DNA in C2’ endo (B-form helix) (picture taken and 
modified from Anosova et al. 2016; Open Source used under the terms of the Creative Commons 
Attribution 4.0) 
Several strategies to identify the proteins bound to the RNA of interest have 
been developed. The most important feature a method should have is to be 
specific, effective and robust. 
1.7 Aims of this Thesis 
RNA-binding proteins (RBPs) associate with RNA from synthesis to decay, 
forming dynamic ribonucleoprotein (RNP) complexes that enable regulation of 
diverse biological functions at multiple levels. The impact of RBPs on all 
components of the cell highlights the importance of studying the function, 
regulation and biology of RBPs. The knowledge about the number of existing 
RBPs has expanded substantially thanks to RNA interactome capture (Baltz et 
al., 2012; Castello et al., 2012), which provided new insights about the 
biological scope of RBPs and the interconnection of RBPs with different cellular 
networks. The method employs UV crosslinking that creates a covalent bond 
between RNA and protein in vivo, a stringent oligo(dT) capture protocol and 
mass spectrometry. The RNA interactome studies revealed both known and 
novel RBPs bound to polyadenylated RNA pool, but cannot be applied to 
defined RNA species or to RNAs lacking poly(A) tails. Currently, identification of 
RBPs associated with specific transcripts is a challenging task; and the 
available strategies to purify specific transcripts and their bound proteome are 
faced with numerous limitations. Thus, new methods to determine the 
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composition of proteins on a given RNA are required to further understand the 
regulation and biological function of the RNA and its associated RBPs 
 
Aim 1: Development of a method for the capture of a specific RNA 
transcript and its bound proteome.  
The aim of my thesis was to develop a method to isolate a specific RNA 
transcript and its bound proteome guided by technical knowledge from the 
established RNA interactome capture protocol. We refer to this protocol as 
“specific RNP capture”. This approach should aim to be highly specific and still 
give a reasonable yield, features achieved through the use of UV protein-RNA 
crosslinking followed by isolation with short LNA (locked nucleic acid)/DNA 
antisense probes. As the probes are covalently linked to beads and proteins are 
covalently bound to the target RNA, the stringency of the washes can reach 
denaturing conditions. These features combined with different specificity 
controls (i.e. non-irradiated samples and scramble LNA probes) allow high 
confidence identification of RBPs with Specific RNP capture. The set-up of 
specific RNP capture should enable RBP purification both in in vitro systems 
and in cell applications, making specific RNP capture a versatile tool for RNA 
biology research.  
 
Aim 2: Validation of the method with a well-established protein-RNA pair 
system as positive control. 
Using the well-characterized RBP-mRNA interaction, Sxl-msl2 mRNA, I aimed 
to validate specific RNP capture in HeLa extracts supplemented with 
recombinant Sxl protein and programmed with an ectopic reporter mRNA 
bearing the sequences from msl2 known to be recognized by this protein. I 
tested the protocol further in D. melanogaster embryo extracts without 
supplementation of exogenous proteins and combined it with quantitative mass 
spectrometry to allow unbiased identification of proteins interacting with the 
defined sequences in the reporter RNAs. 
 
Aim 3: Characterization of 18S and 28S RNPs  
Once specific RNP capture was established in in vitro systems, I aimed to 
challenge it to capture endogenous RBPs. I chose 18S and 28S rRNA as both a 
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proof-of-principle and biologically relevant target because these transcripts are 
highly abundant, there are equally abundant “contaminants” and there is 
incomplete knowledge of rRNA biogenesis, especially in humans. Cross-
referencing of the identified proteins to recent ribosomal biogenesis screens 
(Wild et al., 2010; Tafforeau et al., 2013; Badertscher et al., 2015) and ribosome 
related literature gave further confidence in the identified proteins. It also 
allowed me to identify potential novel proteins involved in rRNA biology. This 
aim should therefore provide new insights into proteins involved in rRNA 
biology, and provide an example of specific RNP capture as new tool for RNA 
biology. 
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2 Results and Discussion 
2.1 Specific RNP capture: concept and experimental strategy 
Figure 2.1; Workflow for the set up and experiments of specific RNP capture. 
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For setting up the protocol for specific RNP capture I followed strategic steps 
required to maximize the specificity and stringency of the protocol (Figure 2.1). 
After the general set-up steps, my workfkow is branching in in vitro and in-cell 
Specific RNP capture experiments. The protocol is built on the principles of 
RNA interactome capture (Castello et al., 2012; Castello et al., 2013), which 
makes use of ultraviolet (UV) irradiation of living cells to covalently cross-link 
native RBPs to RNA. Proteins covalently bound to polyadenylated RNA are 
captured by hybridization of the poly(A) tail with oligo(dT) magnetic beads, 
replacing the oligo(dT) beads of the interactome capture protocol. After 
stringent washes to remove indirect binders, the RBPs are detected by 
quantitative MS. To capture specific RNAs, I modified the current protocol by 
implementing the use of specific target antisense oligonucleotides covalently 
coupled to beads. I performed covalent coupling of the oligonucleotide probes 
to the magnetic beads to allow the use of high stringent washes that cannot be 
withstood by non-covalent protein-substrate interactions. For the set-up of 
specific RNP capture I first had to establish the protocol to covalent couple the 
probes to the beads. Next, I designed oligonucleotide probes composed of a 
mix of LNA and DNA nucleotides (LNA/DNA mixmers) and determined the 
optimal hybridization temperature. Titration experiments helped me to identify 
the optimal UV irradiation energy and the amount of input RNA needed to 
detect the RNA bound proteins by Specific RNP capture. Finally, I applied the 
resulting protocol to an in vitro system, using the well-established sex lethal-
msl2 system, and to an in-cells set up to better understand the composition of 
18S and 28S ribosomal RNPs.  
2.2 Covalent coupling of oligonucleotide probes to magnetic 
beads 
I first examined different strategies for covalent coupling of oligonucleotides to 
magnetic beads. As I was interested in a quantitative and simple readout, I 
established a test system that is based on dual fluorescence measurement on a 
plate reader (Figure 2.2). For coupling, I used 20mer DNA oligonucleotides that 
carried a fluorescent Cyanine 5 (Cy5) label at the 5’end and a primary amine 
with a C6 carbon linker at the 3’end. The carbon linker should allow flexibility for 
efficient hybridization. I tested two different coupling strategies (i.e. coupling to 
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epoxy residues or carboxy residues) and different coupling temperatures. After 
coupling, I used an antisense DNA oligonucleotide carrying a Cyanine 3 (Cy3) 
label at its 3’end to test the hybridization capacity of the probe-coated beads. 
Cy3 and Cy5 have distinct excitation and emission wavelengths from one 
another and can be therefore used together in a dual fluorescent screen. The 
testing conditions were chosen according to suggestions of different bead 
suppliers and knowledge of the chemical reaction conditions of the coupling 
groups. I ensured by the choice of the buffer system and the pH that a reaction 
targeting a primary amine is favored, in order to prevent coupling to exocyclic 
amines of the nucleotide bases. 
 
Figure 2.2; Dual Fluorescence Assay. The assay was established to monitor covalent coupling 
efficiencies and downstream hybridization efficiencies on the same beads. The oligonucleotide that should 
be coupled to the beads carries a 3’ Amino-modifier (includes a primary amine and a flexible carbon C6 
linker) and at its 5’ a fluorescent Cyanine dye (Cy5). The hybridization oligonucleotide is antisense to the 
coupling oligonucleotide and contains a 3’ fluorescent Cyanine dye (Cy3). Two coupling strategies were 
tested, coupling to carboxylic or to epoxy groups. Coupling to carboxylic groups needs the auxiliary 
activating agent N-(3-Dimethylaminopropyl)-N′-ethylcarbodiimide hydrochloride (EDC). 
Comparing the Cy5 fluorescence signal, I observed that the carboxy-beads 
exhibited higher coupling efficiency, the most efficient coupling reaction being 
achieved at 50°C (Figure 2.3 A). For the epoxy-beads, increase of temperature 
improved coupling efficiency but it did not reach the level of coupling of carboxy-
beads. Subsequently, I tested the coupled beads for hybridization efficiency at 
4°C using the in series the buffers employed in the RNA interactome capture 
protocol. The highest amount of antisense DNA captured, measured as Cy3 
fluorescence signal, was achieved with carboxy-beads coupled with the probe 
for 2 h at 50°C (Figure 2.3 B). 
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Figure 2.3; Coupling and Hybridization efficiency of carboxy- and epoxy-beads monitored by dual 
fluorescence assay. Amount of coupled or hybridized oligonucleotide was calculated from a standard. A) 
Coupling efficiency of dA20 with 3’ Aminomodifier and Cyanine dye Cy5 at the 5’end; B) Hybridization 
efficiency of dT20 with Cyanine dye Cy3 at the 3’end. n=3 replicates; error bar = standard deviation 
To ensure that the different base composition of the oligonucleotide does not 
change the coupling efficiency to the beads, I also tested the DNA sequences 
used later to target the Renilla luciferase (Rluc) open reading frame (ORF) 
(named LNA1, LNA2) and the scrambled control (LNAscr) for coupling 
efficiency to carboxy-beads for 2 h and 5 h at 50°C. All probes showed efficient 
hybridization with their target sequences at 4°C, while they fail to do so with 
non-complementary sequences (Figure 2.4). 
 
Figure 2.4; Hybridization efficiencies with different LNA probes. Amount of hybridized probe was 
calculated from a concentration curve of Cy5-labeled target oligo nucleotide. A) Hybridization efficiency of 
LNA1 and LNAscr with their antisense target sequence; B) Hybridization efficiency of LNA1 and LNAscr 
with non-complementary sequences; n=3 replicates; error bar represents standard deviation. 
2.3 Design of the LNA/DNA mixmer antisense probes 
I decided to use a mixture of LNA and DNA nucleotides for a probe of a total 
length of ~20-22 nucleotides. In the LNA nucleosides the ribose ring is “locked” 
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by a methylene bridge that connects the 2’O-atom and the 4’-C atom. This 
bridge forces the conformation equilibrium to an ideal Watson-Crick base 
pairing conformation. The LNA forms therefore more stable hybrids than RNA or 
DNA oligonucleotides. For the placement of the LNA nucleotides with respect to 
the “normal” deoxynucleotides, I followed general design guidelines described 
in Figure 2.5. 
 
Figure 2.5; Design guidelines for LNA/DNA mixmer oligonucleotide probes. (Tm:melting temperature) 
Target selection: The seed sequence of the probe on the RNA is selected 
avoiding sequences present in other transcripts. In the case of few nucleotides 
exhibiting complementarity with a non-target RNA, I avoided insertion of LNA at 
these positions. In addition, probes were designed to hybridize to regions 
lacking stable secondary structures, determined with mfold (Zuker, 2003), a 
RNA folding prediction software, or published structural data. 
Melting Temperature: By incorporating LNA into the oligonucleotide, the 
melting temperature of the hybrid is increased. Every LNA monomer introduced 
in the probe can increase the melting temperature from 2 to10°C (Wahlestedt et 
al., 2000). The increased melting temperature will promote selective 
hybridization with probes as short as 20 nucleotides. All the probes were 
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designed to result in a melting temperature of ~80°C (determined by Exiqon Tm 
prediction tool; https://www.exiqon.com/rna-tm). 
Stability: Introducing LNA also enables stabilization of the probe against 
nucleases. To prevent RNaseH mediated cleavage of DNA/RNA hybrids I 
ensured to have less than 6 DNA oligonucleotides in a row. A length of 6 or 
more DNA/RNA hybrids is sufficient for RNaseH cleavage (Kauppinen et al., 
2005) as this principle is exploited for the specific degradation of RNA targets 
using LNA Gapmers (Exiqon). I introduced around 6 LNA monomers within a 
probe of 20 nucleotides.  
Positioning: The LNA was positioned at approximately every third position. As 
the LNA monomer forces also the neighboring nucleotides to adopt the optimal 
conformation for base pairing, this design allowed the maximal hybridization 
competence with the LNA used. Mixing the LNA with DNA nucleotides prevents 
increased stickiness and excessive rigidity that will result from an 
oligonucleotide with (too) high LNA content. LNA should not be positioned at the 
very end to allow better flexibility for hybridization. In addition, GC rich spots 
should be avoided as these might increase secondary structure or duplex 
formations of the oligonucleotide.  
Coupling tag: To allow covalent coupling, I introduced in the designed probe a 
3’ amino-modifier which carries a primary amine and flexible C6 linker.  
With these principles in mind, I first designed LNA/DNA probes targeting the 
Rluc ORF and, later, targeting human 18S and 28S rRNA. 
2.4 Optimization of hybridization temperatures 
Next, I determined the optimal hybridization temperature for the RLuc-targeting 
probes (LNA1, LNA2) using the buffer conditions employed in specific RNP 
capture. I included the scrambled control (LNAscr) in order to see if the 
experimental noise can be reduced by modulating the hybridization 
temperature. For this experiment I made use of a cell free system, in which I 
could easily test several conditions in replicates. I incubated HeLa 
translationally competent cytoplasmic extracts (Cilbiotech) with in vitro 
transcribed RLuc and control Firefly Luciferase (Fluc) mRNAs in equimolar 
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amounts, adjusted the buffer compositions of specific RNP capture to maximize 
hybridization and then performed specific RNP capture with the LNA coupled 
beads. With this set-up I tested a hybridization temperature range for the LNA 
probes from 40°C - 52.2°C. After pull down, I analyzed RNA purity and relative 
amounts by RT-qPCR. Beside the target Rluc mRNA, I quantified the specificity 
control Fluc and the endogenous 18S rRNA. Rluc was strongly enriched in 
eluates of LNA1 and LNA2 probes, although LNA1 showed the best 
performance, especially when the hybridization was performed at 41°C (Figure 
2.6 A/B). Notably, the efficiency of target RNA capture was not improved by 
mixing the two oligonucleotide probes (LNA1, LNA2) (Figure 2.6 C). RNA traces 
derived from LNAscr pulldown resemble the background off-target hybridization 
of LNA1; LNAscr represents therefore an excellent negative control (Figure 2.6 
D) with no specific enrichments (Figure 2.6 E). LNA1 reached the best 
enrichment of Rluc over the Fluc control of almost 200 fold at 41°C in the test 
set-up (Figure 2.6 E) and I thus chose LNA1 for the further experiments.  
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Figure 2.6; Hybridization efficiency and specificity test of LNA probes coupled to beads. Different 
hybridization temperatures were tested in a gradient PCR machine. LNA1 and LNA2 were designed to 
target Rluc RNA and LNAscr was used as control. After stringent washes and elution, RNA was analyzed 
by RT-qPCR. 18S rRNA, Fluc RNA and RLuc RNA were quantified in relation to the Input RNA in %. Error 
bars represent standard deviation of three experiments. (A) Hybridization of LNA1; (B) Hybridization with 
LNA2; (C) Hybridization with a mixture of LNA1 and LNA2 D) Hybridization with the control LNAscr. (E) 
Enrichment of Rluc target RNA over the equimolar added Fluc control for the different applied LNA probes;  
Covalent coupling allows re-use of the beads in several rounds of pull-down, 
since the probe remains attached throughout the whole protocol. I therefore 
used the hybridization temperature test set-up to monitor the performance of the 
beads upon recycling the beads for several rounds of pull-down. After adding 
fresh sample after each round, I observed comparable performance of the 
beads over three rounds of pull-down (Figure 2.7). 
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Figure 2.7; Bead recovery test. Beads with probes targeting Rluc (LNA1) were used twice after the first 
capture. After stringent washes and elution, RNA was analyzed by RT-qPCR. 18S rRNA, Fluc RNA RLuc 
RNA and GAPDH RNA were quantified in relation to the Input RNA in %. Error bars represent standard 
deviation of three experiments. 
 
2.5 Titration experiments to optimize specific RNP capture 
I next performed titration experiments in order to identify the optimal conditions 
that allow co-purification of proteins bound to the target RNA. I first optimized 
the energy of ultraviolet (UV) light at 254 nm required for efficient crosslinking in 
cell extract. I applied conventional crosslinking (cCl) at 254 nm together with a 
non-crosslinking (NocCl) control in order to visualize proteins directly bound to 
the enriched mRNA after RNA interactome capture. The used cell extract 
cannot be plated akin to a thin monolayer of cells, therefore the UV light 
penetrance and crosslinking efficiency is different. I observed that UV light 
energies above the previously used dose of 150 mJ/cm2 (Castello et al., 2012) 
increase crosslinking efficiency in HeLa cytoplasmic extracts (Figure 2.8 A). 
However, RNA integrity is compromised as the UV radiation energy increases 
(Figure 2.8 B and C. 300 mJ/cm2 of UV light appears as the optimal dose, 
because it induces efficient crosslinking with the minimal effect on RNA 
integrity.  
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Figure 2.8; Titration of the UV dose required for efficient crosslinking. (A) HeLa cytoplasmic extracts 
were crosslinked at 254nm using different UV energies. Proteins crosslinked to oligodT-captured RNA 
were visualized via Silver Staining. (B) RNA integrity upon irradiation with different UV energies; HeLa 
cytoplasmic extracts were UV irradiated with different energy doses. RNA integrity was tested by analyzing 
the eluted RNA after oligodT capture by RT-qPCR. Quantified RNAs were displayed relative to the 
respective Input RNA. (C) as B with extended UV crosslinking energy doses. 
Subsequently, I determined the minimal amount of RNA required to detect co-
purified RBPs in HeLa cell extract and from living HeLa cells, using RNA 
interactome capture followed by Silver Staining. After UV irradiation (300 
mJ/cm2) the minimal amount of RNA required to obtain a detectable protein 
pattern on a silver stained gel was 65 µg of total poly(A)+ RNA in HeLa extracts 
(Figure 2.9 A). No proteins were detected when lower amounts of RNA were 
used. In contrast, a complex protein pattern was already detectable after 
purification of 2-20 µg of total poly(A)+ RNA from living HeLa cells, reflecting a 
higher UV crosslinking efficiency (Figure 2.9 B). To gain insight into the 
detection limits of MS in these samples, proteins purified after applying RNA 
interactome capture to HeLa cells showed that the number of peptide 
identifications using 0.5 µg RNA was similar to background detection of 
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peptides from RNA in non-irradiated control cells (Figure 2.9 C). A larger 
number of peptides was identified with 2 µg of RNA from UV-irradiated cells 
(~300 peptides), implying that this is a more suitable amount of material to 
obtain a comprehensive RNA interactome of specific RNA species.  
 
Figure 2.9; Titration of the RNA amount required for detection of RBPs. (A) HeLa cytoplasmic 
extracts were crosslinked at 254 nm under the chosen energy of 300 mJ/cm2. Different amounts of RNA 
eluted from RNA interactome capture applied to HeLa extracts was processed for protein analysis and 
visualized via Silver Staining. (B-C) HeLa cells were crosslinked at 254 nm with 150 mJ/cm2 in vivo. The 
amount of eluate after oligo(dT) capture was processed for protein analysis and visualized via Silver 
Staining; (B) and Mass spectrometry (C). For the NocCl negative control eluate from 14 µg captured RNA 
was loaded; NocCl = non crosslinked control; cCl = crosslinked sample (conventional crosslinking 
performed). Mass spectrometry analysis was performed by Christian Frese. 
Taken together, these results suggest that UV irradiation of cell lysates in vitro 
is less efficient than on cell monolayers and that at a lower limit of 
approximately 2µg of isolated RNA is expected to be required for specific RNP 
capture from HeLa cells.  
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2.6 Specific RNP capture “rediscovers” Sxl as binding partner 
of msl-2 mRNA 
Figure 2.10; Scheme of specific RNP capture in 
vitro with recombinant Sxl protein. HeLa 
translational active extracts are incubated and UV 
crosslinked with recombinant GST tagged Sxl 
protein and Rluc reporter RNAs harbouring Sxl 
binding sites (wt) or harbouring the mutated sites. 
Specific RNP capture was performed with LNA1 
targeting the Rluc ORF and LNAscr control. 
 
 
 
 
 
 
 
 
 
 
 
To get further insights into the performance of specific RNP capture, I 
performed in vitro pull-down experiments in a well-defined system derived from 
Drosophila, the interaction between the protein Sex lethal (Sxl) and poly(U) 
stretches of male specific lethal-2 (msl-2) RNA. I introduced the well-
characterized Sxl target sequences upstream and downstream of the Rluc 
reporter ORF following the binding site architecture of the endogenous msl-2 
mRNA (scheme in Figure 2.10; Gebauer et al., 2003). This construct harbors 
two motifs of 7 nucleotide long U stretches in the 3’UTR, referred to as E and F 
site. Furthermore, a 16 nucleotide long U stretch is present in the 5’UTR of this 
RNA, which is called B site. A mutant version of these sites known to prevent 
Sxl-binding was generated by mutating every second U to a C in all binding 
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sites of E, F and B (Gebauer et al., 2003). Considering the previous analyses, I 
used 65 µg (200 pmol) of each of wild-type (wt) and mutant (mut) reporter 
mRNA in order to detect bound proteins by silver staining and western blot 
analysis. I added four times molar excess of the recombinant Sxl (dRBD4)-GST 
protein to the mixture and started in vitro translational reactions with either the 
wt or the mut reporter RNA in HeLa cytoplasmic extracts. Afterwards the 
extracts were irradiated with 300 mJ/cm2 of UV light (254 nm) and specific RNP 
capture was performed with a probe targeting the Rluc ORF (LNA1) or with a 
control probe (LNAscr). 
Notably, silver staining and western blotting analyses revealed that the Rluc-
specific LNA1 probe successfully enriched the GST-tagged Sxl from HeLa 
extracts only when the wt reporter mRNA was used (Figure 2.11 A/B). In 
contrast, the LNAscr control failed to isolate Sxl, highlighting the selectivity of 
the LNA/DNA mixmer probes. Moreover, mutations that abrogate Sxl-binding to 
the reporter also prevented purification of the exogenous protein using LNA1 
probe. Notably, I observed Sxl binding to endogenous mRNAs in both wt and 
mut mRNA supplemented extracts when the complete poly(A)+ RNA pool was 
purified with oligo (dT). These results reflect that other mRNAs present in the 
extract do bear analogous U-rich sequences to those present in the reporter 
and can effectively be bound by Sxl. Moreover, these results demonstrate that 
the exogenously added Sxl is active in both loaded samples with wt or mut 
mRNAs. Thus, the lack of binding of Sxl to mut mRNA in pulldowns with LNA1 
cannot be explained by a dysfunction of the protein. Taken together these 
results, I can conclude that Sxl 1) binds to the wt reporter mRNA; 2) does not 
bind the exogenous RLuc mRNA when mutations are introduced in its binding 
site and 3) Sxl can interact with other mRNAs within the extract. Therefore, 
Specific RNP capture successfully recapitulated data generated in the past by 
orthogonal approaches. 
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Figure 2.11; Capture of recombinant Sxl bound to the reporter RNA in HeLa cell extracts. (A) 
Proteins were separated on a SDS-PAGE and detected via Silver Staining. The recombinant protein (Sxl-
GST) was loaded on the gel as a running control. (B) Western Blot result confirmed the silver staining 
results with regard to Sex lethal specific pull-down via the wt reporter RNA with the specific LNA1. The 
contaminant Tubulin could not be detected in either of the pull-downs.(C) RNA analysis of the specific 
pulldowns with LNAs. The quantified RNAs are displayed relative to the Input used for the specific 
pulldown protocol. The pulldown levels of the wt and mut reporter are specific and comparable. 
2.7 Identification of proteins bound to an in vitro transcribed 
mRNA in Drosophila embryo extracts 
To follow up the encouraging results for specific RNP capture with exogenously 
added protein and mRNA, I wanted to determine if specific RNP capture can be 
applied to endogenous proteins using D. melanogaster embryo extracts 
supplemented with the previously used reporter mRNA. This time, I combined 
specific RNP capture with quantitative mass spectrometry to identify the 
proteins bound to the RNA of interest (Figure 2.12). By using dimethyl labelling, 
three samples were labelled 1) pulldown of wt or 2) mut RLuc mRNA captured 
with LNA1 and the 3) control pulldown using wt mRNA and LNAscr probe. The 
labeling was coupled to a recently developed protocol for efficient sample 
preparation when protein material is low, called Single-Pot Solid-Phase-
enhanced Sample Preparation (SP3) (Hughes et al., 2014). Comparison of 
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LNA1 vs LNAscr is applied to determine the proteins that bind to the RLuc 
mRNA irrespectively of Sxl binding sites, while comparison between LNA1 
targeted wt reporter RNA and LNA1 targeted mut reporter RNA will serve to 
identify the alterations in the RNP promoted by the presence of Sxl binding 
sites. I performed specific RNP capture for these set-ups in four replicates for 
stringent statistically evaluation of the data. 
Figure 2.12; Scheme of specific RNP capture in vitro. 
Translational active Drosophila embryo extracts are incubated 
and UV crosslinked with Rluc reporter RNAs harbouring Sxl 
binding sites (wt) or harbouring the mutated sites. Specific 
RNP capture was performed with LNA1 targeting the Rluc 
ORF and LNAscr control. After RNase treatment proteins are 
analyzed via quantitiative mass spectrometry, that allows the 
comparison of 3 labels. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
LNA1 isolated both wt and mut Rluc mRNAs to a similar extent (Figure 2.13 A). 
As in the previous experiment, the LNAscr control was not enriching specifically 
for any RNA and resembled the background capture of RNA performed by 
LNA1.  
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Proteomic analysis revealed that capture with LNA1 yields a notable enrichment 
of peptides over LNAscr (Figure 2.13 B; Figure S 7.1). These results show that 
peptide purification relies on the capture of the RLuc mRNA. I can therefore 
conclude that the purification of proteins is not due to unspecific binding of 
proteins to the bead surface or to the LNA itself. 163 proteins could be identified 
via specific RNP capture, 109 of them could be quantified in wt/mut samples 
(Table S 7.1). However, I only observed minor differences between the wt and 
the mut reporter using LNA1 for specific pull-down (Figure 2.13 C). These 
alterations very well reflect the small differences in primary sequence between 
the wt and the mut reporter mRNAs. Strikingly, specific enrichment of sister of 
sex lethal (Ssx), Heterogeneous nuclear ribonucleoprotein at 98DE (Hrb98DE, 
Hrp38) and Heterogeneous nuclear ribonucleoprotein at 87F (Hrb87F, Hrp36) in 
the wt over the mut samples was reproducibly observed. Unexpectedly, Ssx but 
not its paralog Sxl, which was previously described to bind the U-rich 
sequences introduced in the reporter RNA, was identified as specific binder of 
the wt mRNA. This protein has high homology with Sxl, but its RNA-binding 
activity was only recently reported in the RNA interactome capture studies 
performed in D. melanogaster embryos (Wessels et al., 2016; Sysoev et al., 
2016). The identity score between these two proteins is especially high across 
the two RNA recognition motifs (RRMs) as well as in the glycine rich region in 
the N-terminus (Figure S 7.2). Supporting the idea of Ssx RNA binding activity, I 
purified Ssx bound to poly(A) RNA by RNA interactome capture followed by 
Western blot (Figure 2.13 D). Taken together, these results show that Ssx is an 
RBP that displays similar specificity for U-rich sequences as its paralog Sxl. 
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Figure 2.13; Specific RNP capture from Drosophila embryo extract. Mass spectrometry 
measurements were performed by the EMBL proteomics core facility (A) RNA analysis of the specific 
pulldowns with LNAs. The quantified RNAs are displayed relative to the Input used for the specific 
pulldown protocol. The pulldown levels of the wt and mut reporter are specific and comparable. The error 
bars represent standard deviation coming from four biological replicates (B) Vulcano plot comparing the 
enrichments in the wt sample over the scramble sample in 4 biological replicates. The axes display the 
log2-fold changes (orange: 5% FDR, red: 1% FDR). Statistical analysis and plot was created by Bernd 
Fischer (C) Vulcano plot comparing the enrichments in the wt sample over the mut sample in 4 biological 
replicates. The axes display the log2-fold changes (orange: 5% FDR, red: 1% FDR). Statistical analysis 
and plot was created by Bernd Fischer (D) Western Blot with antibodies raised against Sister of Sex lethal 
(Ssx),Tubulin and PABP after oligodT capture of crosslinked Drosophila embryo extract. Ssx was strongly 
enriched in the crosslinked eluate, the negative control Tubulin was not detected in the eluates. 
Sxl and UNR (normally co-recruited by Sxl to perform translational repression) 
could not be detected in MS and were therefore also not enriched in the wt 
sample, as expected. In order to understand the absence of Sxl and UNR in the 
specific RNP interactome, the EMBL proteomics core facility analyzed the 
whole proteome of the embryo extracts for this study. While Ssx was identified 
with a medium intensity score, Sxl and UNR were not detected. I can therefore 
conclude that Sxl and UNR are present at very low concentrations in the 
embryo extracts used in this work and is, most probably, outcompeted by its 
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ubiquitously expressed paralog Ssx. This can be due to the use of male/female 
mixed extracts or the developmental stage of the embryos that were collected.  
Hrb87F and Hrb98DE are splicing factors with high homology between them in 
both sequence and structure (Haynes et al., 1991; Blanchette et al., 2009). 
They were enriched from wt RLuc reporter over its mutant version. Sxl 
molecules can interact with Hrb87F, most likely through a common glycine-rich 
region, and increases the affinity of Hrb87F for U-rich sequences (Wang et al., 
1997). Ssx shares the N-terminal glycine rich track with Sxl, suggesting that Ssx 
can also recruit Hrb87F. These results imply some degree of functional 
redundancy between the two paralogs. The biological role of Ssx is not well 
understood, its similarity to Sxl suggests an involvement in translational or 
splicing regulation. As my results suggest that both proteins recognize similar 
RNA signatures, it will be of interest to determine if both proteins bind the same 
mRNA targets. This is especially important since Sxl plays an essential function 
in sex determination and dosage compensation, whereas there is no evidence 
that its partially redundant paralog Ssx does. 
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2.8 Identification of proteins bound to human 18S and 28S 
rRNA 
 
Figure 2.14; Scheme of specific RNP capture of 18S rRNA from HeLa cells. HeLa cell are UV 
irradiated in vivo, followed by lysis and short heat treatment at 60°C to unfold the RNA. Ethylenecarbonate 
is added as hybridization enhancer. Specific RNP capture is performed with LNA/DNA mixmer probes 
targeting 18S rRNA (18S LNA) in crosslinked and non crosslinked sample. Another control is the capture 
with the control probe (LNAscr) in the crosslinked sample. After elution, RNA composition is analysed 
using bioanalyzer. After Benzonase digestion and alkaline Hydrolysis, released proteins are analyzed via 
quantitative Mass spectrometry using dymethyl labeling labels. NocCl= non crosslinked control; cCl= 
crosslinked sample (conventional crsllinking performed) 
 
2.8.1 Protocol adjustment of specific RNP capture protocol for the rRNA 
interactome 
To finally extend this method to in-cell applications, I performed specific RNP 
capture for human 18S and 28S rRNA (exemplified on 18S rRNA in Figure 
2.14). I targeted regions of the ribosomal RNA that were predicted to exhibit a 
minimal degree of secondary structure. As these probes hybridize specifically to 
the expansion segment ES6S in 18S rRNA and ES27L in 28S rRNA, it will be 
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possible to adapt Specific RNP capture to study these expansion segments in 
more detail.  
As dimethyllabeling allows the use of three labels, I could include two controls 
to the capture of the ribosomal RNP: i) a non-crosslinked sample with the same 
ribosomal targeting probe that should be devoid of proteins, and ii) a LNAscr 
probe applied to a crosslinked sample that should not enrich for ribosomal RNA. 
By including these two controls, results are corrected against both purification of 
non-covalently bound proteins and the signature of unspecific RNA capture, 
which increases data quality.  
I had to adjust the initial protocol to the pull-down of ribosomal RNAs. As the 
ribosomal RNAs are highly structured, I tested the chemical ethylenecarbonate 
that was used previously in in situ hybridizations as a non-toxic substitute for 
formamide (Matthiesen & Hansen, 2012). This compound allows faster probe-
RNA hybridization by lowering the melting temperature of the target RNA and 
thereby helps to remove RNA structures. Addition of 15% ethylenecarbonate to 
the lysate increased the hybridization efficiency for ribosomal RNA (Figure S 7.3 
A) and the structured Drosophila mRNA oskar (Figure S 7.3 B). Previous 
experiments showed that the standard RNase digestion before MS analysis was 
inefficient in the case of rRNA due to its high and stable secondary structure. 
Unprocessed rRNA caused precipitation, which produced technical dysfunction 
of the mass spectrometer by blocking the capillary/column. To circumvent this 
problem, I added to the RNase digestion a step of alkaline hydrolysis, which 
enabled efficient processing of the rRNA. The scale of the experiment was 
another adjustment that was required for the ribosomal RNA interactome 
capture. Based on previous tests (Figure 2.9 B), I captured around 2 µg RNA in 
the first experiments; however, the number of identified proteins by mass 
spectrometry was low. Therefore, I scaled-up the experiment accordingly to 
capture an amount of 4-9 µg of RNA from the crosslinked samples.  
2.8.2 Specific enrichment of 18S and 28S rRNAs. 
With the designed LNA/DNA mixmer probes, I achieved specific enrichments of 
both the 18S and 28S rRNA in a selective way. Bioanalyzer traces of the RNA 
revealed an enrichment of the rRNA matching the used probe and depletion of 
the respective other rRNAs (Figure 2.15). The LNAscr control defined the 
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background signal that was similar to the background detected for the rRNA 
pull-downs using specific probes. Nevertheless, the capture of rRNA is not very 
efficicent (1-5% of the total) with the LNA/DNA mixmer probes (Figure S 7.4). A 
possible explanation is unexpectedly strong secondary structure formation or 
the induction of RNA-RNA crosslinks that may affect hybridization with the 
probe.  
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Figure 2.15 RNA analysis after specific RNP capture of 28S rRNA and 18S rRNA. (A) 
Electropherograms of RNAs coming from Bioanalyzer measurements from one representative 28S rRNP 
capture replicate; After UV crosslinking (Ccl) or non-crosslinking (NocCl) of Hela cells the specific RNA 
capture protocol was performed with oligonucleotides targeting 28S or with scrambled probe as control. 
Released RNAs were analyzed using a 6000 Pico bioanalyzer. The 2 peaks from the Input samples 
represent 18S (runs at 2000 nt) and 28S (runs at 4000 nt) rRNAs. The y-axes display the fluorescence 
intensity coming from a dye labeling the RNA quantitatively. (B) Electropherograms of RNAs from one 
representative 18S rRNP capture replicate (as A). 
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2.8.3 Protein identification in the rRNA interactomes. 
In the quantitative mass spectrometry measurements a reproducible strong 
enrichment of proteins on the experimental over the controls could be observed. 
The fact that most proteins could only be detected in the crosslinked specific 
capture sample, did not allow an analysis that is limited on ratio formation to the 
controls. Therefore, a semi-quantitative method was implemented that 
considers the presence or lack of peptide intensity signal for each label across 
biological replicates. When the MS signal was too low to assign a protein to a 
specific label, the protein could not be included into the analysis. A stringent 
cut-off was chosen; all genes were counted that were quantified in at least two 
more cCL samples than in control samples. Although only a limited amount of 
proteins could be detected, the data could show the expected enrichments for 
ribosomal proteins in the 18S (Table 2.1) and 28S (Table 2) rRNA interactomes. 
Moreover, the 18S and 28S rRNA interactomes display the expected 
differences regarding the known interaction of each rRNA with the protein 
components of the large and small ribosomal subunit. Most identified proteins 
were either part of the cytoplasmic ribosome, were associated with ribosomal 
function or involved in ribosomal biogenesis. Interestingly, many heterogenous 
ribonucleoproteins (HNRNPs) were identified in both data sets, suggesting a 
role of these proteins in the biogenesis of ribosomal RNA. When considering 
proteins enriched only in one replicate (low confidence binders) the amount of 
HNRNP proteins increased substantially (Table S 7.2;Table S 7.3). String 
cluster analysis of high confidence hits (Figure 2.16) showed a strong 
interconnection between the proteins enriched in both or either datasets. This 
strong interconnection supports the specific enrichments of protein complexes 
associated to rRNAs. 
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Table 2.1 Proteins enriched from 18S rRNA after specific RNP capture. Mass spectrometry 
measurements were performed by the EMBL proteomics core facility; Bernd Fischer did the semi-
quantitative analysis of the three replicates. The amount of enrichments (n) in crosslinked sample (cCl) 
was compared to the non crosslinked (NocCl) and scrambled control (Scr). The estimated false discovery 
rate was calculated with following formula: (0+1)/n; being 7.1% for the listed proteins; Proteins were sorted 
according to the knowledge about relation to ribosome biology including cytoplasmic ribosome 
constituents, knowledge from human ribosome biogenesis screens or literature reports; Three recent 
ribosomal biogenesis screens were taken into consideration: Wild et al., 2010 (siRNA depletion based 
biogenesis screen of the 40S and 60S ribosomal subunit, with microscopic readout); Tafforeau et al., 2013 
(siRNA depletion based rRNA maturation screen; with Northern blot readout); Badertscher et al., 2015 
(genome wide siRNA depletion based biogenesis screen of the 40S ribosomal subunit; with microscopic 
readout.) Red: ribosomal proteins from the large ribosomal subunit; 
 
Table 2.2 Proteins enriched from 28S rRNA after specific RNP capture. Mass spectrometry 
measurements were performed by the EMBL proteomics core facility; Bernd Fischer did the semi-
quantitative analysis of the three replicates. The amount of enrichments (n) in crosslinked sample (cCl) 
was compared to the non crosslinked (NocCl) and scrambled control (Scr). The estimated false discovery 
rate was calculated with following formula: (0+1)/n; being 5.3% for the listed proteins; Proteins were sorted 
according to the knowledge about relation to ribosome biology including cytoplasmic ribosome 
constituents, knowledge from human ribosome biogenesis screens or literature reports; Three recent 
ribosomal biogenesis screens were taken into consideration: Wild et al., 2010 (siRNA depletion based 
biogenesis screen of the 40S and 60S ribosomal subunit, with microscopic readout); Tafforeau et al., 2013 
(siRNA depletion based rRNA maturation screen; with Northern blot readout); Badertscher et al., 2015 
(genome wide siRNA depletion based biogenesis screen of the 40S ribosomal subunit; with microscopic 
readout.) 
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Figure 2.16; String cluster analysis (string-db.org) with the proteins enriched in 18S and/or 28S 
rRNA specific RNP captures. The enriched proteins are highly interconnected and form clusters of 
ribosomal proteins and HNRNP proteins. 
The two rRNA interactomes also overlap in proteins, which were not described 
before to be part of the ribosome or being associated with the rRNA (YBX3, 
ELAVL1, HNRNPA1,HNRNPH). The overlap suggests a general role of these 
proteins in rRNA biology. These proteins have multifunctional roles as RBPs in 
the cell; they could therefore be general RNA binders. As some proteins of the 
HNRNP family were identified in recent ribosomal biogenesis screens 
(Tafforeau et al., 2013, Badertscher et al., 2015), a functional role of HNRNPA1 
and HNRNPH in rRNA biogenesis could also be taken into consideration. YBX3 
is interacting with many RNAs and is involved in a multitude of biological 
functions. YBX3 hasn’t been described before to be involved in ribosomal 
biogenesis or being associated with the ribosome. It would be therefore 
interesting to see, which role YBX3 would have specifically in ribosome biology. 
ELAVL1 (also known as HUR) is a RBP known to interact with AU rich elements 
(AREs) (Herdy et al., 2015). An interesting characteristic of ELAVL1 RNA 
binding has been described in embryonic stem cells (ESCs) differentiation: In 
this biological context ELAVL1 preferentially binds mRNAs that do not harbour 
N6-methyladenosine (m6A) sites and stabilizes those specifically (Wang et al. 
2014). As human 18S and 28S rRNAs carry m6A modifications (positions 1832, 
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1851 for 18S rRNA and 4189 and 4190 for 28S rRNA) (Motorin & Helm 2011), 
ELAVL1 could also bind to rRNA dependent on the modification status of the 
rRNA during biogenesis. 
2.8.4 Detection of inter-subunit and subunit-specific ribosomal proteins. 
After having a closer look on the distribution of the enriched ribosomal proteins 
on the human ribosomal structure (Figure 2.17 A/B), I could confirm that the 
identified proteins are covering all regions of the respective ribosomal subunits. 
Therefore, I could exclude any targeting region biases. Biases could have 
evolved if the rRNA would have been partially disrupted during specific RNP 
capture, although I could not observe any rRNA integrity loss on the RNA 
bioanalyzer traces.  
 
Figure 2.17; Position of enriched ribosomal proteins in the structure of the cytoplasmic ribosome. 
The structure of the human ribosome is from Anger et al. 2013 (PDB entry 4V6X). The programme 
Chimera (cgl.ucsf.edu/chimera) was used to display the structure. (A) small ribosomal subunit proteins 
enriched with the 18S rRNA. (B) large ribosomal subunit proteins enriched with the 28S rRNA. There is no 
bias in location of the enriched ribosomal proteins. 
Two large ribosomal proteins were enriched in the 18S rRNA interactome (Rpl8, 
Rpl22). Therefore I had a closer look at the position of these proteins in the 
human ribosomal structure (Figure 2.18). Rpl8 was detected in previous 
ribosomal biogenesis screens (Wild et al., 2010; Badertscher et al., 2015) and 
resides close to the inter-subunit space. It could therefore have contact points 
with both the 18S and the 28S rRNA.  Rpl22 on the other hand might be too 
distant from the 18S rRNA in the mature ribosome. An explanation for the 
detection of Rpl22 in both the 18S rRNA and 28S rRNA interactome could be 
that the protein associates during ribosomal biogenesis steps with the 
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unprocessed pre-rRNA, although a role of Rpl22 during maturation of the rRNA 
has not been described so far. 
Figure 2.18; Position of enriched 
ribosomal proteins coming from the 
respective other subunit of the 
cytoplasmic ribosome. The structure of 
the human ribosome is from Anger et al. 
2013 (PDB entry 4V6X). The programme 
Chimera (cgl.ucsf.edu/chimera) was used 
to display the structure.  
 
 
 
 
2.8.5 Specific differences between the two rRNA interactomes 
The 18S rRNA and 28S rRNAs show some distinct differences from each other. 
Proteins that were specifically enriched with the 18S rRNA but not the 28S 
rRNA interactome were eiF3J, SERBP1, Rps15, LRPPRC, Rpl8, RPS24 and 
RPSA. The small subunit proteins RPS15, RPS24 and RPSA were expected to 
associate specifically with 18S rRNA. The occurrence of Rpl8 in the small 
subunit rRNA dataset might be there due to its position at the intersubunit space 
of the ribosome (discussed above).  
SERBP1 (also known as plasminogen activator inhibitor 1 RNA-binding protein) 
was previously identified in the 80S ribosomal structure. It mostly associates 
with the 40S subunit but reaches to the 60S subunit (Anger et al., 2013), which 
fits with the enrichment of SERBP1 in the 18S rRNA interactome. SERBP1 is a 
RBP that simultaneously shifts to cytoplasmic stress granules and nucleoli upon 
stress. SERBP1 is homologous to the translation repressor Stm1 (Balagopal & 
Parker, 2011) and might therefore also possess a role in translational 
repression when localized to stress granules. Its observed localization to 
nucleoli suggests a possible involvement in ribosomal biogenesis.  
The initiation factor eiF3J is a component of the eukaryotic translation initiation 
factor 3 (eIF3) complex that associates with the 40S ribosomal subunit (Fraser 
et al., 2003). In Saccharomyces cerevisiae, eIF3J has also been shown to be 
required for the processing of 20S pre-rRNA in 18S rRNA and also binds to 18S 
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rRNA (Valásek et al., 2001). For LRPPRC (Leucine Rich Pentatricopeptide 
Repeat Containing) there is no documentation about a biological role 
associated with the function or biogenesis of the cytoplasmic ribosome. 
LRPPRC is a RBP that associates with both nuclear and mitochondrial mRNAs 
(Mili & Piñol-Roma, 2003). For nuclear RNAs, LRPPRC is described to be 
involved in mRNA export from the nucleus. In mitochondria, LRPPRC controls 
RNA processing and translational control (Sasarman et al., 2010; Chujo et al., 
2012). A possible role of LRPPRC in cytoplasmic ribosomal biogenesis or 
translational activity of the ribosome has not been described yet and it might be 
therefore intriguing to see if LRPPRC could be identified as a novel factor for 
ribosomal RNA processing or ribosomal activity. Potentially it could be involved 
in rRNP export from the nucleus as this function was already described for the 
export of mRNA. 
Proteins that were specifically enriched with the 28S rRNA but not the 18S 
rRNA interactome were Rpl29, Rpl31, Rpl5, Rpl4, PA2G4, HNRNPC, HNRNPD, 
BTF3, HNRNPA2B1, HNRNPM, PLIN4, DSG1. The large subunit proteins were 
expected to associate specifically with 28S rRNA. HNRNPC,-D and –F could 
also be identified in the biogenesis screens that were used for cross-referencing 
(discussed later).  
PA2G4 (proliferation-associated 2G4; other name = EBP1) is a double stranded 
RNA binding protein (Squatrito et al., 2006) that is present in pre-ribosomal 
ribonucleoprotein complexes and is implicated in ribosome maturation and the 
regulation of rRNA processing (Squatrito et al., 2004). Its orthologue in yeast, 
Arx1, is a nuclear export receptor for the 60S ribosomal subunit (Hung et al., 
2008). Structural data in yeast show that Arx1 interacts with the expansion 
segment ES27L (Greber et al., 2012). It positions close to the peptide exit 
tunnel where it inhibits the association of translation factors before the 
maturation is complete. In summary, these observations are in line with the 
significant enrichment of PA2G4 with the 28S rRNA. 
BTF3 (also known as Nascent Polypeptide-Associated Complex Subunit Beta) 
is part of the Nascent polypeptide associated complex and was described to be 
associated with the ribosome and to prevent inappropriate ribosome binding to 
ER membranes (Beatrix et al., 2000). As the ribosomal exit tunnel resides in the 
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large ribosomal subunit, it is an expected finding that BTF3 was identified in the 
28S rRNA interactome but not in the 18S rRNA interactome. 
The occurrence of Perilipin-4 (Plin4) and Desmoglein-1 (Dsg1) in the 28S rRNA 
interactome is interesting because both proteins have not been described 
before to be associated with RNA, to bear RNA binding motifs, or to have a 
biological function related to the ribosome. Desmoglein is associated with cell 
junctions (Ohsugi et al., 1997), whereas Plin4 might play a role in the 
biogenesis of lipid droplets (Heid et al., 2014). It would be interesting, in which 
biological context these proteins interact with the 28S rRNA and if their 
association with the ribosomal RNA involves translational control, ribosomal 
maturation or other functions. 
2.8.6 Enrichment of HNRNP proteins and their possible role in rRNA 
biology 
HNRNPs are involved in mRNA maturation. Not so much is known about their 
possible role in rRNA maturation. In the case of HNRNPK it was shown that it 
associates with rRNA and is then required for rRNA stability in non-stressed 
cells (Wen et al., 2012).  
The occurrence of some HNRNPs in the ribosomal biogenesis screens are a 
strong indicator that the here identified may play an important role in the 
biogenesis of the ribosomal subunits; although this role is so far unexplored. 
The northern blot readout used in Tafforeau et al., 2013 showed that HNRNPC 
knockdown affects the early processing of 18S and 28S rRNAs. HNRNPC might 
therefore interact with the pre-rRNA before cleavage of the internal transcribed 
spacer 1 (ITS1) that separates 18S and 28S rRNA. HNRNPF is, as HNRNPC, 
involved in the early pre-rRNA processing. The northern blot results of 
HNRNPD in the siRNA screen imply an involvement in the large subunit 
maturation. This complies with the high confidence enrichment of HNRNPD in 
the 28S rRNA interactome but not in the 18S rRNA interactome.  
Interestingly, a recent study revealed that RNA binding of HNRNPC binding is 
enhanced when mRNAs carry m6A modifications (Liu et al., 2015). As human 
18S and 28S rRNAs carry m6A modifications (Motorin & Helm, 2011), it is 
possible that HNRNPC or other HNRNPs interact with rRNA in an m6A- 
dependent manner. In addition, there is the possibility that other rRNA 
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modifications regulate HNRNP binding to rRNA. iCLIP or ECLIP data will 
provide insights into the exact interaction sites of HNRNP proteins with 18S and 
28S rRNAs.  
In summary, with the rRNA interactomes I could provide evidence that specific 
RNP capture in addition to its use in vitro can also be applied to purify RNA-
binding proteins bound to specific RNA species in cells. The two rRNA 
interactomes displayed the clean biochemical performance of the protocol. Most 
of the differences in the rRNA interactomes could be cross-correlated to 
previous observations in literature. Thus, specific RNP capture again 
successfully recapitulated data generated in the past by orthogonal approaches. 
In addition specific RNP capture provided data about potential novel proteins 
involved in ribosome biology or function. 
2.8.7 rRNA capture after cell fractionation 
In order to distinguish cytoplasmic interactors of rRNA from interactors of rRNA 
that are involved in the early processing and assembly steps in the nucleolus 
and nucleus, I performed rRNA capture with subcellular fractions of HeLa cells. 
The subcellular fractionation was biochemically clean as shown by the 
enrichment of cytoplasmic proteins and depletion of the nuclear proteins in the 
cytoplasm and vice versa. By using the subcellular fractions I could then 
specifically pull-down 18S rRNA with the LNA/DNA mixmer probes. However, I 
could observe RNA degradation in the nuclear fraction. This degradation could 
be due to sonication of the nuclear fraction to disrupt the chromatin. For specific 
RNP capture of the nuclear fraction, I will have to apply a different strategy to 
maintain RNA integrity. Prospectively, specific RNP capture of fractionated 
sample in principle works and can be used in future experiments. It will allow 
distinguishing better biogenesis factors from factors involved in ribosomal 
function in protein synthesis or ribosomal degradation. 
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Figure 2.19; Specific RNA capture of 18S rRNA after cellular fractionation of HeLa cells subjected 
to UV crosslinking. (A) After fractionation, the cytoplasmic and nuclear fractions were analyzed via 
Western Blot to monitor clean separation of the subcellular fractions. Ki67 was used as a nuclear marker 
and Tubulin (Tub) was used as the respective cytoplasmic marker. Clean separation of both sub-cellular 
fractions could be performed. (B) 18S rRNA capture was performed with the respective sub-cellular 
fractions. The enriched RNA was analyzed using a 6000 Pico bioanalyzer. The 2 peaks from the Input 
samples come from 18S (runs at 2000 nt) and 28S (runs at 4000 nt). The y-axes display the fluorescence 
intensity coming from a dye labeling the RNA quantitatively. 18S rRNA could be enriched in both sub-
cellular fractions. Degradation of RNA could be monitored in the nuclear fraction. 
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3 Conclusions 
3.1 Specific and stringent isolation of RNPs by Specific RNP 
capture 
I have demonstrated that the protocol of specific RNP capture specifically 
enriches the targeted RNA and its bound proteome in eluates. I was also able to 
extend the protocol from in vitro to in-cell applications.  
Specific RNP capture performed in Drosophila embryo extracts with reporter 
RNAs not only “re-discovered” the Sxl-msl2 U-rich motif interaction, but also 
uncovered that Ssx exhibits similar binding preferences as its paralog. With 
these experiments I could also demonstrate that specific RNP capture can be 
used in comparative binding studies on reporter RNAs as Ssx showed 
differential association to the wt over the mut reporter RNA. When I used 
specific RNP capture in cells to isolate human 18S and 28S rRNA, I could 
specifically purify the targeted rRNA and effectively remove the other 
(abundant) rRNA. The specificity of the pulldown allowed me to generate two 
distinct datasets, the 18S rRNA interactome and the 28S rRNA interactome. 
Although the amount of detected proteins is limited (reasons and solutions 
discussed below) the good biochemical performance of the method could be 
confirmed by the nature of the identified proteins. Many of the enriched proteins 
were identified as components of the cytoplasmic ribosome or playing potential 
roles in ribosomal biogenesis.  
3.2 Limitations of specific RNP capture and how to circumvent 
them 
The stringency included at all levels of the specific RNP capture protocol 
imposes limitations, such as relatively low level of purified RNA and co-purified 
proteins. I observed that a substantial amount of RNA is required in order to 
generate a comprehensive interactome of the RNA of interest, reaching the 
order of micrograms. Micrograms of RNAs for an in vitro experiment are in 
principle not a problem because exogenous RNA can be used in high quantities 
by scaling-up proportionally the amounts of cell extracts as needed. However, 
this represents a challenge when applied to endogenous RNA. A typical 
mammalian cell contains 10–50 pg total RNA, whereas the majority of RNA 
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molecules are tRNAs and rRNAs (Boon et al. 2011). mRNA accounts for only 
1–5% of the total cellular RNA although the actual amount depends on the cell 
type and physiological state. During my PhD thesis I applied specific RNP 
capture to 18S and 28S rRNA, targeting therefore highly abundant transcripts in 
the cell. I was able to isolate 4-9 µg of ribosomal RNA from around 2*108 cells. 
Nonetheless, I observed that the recovery of the ribosomal RNA was in the low 
percentage range (1-5%), which is contrary to the recovery in vitro (~20%). 
Possible explanations could be the nature of the RNA with regard to RNA 
modifications, RNA degradation during hybridization, strong secondary structure 
formation or RNA-RNA crosslink formation. Even when using 4-9 µg of 
crosslinked rRNA, I still had problems in terms of MS detection depth. Enriched 
proteins were nevertheless different between the 18S and 28S rRNA 
interactome, implying that even if the datasets is not complete, it was highly 
specific.  
One possible way to overcome these limitations will involve the use of 
alternative MS measurement strategies following the newest developments in 
the field of MS. The targeted proteomics technique, based on the processing 
technique called selected reaction monitoring (SRM), allows highly sensitive 
protein detection, expanding the limits of the conventional discovery proteomics 
(Picotti & Aebersold, 2012). But targeted proteomics is also biased towards a 
pre-selection of proteins of interest. Only peptides will be processed by the MS 
apparatus that have been pre-selected before. One pre-selection criteria in the 
case of specific RNP capture could be proteins enriched via RNA interactome 
capture. Targeted proteomics is a recent development and it will be interesting 
to explore in the context of Specific RNP capture. 
Another possible way to circumvent detection limits are related to the 
crosslinking strategy. UV crosslinking allowed specific enrichments of proteins 
that directly contact the RNA of interest. Nevertheless, it is known that the usual 
efficiency of UV crosslinking at 254 nm and energy of 150 mJ/cm2 is between 1-
5% (Darnell, 2010); although this limit could be pushed to 20% for certain 
proteins such us CUG-BP using optimized protocols (Castello et al., 2012). One 
way to address this limitation would be to increase the crosslinking energy. 
Nevertheless, I observed that the RNA integrity is compromised reducing 
recovery rates. A multitude of targeting probes covering the whole transcript 
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length (a strategy referred to as “tiling”) would circumvent the problematics of 
RNA fragmentation. The tiling strategy has been already used to target lncRNA 
(West et al., 2014; Chu et al., 2015; McHugh et al., 2015). Nonetheless, as 
LNA/DNA mixmer probes are more expensive in synthesis than the DNA 
oligonucleotides used in the “tiling” strategies, specific RNP capture would 
become an inaccessible protocol. 
Another way to address the crosslinking limitations, would be to use 4-
thiouridine (4SU). Since 4SU-mediated crosslinking is achieved at 365 nm and 
conventional bases do not absorb at this wavelength, RNA fragmentation would 
be reduced upon high energy irradiations. Nonetheless, in the case of the rRNA 
interactome the use of 4SU can cause rRNA biogenesis defects (Burger et al., 
2013) and thereby would result in an interactome dataset which does not reflect 
the normal physiological state of the cell. 
Alternatively, a chemical crosslinker like formaldehyde can be used, although 
this strategy would promote protein-protein crosslinks that will mediate the 
isolation of proteins that do not directly contacting the RNA. However, using 
limited formaldehyde crosslinking would still enrich for proteins that are forming 
part of RNP complexes. Direct vs indirect RNA binders can be separated a 
posteriori by cross-referencing the resulting datasets with the repertoire of 
known RBPs (derived from the RNA interactome studies). In summary, if the 
protein-RNA crosslinking is enhanced and the downstream analysis and data 
interpretation are performed carefully, the advantages of chemical crosslinking 
can overcome its disadvantages. 
3.3 Comparison of specific RNP capture to other recent 
protocols based on antisense oligonucleotide probes  
For the identification and characterization of proteins bound to lncRNAs, several 
methods based on the usage of antisense oligonucleotides have been 
established (Table 3.1). 
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Table 3.1; Comparison of recent antisense oligonucleotide approaches to identify RBPs bound to a 
specific transcript. CHART-MS (West et al., 2014); CHIRP-MS (Chu et al., 2015); RAP-MS (McHugh et 
al., 2015) 
“Tiling” versus single antisense nucleotide: The recent protocols of CHART-
MS (Capture Hybridization Analysis of RNA Targets) (West et al., 2014), 
CHIRP-MS (Chromatin Isolation by RNA Purification) (Chu et al., 2015) and 
RAP-MS (RNA Antisense Purification) (McHugh et al., 2015) are all based on 
the so called “tiling” approach, in which a number of overlapping biotinylated 
oligonucleotides that cover the whole transcript length are used. The advantage 
of the tiling approaches is that the RNA integrity is not as crucial as for Specific 
RNP capture, in which just one oligonucleotide is applied to target the RNA of 
interest. Nevertheless, the disadvantage of using a broad number of 
oligonucleotides is that it is very challenging to estimate the contribution to 
noise and signal of each individual probe. Moreover, it would be difficult to 
target distinct transcript isoforms or particular regions of the RNA of interest, 
since the probes cover the whole transcript. Specific RNP capture can for 
example be utilized to compare the RBPs bound to different splice variants of 
one transcript. Another application for which specific RNP capture can 
outperform its competitor methods is enrichment of a specific region within a 
transcript by combining specific RNP capture with site selective RNaseH 
digestion (see Outlook; Figure 4.1).  
Nucleotide length, composition and hybridization temperatures: An 
interesting difference between the mentioned methods is the nature and length 
of the oligonucleotides. All “tiling” approaches employ DNA oligonucleotides 
Method 
No of 
cells 
Immobilization 
of oligos 
crosslinking 
Length 
of 
oligos 
Hybridization 
Release 
from 
beads 
MS 
quantification 
method 
CHART-
MS 
108 Streptavidin - 
Biotin 
3% 
Formaldehyde 
25 nts 
20°C over 
night 
RNaseH spectral counts 
CHIRP-
MS 
108 – 
5*108 
Streptavidin - 
Biotin 
3% 
Formaldehyde 
20 nts 
37°C over 
night 
Biotin 
elution 
buffer 
peptide counts 
RAP-MS 
2*108-
8*108 
Streptavidin - 
Biotin 
UV254 
800mJ/cm2 
90 nts 67°C 2h Benzonase SILAC 
Specific 
RNP 
capture 
2*108 
Covalent 
coupling to 
carboxy beads 
UV254 
150 mJ/cm2 
20 nts 41°C 2h 
Heat 3’ 
90°C 
Dimethyllabeling 
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because they are easy to obtain and cheap. CHART-MS and CHIRP-MS use 
relatively short DNA oligonucleotides and accordingly low hybridization 
temperatures (20-37°C). This might lead to lower specificity of the hybridization. 
RAP-MS uses rather long oligonucleotides and accordingly higher hybridization 
temperatures (67°C). As specific RNP capture uses LNA/DNA mixmer, the 
oligonucleotides could be as short as 20 oligonucleotides with increased 
hybridization temperatures for specificity. LNA/DNA mixmers also hybridize 
better to RNA than DNA oligonucleotides. DNA oligonucleotides could also 
hybridize to a higher extent to genomic DNA, leading to increased 
contaminations with DNA and proteins bound to it. 
Immobilization of the oligonucleotides to beads: Another difference to 
specific RNP capture is the way in which the probes are immobilized to beads. 
In the specific RNP capture protocol the probes are covalently coupled to 
magnetic beads before the hybridization step. For the “tiling” approaches, the 
oligonucleotides carry a biotin tag and are immobilized on the beads after the 
hybridization to the target RNA. An advantage of this approach might be the 
higher flexibility of the soluble oligonucleotides during hybridization. 
Nonetheless, the biotin-streptavidin coupling has the disadvantage that several 
proteins contain biotin molecules and can bind to the streptavidin beads in a 
RNA-independent manner. As the bead surface of the covalent coupling 
strategy is in principle inert, the bead surface is less prone for unspecific 
interactions. Another disadvantage is that the used biotinylated oligonucleotides 
cannot be applied in several rounds of capture as in the case for the covalently 
coupled oligonucleotides.  
Crosslinking: The methods CHART-MS (West et al., 2014) and CHIRP-MS 
(Chu et al., 2015) make use of extensive formaldehyde crosslinking, which 
leads to the detection of many indirectly interacting proteins. The high 
percentage of formaldehyde (3%) used in these approaches might even lead to 
a fixation of the whole cell. RAP-MS on the other hand is based on UV 
crosslinking at high energies (800 mJ/cm2). This extensive crosslinking leads to 
perturbations of RNA integrity. In contrast to specific RNP capture it is still 
possible to capture RNA fragments with the “tiling” approaches. It is important to 
know when using such high crosslinking energies that fragmentation of the RNA 
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can affect the downstream RNA quality control steps performed with RT-qPCR 
or RNA bioanalyzer.  
Mass spectrometry quantification methods: The afore mentioned protocols 
use different mass spectrometry methods to identify the proteome bound to the 
RNA of interest. CHART-MS and CHIRP-MS use label-free quantification. In 
label-free quantification, no label is introduced to the samples; the comparison 
is then done by comparing different MS runs, with the difficulty of aligning 
peptide peaks in non-identical profiles. A drawback is that technical variations of 
the Mass Spectrometer runs or properties of the compared peptides can make 
such analyses difficult and can generate biases due to the analytic software 
used.  
RAP-MS uses SILAC ratios formed between a pulldown of an abundant RNA to 
the RNA of interest. The advantage of the SILAC label is that the label is 
introduced at an early point during the protocol and the quantification is 
therefore less biased by technical variations. The comparison to an abundant 
RNA can be problematic when the interacting RBPs are also strong interactors 
of the abundant RNA. Specific RNP capture uses dimethyl labeling which allows 
comparing up to two different controls with the sample of interest. The strength 
of dimethyl labeling is used for specific RNP capture in HeLa cells by including 
the scrambled oligonucleotide and non-crosslinking control. As in SILAC, the 
three samples are processed together in the same MS run, which makes 
quantification more accurate than the label-free approach. As a drawback, 
dimethyl labeling requires multiple processing steps that are known to account 
for sample losses, thus promoting accuracy over sensitivity. In addition, specific 
RNP capture gives statistics based on three replicates. No statistical analysis 
has been performed in any of the “tiling” studies. Including statistical tests or at 
least comparing replicates directly would increase the confidence of the 
identified candidates in these studies. 
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4 Outlook 
4.1 The biological role of Ssx 
In the in vitro experiment performed with Drosophila embryo extract it was 
expected to re-identify Sxl to interact with the established Sxl binding sites 
introduced in the reporter RNA. Nonetheless, the surprising finding was that 
instead of Sxl, its paralog Ssx together with the HNRNP proteins Hrb87F and 
Hrb98DE were identified to interact with the reporter RNA bearing Sxl-binding 
sites. Sxl was previously shown to interact with Hrb87F, most likely through a 
common glycine-rich region, and increases the affinity of Hrb87F for U-rich 
sequences (Wang et al., 1997). As Ssx shares the N-terminal glycine-rich 
feature with Sxl, the results suggest that Ssx can also recruit Hrb87F, implying 
functional redundancy between the two paralogs. Co-Immunoprecipitation (Co-
IP) experiments could give first insight into a possible interaction of these 
proteins. In the co-IP experiments one could also test protein fragments to 
narrow down the interaction site and include RNase digestion to determine if the 
interaction is RNA dependent or not. 
Specific RNP capture could provide evidence that Ssx and Sxl proteins bind 
similar target sites in the RNA. It might be therefore interesting to compare the 
RNA targets and binding sites of both proteins by performing CLIP experiments. 
It would be interesting which differences in the binding site determine that Sxl, 
in contrast to Ssx, has an essential function in sex determination and dosage 
compensation.  
Based on the similarity of both proteins it would be interesting if Ssx can, as Sxl, 
act as a splicing and translational regulator. Reporter RNAs bearing Sxl splicing 
sites could be tested with recombinant Ssx. An ECLIP or iCLIP experiment 
could show if the Ssx target RNAs share the same splice sites as the Sxl target 
RNAs.  
4.2 The role of HNRNP proteins during ribosomal biogenesis 
The occurrence of several HNRNP proteins in the 18S rRNA and 28S rRNA 
interactome is intriguing.  Especially in the context that several HNRNP proteins 
have also been identified in ribosomal biogenesis screens (Tafforeau et al., 
2013; Badertscher et al., 2015). As HNRNP proteins are involved in the 
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maturation of mRNA, a similar role could be true for the maturation of rRNA. As 
in Tafforeau et al., 2013, knockdown of HNRNP proteins could be coupled to 
Northern Blot experiments in order to see if HNRNP proteins influence the pre-
rRNA maturation.  
It would be interesting to see if HNRNP proteins interact with rRNA and pre-
rRNA by analyzing the recent ECLIP and iCLIP datasets under this aspect. 
Previous ECLIP and iCLIP analysis pipelines exclude rRNA as a contaminant. 
Additionally, rRNA is excluded with multiple genome mappers because rRNA is 
transcribed in highly repetitive genomic clusters. It is therefore necessary to 
adjust the analytical pipeline by mapping the sequences to the transcriptome 
instead of mapping it to the genome. The enriched crosslink sites could then tell 
if HNRNP might preferably bind pre-rRNA. A question that could be addressed 
is if the binding of HNRNP proteins target sites in the rRNA that are modified. It 
would be intriguing to see if the binding during ribosomal biogenesis is 
influenced by modifications on the rRNA such as m6A. m6A dependent RNA 
structural switches were observed previously to modulate binding of HNRNPC 
to a target mRNA (Liu et al., 2015). Progress in the epitranscriptomic field might 
give more insight into dynamics and variety of rRNA modifications. 
4.3 Future applications of specific RNP capture 
When the limitations of specific RNP capture have been overcome by 
increasing the crosslinking efficiency with the use of limited chemical 
crosslinking, the specific RNP capture protocol can be expanded from targeting 
rRNA also to other, less abundant RNA species. Progress with regard to 
targeted mass spectrometry might additionally increase the sensitivity of the 
methods. The stringency of the protocol in combination with quantitative mass 
spectrometry will help to generate lists of proteins that interact with high 
probability with the RNA of interest. The high specificity of the protocol will 
facilitate the downstream analyses. 
With regard to the rRNA interactome a comparison could be made between 
different cell types or development. It is now known that specialized ribosomes 
with specialized translational machineries are important regulators of gene 
expression (Xue & Barna, 2012). Other experiments based on the rRNA 
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interactome could be the region specific enrichment of ribosomal RNA by 
combining specific RNP capture with RNase H digest (Figure 4.1). This type of 
protocol is dependent on the respective sensitivity improvements of the method. 
The approach would then allow the specific enrichment of ribosomal expansion 
segments with the bound proteome. Identification of the expansion segment 
RBPs would give more insight about the biological role of these expansion 
segments, for which the function especially in human cells is still poorly 
understood. 
 
Figure 4.1; Specific RNP capture of ribosomal expansion segments. After UV crosslinking of cells, the 
specific RNP capture protocol is performed to capture 18S or 28S rRNA. After the enrichment of the 
respective rRNA, DNA probes (scissor probes) complementary to upstream and downstream regions of 
the ribosomal expansion segment are added and a digest with RNAseH is performed. The RNAseH digest 
enables a dissection of the target ribosomal expansion segment. Subsequently, a second specific RNP 
capture step targeting the expansion segment with complementary LNA/DNA mixmer probe is performed. 
This step allows an enrichment of the respective expansion segment together with the bound proteins. The 
proteins are finally analyzed via mass spectrometry. 
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Another application for “specific RNP capture” could be in the context of viral 
infection of eukaryotic cells. Eukaryotic RNA viruses utilize host factors for their 
virus life cycle. For many RNA viruses there is a lack of knowledge of host 
factors interacting with the viral RNA. A deeper understanding of the role of 
specific host factors in the viral life cycle will enable the development of new 
antiviral treatment possibilities (de Chassey et al., 2014). Some RNA viruses 
can produce a high copy number of viral RNA within the host cell and thereby 
the sensitivity limits of “specific RNP capture” could be overcome. Specific RNP 
capture would therefore be a suitable tool for the identification of cellular 
proteins interacting with high copy number viral RNA during the viral life cycle.  
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5 Materials and Methods 
 
5.1 Materials 
5.1.1 Chemicals/Disposables/Kits 
 
Chemicals / Disposables / Kits Company 
  
100bp DNA ladder New England Biolabs 
1kb DNA ladder New England Biolabs 
2-(N-morpholino)ethanesulfonic acid (MES) Merck 
30% Acrylamide/Bis Solution 37,5:1 Biorad 
4-15%™ TGX™ Precast gel Biorad 
5 mL, 10 mL, 25 mL serological pipets Falcon 
500 cm2 cell culture dishes Corning 
Acetonitril Sigma-Aldrich 
Agarose Sigma-Aldrich 
Amino acid mixture, complete Promega 
Ammoniumpersulfate (APS) Sigma-Aldrich 
Ampicilline Sigma-Aldrich 
Bactotryptone Difco 
Benzonase Novagen 
boric acid Sigma-Aldrich 
BSA in solution (20 mg/mL) NEB 
Calf Intestine Phosphatase (CIP) NEB 
Carboxylated magnetic beads (M-PVA C11) Perkin Elmer 
Cell culture dishes NuncThermo 
Cell culture flasks Falcon 
Complete EDTA-free Protease Inhibitor Cocktail Roche 
Creatinekinase Roche 
Creatinephosphate Sigma-Aldrich 
DC protein assay Biorad 
Deoxynucleotides (dNTPs) Peqlab 
Dithiothreitol Biomol 
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DMSO Sigma-Aldrich 
DNA/RNA LoBind Tubes Eppendorf 
Dnase 1 Ambion 
Dual Luciferase Assay System Promega 
Dual-Luciferase Reporter 1000 Assay System Promega 
Dulbecco’s Modified Eagle’s Medium Sigma-Aldrich 
EDTA Sigma-Aldrich 
Epoxy magnetic beads  M-PVA E01 Perkin Elmer 
Ethanolamine Sigma-Aldrich 
Ethidium bromide MP Biomedicals 
Ethylenecarbonate Sigma-Aldrich 
Fetal Bovine Serum (Gold) GE Healthcare 
Fluorescent modified DNA oligonucleotides MWG 
Formic Acid Sigma-Aldrich 
Glycerol Merck 
Glycine Sigma-Aldrich 
HeLa cytoplasmic extracts Cilbiotech 
HEPES Biomol 
Immobilon Western HRP substrate Millipore 
Iodoacetamide (IAA) Merck 
KCl Sigma-Aldrich 
KH2PO4 Sigma-Aldrich 
L-Amino Acids Kit, 21 Amino Acids Sigma-Aldrich 
L-glutamine Gibco 
Lithium Chloride Roth 
Lithium Dodecylsulfate (LiDS) Roth 
Locked Nucleic Acids (LNA) Exiqon 
MEGAscript®  Transcription Kit Thermo 
Milk Powder Frema Reform 
N-(3-Dimethylaminopropyl)-N′-ethylcarbodiimide 
hydrochloride (EDC) E7750 
Sigma-Aldrich 
N,N,N';N'-tetramethylethylenediamine (TEMED) Fluka 
Na2HPO4 Sigma-Aldrich 
NaCl Merck 
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Nitrocellulose Membrane Whatman 
NP-40 Igepal CA630 Sigma-Aldrich 
NuPAGE® LDS Sample Buffer Thermo 
OASIS 96 well plate Waters 
oligodT beads NEB 
Penicillin-Streptomycin Mix (P4333) with 10,000 
units penicillin and 10 mg streptomycin/mL 
Sigma-Aldrich 
Phusion High Fidelity PCR kit NEB 
Plasmid Maxi Prep Kit Qiagen 
Protein ladder; Precision Plus Protein Dual 
Color 
Biorad 
Proteinase K Roche 
QIAquick Gel Extraction Kit Qiagen 
Random hexamer primers Life Technologies 
RNA 6000 Pico Kit Agilent 
RNA Micro Prep kit Zymo 
RNA Mini Prep kit Qiagen, Zymo 
RNase A  Sigma-Aldrich 
Rnase free H2O Ambion 
RNAse Inhibitor protein purification prepared 
in house 
Rnase T1 Sigma-Aldrich 
SDS Sigma-Aldrich 
Silvernitrate Merck 
sodium cyanoborohydride (NaBH3CN, 
NaBD3CN) 
Sigma-Aldrich 
Sodiumhydroxide Roth 
Spermidine Sigma-Aldrich 
SteriCup Filters Millipore 
SuperScript II Life Technologies 
T4 DNA ligase NEB 
Tri Reagent Sigma-Aldrich 
Trichloracetic Acid (TCA) Sigma-Aldrich 
Tris base (Tris(hydroxymethyl)aminomethane) Sigma-Aldrich 
Materials and Methods  
 
85 
 
Trypsin Gibco 
Turbo DNAse Ambion 
Tween-20 Sigma-Aldrich 
Western X ray films Advansta 
yeast extract Difco 
yeast trna  Thermo 
5.1.2 Buffers and Solutions 
All solutions were prepared with double deionized water (ddH2O). Buffers for 
RNA methods and Cell Culture were autoclaved and filtered. Buffers for 
Bacteria were autoclaved. 
DNA loading buffer (6x) 0.25 % (w/v) Bromphenol blue 
 0.25 % (w/v) Xylene cyanol FF 
 40 % (w/v) Sucrose 
  
TBE Buffer (10x) 1L 108 g Trizma base 
 55 g boric acid 
 40 mL 0.5 M EDTA pH 8 
  
Semidry Transfer Buffer (1L) 5.82 g Trizma Base 
 2.93 g Glycine 
 20 % MeOH 
  
Laemmli Buffer (10x) (1L) 30 g Trizma Base 
 144.2 g Glycine 
 10 g SDS 
  
L-Broth (LB) (1L) 10 g Bactotryptone 
 5 g yeast extract 
 5 g NaCl 
  
L-Agar (1L) 10 g Bactotryptone 
 5 g yeast extract 
 10 g NaCl 
 15 g Agar 
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PBS-Dulbecco (1L)  0.2 KCl 
 0.2 g KH2PO4 
 1.15 g Na2HPO4 
 8 g NaCl 
  
TE Buffer pH 7.5 10mM Tris pH 7.5  
 1mM EDTA 
  
Light labeling reagent for Peptide labeling 
on OASIS plate 
9 mL of 50 mM Sodium 
Phosphate buffer pH 7.5 
 500 µL of 600 mM NaBH3CN 
 500 µL of 4% formaldehyde 
  
Medium labeling reagent for Peptide 
labeling on OASIS plate 
9 mL of 50 mM Sodium 
Phosphate buffer pH 7.5 
 500 µL of 600 mM NaBH3CN 
 500 µL of 4% D-formaldehyde 
  
Heavy labeling reagent for Peptide labeling 
on OASIS plate 
9 mL of 50 mM Sodium 
Phosphate buffer pH 7.5 
 500 µL of 600 mM NaBH3CN 
 500 µL of 4% D-13C-
formaldehyde 
  
Nuclear Buffer  10 mM Tris HCl pH 7.5 
(for Nuclear Cytoplasmic Fractionation) 20 mM KCl 
add 0,5% NP40 for Fractionation; 1.5 mM MgCl2 
add freshly RNAsIn and protease Inhibitor 1 mM DTT 
  
200x Dnase Solution                                           500 mM MgCl2 
(for Dnase digest in Nuclear fraction) 100 mM CaCl2 
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Buffers for RNA interactome captures: 
  
Lysis Buffer 20 mM Tris-HCl (pH 7.5) 
 500 mM LiCl,  
 0.5% LiDS (w/v, stock 10%) 
 1 mM EDTA  
 5 mM DTT 
  
2x lysis Buffer  40 mM Tris-HCl (pH 7.5) 
 1 M LiCl 
  1% LiDS (w/v, stock 10%) 
  2 mM EDTA 
(add DTT and LiDS separately to sample); 
LiDS precipitates at higher concentrations in 
cooled buffer 
10 mM DTT 
 
 
  
5x lysis Buffer  100 mM Tris-HCl (pH 7.5) 
 2.5 M LiCl 
 2.5% LiDS (w/v, stock 10%) 
 5 mM EDTA 
(add DTT and LiDS separately to sample); 
LiDS precipitates at higher concentrations in 
cooled buffer 
 
25 mM DTT 
 
  
Buffer 1 20 mM Tris-HCl (pH 7.5) 
  500 mM LiCl 
 0.1% LiDS (w/v, stock 10%) 
 1 mM EDTA 
 5 mM DTT 
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Buffer 2  20 mM Tris-HCl (pH 7.5) 
 500 mM LiCl 
  1 mM EDTA 
  5 mM DTT 
  
Buffer 3 20 mM Tris-HCl (pH 7.5) 
 200 mM LiCl 
 1 mM EDTA 
 5 mM DTT 
  
5x proteinase K buffer 50 mM Tris-HCl (pH 7.5) 
 750 mM NaCl 
 1% (w/v) SDS 
 50 mM EDTA 
 2.5 mM DTT  
 
5.1.3 Antibodies 
 
25 mM CaCl2 
 
 
Antigen Clonality Species Company 
Dilution 
used 
HRP coupled 
secondary 
antibody 
rabbit, mouse goat 
Santa Cruz (sc-2005; sc 
2004) 
1:10,000 
Ki67 polyclonal rabbit Abcam (ab15580) 1:7000 
Drosophila Sxl polyclonal rabbit prepared in house 1:2000 
Tubulin monoclonal mouse Sigma (T5168) 1:10,000 
Drosophila Ssx polyclonal rabbit 
kind gift from Jan 
Medenbach 
1:2000 
Actin monoclonal mouse Sigma (A5441) 1:10,000 
Drosophila PABP polyclonal rabbit prepared in house 1:2000 
HRP coupled 
secondary 
antibody 
rabbit, mouse 
sheep, 
donkey 
GE Healthcare (NA931-
1ML;NA934-1ML ) 
1:10,000 
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5.1.4 Instruments 
 
Instrument Company 
  Acrylamide Gel Electrophoresis chamber EMBL 
Agarose Gel Electrophoresis chamber EMBL 
Balance Scaltec 
Bioanlayzer; lab on chip Agilent 
Cell Cryo Freezing Container Inalgene 
Cell Cryo Freezing Container Biocision 
Cell Culture Hood Heraeus 
Cell Incubator Thermo Scientific Fisher 
Cell Incubator Hera cell 240 Heraeus 
Centrifuge 5810R  Eppendorf 
Cooled tabletop microcentrifuge (5415R) Eppendorf 
Dual Intensity Transilluminator Table Herolab 
Electrophoresis Power Supply EMBL 
Electrophoresis Power Supply Biometra 
Film Developer RP X-OMAT Kodak 
Luminometer Centro XS LB960 Berthold Technologies 
Macrofuge Heraeus Instruments 
Magnetic stirrer Heidolph 
Megafuge 1.0R Heraeus 
Micropipette Gilson 
Microscope Olympus 
Microwave Bosch 
Multipette Plus Eppendorf 
pH meter Inolab 
Pipetboy acu Integra Biosciences 
Rocker EMBL 
Rotator Starlab 
Semi Dry Protein Blotter Biometra 
Shaker Infors AG 
Spectrophotometer Ultraspec 2100 pro Amersham Biosciences 
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Spectrophotometer, Nanodrop1000 Nanodrop 
Step One qPCR machine LifeTechnologies 
T100 Thermal Cycler Biorad 
Tabletop Microcentrifuge (5424) Eppendorf 
Tecan Safire2 M1000 Tecan 
Thermomixer Eppendorf 
Thermoprinter for Gel Images Mitsubishi 
Trans Blot Turbo Biorad 
Transilluminator Peqlab 
UV Stratalinker 2400 Stratagene 
Vortexer IKA Labortechnik 
Waterbath EMBL 
Waterbath for Cell Culture GFL 
nanoAcquity UPLC system Waters 
LTQ Orbitrap Velos Pro Thermo Scientific Fisher 
Sonifier Cell Disruptor B15 Branson 
5.2 Methods 
All commercial kits and reagents were used according to the manufacturer’s 
instructions unless otherwise stated. 
 
5.2.1 Molecular Biology Methods 
 
5.2.2 Plasmid constructions 
The plasmids pBluescript-BLEF and p-Bluescript-BmL(EF)m were described 
before (Gebauer et al., 2003). The plasmids p-Bluescript-BREF and p-
Bluescript-BmR(EF)m were generated by exchanging the Firefly Luciferase 
(Fluc) ORF of pBluescript-BLEF and p-Bluescript-BmL(EF)m by Renilla 
Luciferase (Rluc) ORF via restriction digest with XmaI and HpaI. Rluc ORF was 
PCR amplified from pRL-null plasmid (Promega).  
Used cloning primers for p-Bluescript-BREF and p-Bluescript-BmR(EF)m: 
XmaI Renilla for (5’-3’) TCCCCCCGGGATGACTTCGAAAGTTTATGATCCAGAACAAAGG 
HpaI Renilla rev (5’-3’) AGCTTTGTTAACTTATTGTTCATTTTTGAGAACTCGCTCAACGAA 
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The plasmid carrying Fluc ORF for in vitro transcription was previously 
described (Iizuka et al., 1994).  
The plasmid carrying chloramphenicol acetyl transferase (CAT) ORF for in vitro 
transcription was described before (Preiss et al., 1998). 
5.2.2.1 Polymerase Chain Reaction (PCR) 
Phusion High Fidelity (NEB) was used for PCR reactions following the protocol 
below: 
• 5 µL 10 x reaction buffer 
• 1 µL dNTPs (each 10 mM) 
• 1 µL template Plasmid (100 ng/µL) 
• 1 µL forward primer (100 µM) 
• 1 µL reverse primer (100 µM) 
• 1 µL Phusion HF 
• 40 µL H2O 
PCR cycle program: 
1. 98°C  30’’ 
2. 98°C  10’’ 
3. 55°C  10’’ 
4. 72°C  1’ per kb 
35 repeats of steps 2.-4. 
5. 72°C  10’ 
5.2.2.2 Digestion of DNA 
Restriction digestion enzymes from NEB were used for digestion of DNA. 
Reaction volumes were either 10 µL with 0.5 µL of each enzyme or  40 µL with 
2µL of each enzyme for analytical mini test or preparative reactions 
respectively. For cloning, linearized vectors were additionally incubated for 1h 
with 1 µL of calf intestine phosphatase (CIP; NEB). DNA fragments and 
digested vectors were separated on a 1% agarose gel in 1x TBE Buffer and 
extracted from the gel using the Qiagen gel extraction kit.  
5.2.3 Ligation 
DNA ligation of sticky ends was performed using the T4 DNA Ligase (NEB) in 
its respective buffer for 2h at 25°C in a final volume of 20 µL. 
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5.2.3.1 Transformation in chemical competent E.coli cells 
For molecular cloning, plasmids carrying Ampicillin resistance were transformed 
into chemically competent Escherichia coli TOP10 cells. The used TOP10 cells 
did not need any heat shock for efficient transformation. 50 µL cells were added 
to the ligation mix and incubated 20’ on ice. Afterwards cell were transferred on 
LB plates with Ampicillin. 
5.2.3.2 Isolation of plasmid DNA from E.coli 
Single colonies were picked and inoculated in 4 mL LB medium with Ampicillin . 
For Maxi Culture 100-400 mL culture was prepared. Plasmid DNA was isolated 
using either mini (Sigma; Qiagen) or maxi prep kit (Qiagen) according to the 
manufacturer’s instructions. 
5.2.4 Standard Biochemistry Methods 
5.2.4.1 In vitro transcription 
10 µg Plasmid templates for the Rluc, Fluc and CAT reporter mRNAs were 
linearized with HindIII. 1 µg of the Plasmid was used as template for in vitro 
transcription using the T7 RNA in vitro transcription kit (MEGAscript®; 
ThermoAmbion) or T3 RNA in vitro transcription kit. The capping with m7GpppG 
cap (Darżynkiewicz lab) was included during the in vitro transcription protocol: 
• 1 µg linearized template plasmid 
• 2 µL ATP (75 mM) 
• 2 µL CTP (75 mM) 
• 2 µL UTP (75 mM) 
• 2 µL CAP (40 mM) 
• 2 µL 10x reaction buffer 
• 2 µL Enzyme Mix 
• Fill up to 10 µL with RNase free H2O 
• Incubate first 5´at 37°C for capping then add 2 µL GTP (75 mM) to 
perform in vitro transcription for 4 h at 37°C. 
After purification using Quick-RNA™ MiniPrep kit (Zymo), aliquots were 
analyzed by Agarose gel electrophoresis to confirm integrity. For this, the RNA 
was denatured in Gel Loading Buffer II (Ambion) for 5’ at 95°C and loaded on a 
1% Agarose Gel and run in 1x TBE Buffer.  Fluc and Rluc mRNAs were 
additionally tested in an in vitro translation assay. Rluc RNA contained a poly(A) 
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tail of 72 nt, Fluc RNA contained a poly(A) tail of 73 nt CAT RNA contained a 
poly(A) tail of 15 nt. 
5.2.4.2 Translation Assays 
Drosophila melanogaster embryo translation extracts were taken from previous 
lab members and were prepared as described before, without micrococcal 
nuclease treatment for translation of reporter RNAs to occur in a competitive 
mode as in vivo (Gebauer et al., 1999). For luciferase assays in Drosophila 
embryo extracts, 6 fmol of Fluc and 6 fmol of Rluc reporter mRNA were 
translated in a final volume of 10 μl containing 16 mM HEPES/KOH (pH 7.4), 50 
µM Spermidine, RNase Inhibitor, 100 µM GTP, 800 µM ATP, 80 mM 
KOAc,2 mM Mg(OAc)2, 60 μM amino acids, 20 mM creatine phosphate, 400 ng 
creatine kinase, and 40% Drosophila m. embryo extract for 90 min at 25°C. 
Luciferase activities were assayed with the Dual Luciferase Assay System 
(Promega) in a microplate luminometer (Berthold) with the following program: 
Fluc measurement:  
Inject: 10 µL volume Dual-Glo ® Luciferase Buffer + Substrate 
Delay: 1.6 seconds 
Rluc measurement: 
Inject: 10µL volume Dual-Glo ® Stop & Glo ® Buffer + Substrate 
Hela cytoplasmic extracts (Cilbiotech) were precleared for 5’ at 13.000g.  
For luciferase assays in precleared HeLa cytoplasmic extracts (Cilbiotech), 4 
fmol of Fluc and 4 fmol of Rluc reporter mRNA were translated in a final volume 
of 10µL containing 16 mM HEPES/KOH (pH 7.4), 50 µM Spermidine, RNase 
Inhibitor (produced in house), 100 µM GTP, 800 µM ATP, 80 mM KOAc,2 mM 
Mg(OAc)2, 60 μM amino acids, 20 mM creatine phosphate, 400 ng creatine 
kinase, and 40% HeLa cytoplasmic extract for 30 min at 37°C. Luciferase 
activities were assayed with the Dual Luciferase Assay System (Promega) in a 
microplate luminometer (Berthold) (see above). 
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5.2.4.3 Real-Time PCR 
Isolated and proteinase K-digested RNAs as well as total RNA from whole-cell 
lysate, were purified using Quick-RNA™ MicroPrep kit (Zymo), and then 
retrotranscribed with random primers (LifeTechnologies) into cDNA (Superscript 
II, LifeTechnologies) CAT RNA was spiked in as efficiency control. First, 10 µL 
RNA solution, 1 µL dNTPs (10 mM) and 1 µL random primers (150 ng/µL, 
LifeTechnologies) were incubated at 65°C for 5’ and then let cool down. Then 2 
µL DTT (0.1 M), 4 µL 5x Buffer, 1 µL RNAsIn (prepared in house) and 1 µL 
Superscript II reverse transcriptase was added. The reaction was performed for 
10’ 25°C, 60’ 42°C, 10’ 70°C. For each RNA a reaction without reverse 
transcriptase was added as control (-RT control). Reverse-transcriptase 
quantitative PCR (RT-qPCR) was performed by SYBR green (Applied 
Biosystems) with specific primers against different RNAs in StepOne Real time 
PCR system (LifeTechnologies). 
Used RT-qPCR primers (all from 5’ to 3’; f:forward; r:reverse): 
hs18S rRNA: f: GAAACTGCGAATGGCTCATTAAA; r: CACAGTTATCCAAGTGGGAGAGG 
hsGAPDH: f: GTGGAGATTGTTGCCATCAACGA; r: CCCATTCTCGGCCTTGACTGT 
hsbetaActin: f:TCACCGGAGTCCATCACGAT; r:CGCGAGAAGATGACCCAGAT;  
dm18S rRNA: f:CGGAGAGGGAGCCTGAGAA; r:AGCTGGGAGTGGGTAATTTACG 
dmGAPDH: f:TTCACCACCATTGACAAGGC; r:CTTCATGTCGGGGCTGTAGG 
Rluc: f:GAATTTGCAGCATATCTTGAACCAT; r:GGATTTCACGAGGCCATGATAA 
Fluc: f:CCTCTGGATCTACTGGGTTACCTAAG; r:TCTGGCATGCGAGAATCTGA 
CAT: f:GCAAGATGTGGCGTGTTACG; r:AAAACGGGGGCGAAGAAGTT 
5.2.4.4 Protein quantification with DC protein assay 
HeLa cell extracts and Drosophila melanogaster embryo extracts were tested 
for protein content before the application in experiments. For this purpose DC 
protein assay (Biorad) was used. For every measurement a standard with 7 
BSA concentrations between 0-20 µg was prepared. Different amounts of the 
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test samples were prepared in triplicates. 125 µL of Buffer A and 1 mL of Buffer 
B were added to the samples. After 15’ incubation at RT the samples were 
measured in cuvettes at 750 nm using a spectrophotometer (Ultraspec 2100 
pro, Amersham Biosciences). 
5.2.4.5 Silver Staining of Protein Polyacrylamide gels  
For protein analysis eluates from RNA pull downs were treated with 0.5 µL 
RNAse T1 (1 mg/mL; Sigma) and 0.5 µL RNase A (2 mg/mL; Sigma) or 1 µl 
Benzonase (Novagen, 25 U/µl). Subsequently, proteins were loaded on a 10% 
Tris-Glycine SDS-polyacrylamide gel or a 4-15% TGX™ Precast gel (Biorad). 
First the gel was fixed for 20’ in fixing solution (50% Methanol, 5% Acetic Acid). 
Then washing of the gel was performed for 5’ in the respective washing solution 
(washing 1: 50% Ethanol; washing 2: 30% Ethanol). Afterwards, the gel was 
washed for another 10’ in H2O. The gel was then impregnated for 60’’ with 
freshly prepared sodium thiosulfate solution (0.02%). After three times 20-30’’ 
washings in H2O, the gel was incubated for 20’ in silver solution (6 mM silver 
nitrate, 0.0185% formaldehyde). Then the gel was rinsed three times for 20-30’’ 
in H2O. The stain was developed by adding developer solution (2% sodium 
carbonate (anhydrous), 0.0185% formaldehyde, 0.0004% sodium thiosulfate). 
The developing reaction was stopped by adding stopping solution (5% acetic 
acid). Before scanning the silver stained gel the gel was stored in H2O.  
5.2.4.6 Western Blot Analysis 
For protein analysis, eluates from RNA pull downs were treated with 0.5 µL 
RNAse T1 (1 mg/mL; Sigma) and 0.5 µL RNase A (2 mg/mL; Sigma) or 1 µl 
Benzonase (Novagen, 25 U/µl). Proteins were resolved on a 10% Tris-Glycine 
SDS-polyacrylamide gel or a 4-15%™ TGX™ Precast gel (Biorad) transferred 
onto 0.45 μm pore size nitrocellulose membranes (Whatman) with the Semidry 
Protein Blotter or on a 0.2 µm pore size nitrocellulose membrane with the turbo 
Blot system (Biorad).  Protein loading was assessed by Ponceau Red (Sigma) 
staining. Membranes were then blocked in PBS containing 0.1% Tween-20 and 
5% milk powder, incubated with antibodies diluted in the same solution over-
night at 4°C, and washed in PBS containing 0.1% Tween-20. Horseradish 
Peroxidase (HRP) -coupled secondary antibodies (Santa Cruz or GE 
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Healthcare) in combination with Immobilon Western HRP substrate (Millipore) 
and X-ray films (Advansta) were used for detection. Films were documented 
using Kodak RP-X-OMAT.  
5.2.5 Design of LNA/DNA mixmer oligonucleotides 
LNA/DNA mixmer oligonucleotides were designed antisense to the RNA of 
interest. For efficient performance of the oligonucleotide different design 
guidelines were considered as the incorporation of LNA in an oligonucleotide 
sequence can strongly affect the properties of the probe. Regions of strong 
secondary structure in the target RNA were avoided. Secondary structure was 
either predicted using secondary structure prediction tools (mfold: Zuker, 2003) 
or making use of published RNA secondary structure (ribosomal RNA). The 
length of the oligonucleotides was designed to be between 21-23 nucleotides. 
The specificity of the antisense sequence was checked by performing a BLAST 
search for possible other RNA targets. Single LNA residue stabilizes not only 
base pairing with the complementary RNA nucleotide, but also that of 
immediate DNA neighbors with their complementary RNA bases. Thus, 
LNA/DNA mixmers confer substantial duplex stabilization, making the use of all-
LNA probes unnecessary. The end positions of the oligonucleotide were 
avoided in order to keep flexibility of the probe for hybridization. Self-
complementarity and dimerization can increase when positioning of the LNA is 
wrong. The general design tools provided by Exiqon 
(https://www.exiqon.com/oligo-tools) were used to check melting temperature 
(Tm), self-complementarity and dimerization. At the 3’end a flexible C6 linker 
carrying a primary Amine was introduced for covalent coupling chemistry. All 
oligonucleotides were purified by Exiqon via HPLC purification.  
LNA scramble: A+CAC+TTAAC+CGTA+TAT+TCC+TA/3AmMO 
LNA1: ACC+TATA+AGA+AC+CAT+TACC+AGA/3AmMO/ 
LNA2: T+TCAA+TCA+CAT+CTA+CTAC+ACTT/3AmMO/ 
LNA 18S rRNA: T+TAA+TCA+TGG+CCTC+AGTT+CCGA/3AmMO/ 
LNA 28S rRNA: CC+AA+TCC+TTAT+CCCG+AAGTT+AC/3AmMO/ 
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5.2.6 Oligonucleotide coupling to carboxylated magnetic beads 
For the coupling procedure, DNA/RNA LoBind tubes (Eppendorf) were used to 
reduce the loss of oligonucleotide to the tube surface. During the coupling 
process, the oligonucleotide was coupled to the carboxy activated surface of the 
magnetic beads (Perkin Elmer MPVAC11) via its 3’ Aminomodifier. Coupling 
was performed in 100 µL bead slurry portions (50 mg/mL). First, beads were 
washed three times in 50 mM MES buffer pH 6. The coupling activator N-(3-
Dimethylaminopropyl)-N′-ethylcarbodiimide hydrochloride (EDC-HCl; Sigma) 
was freshly prepared in a 20 mg/mL solution in MES buffer and cooled on ice 
before usage. To 100 µL beads 100 µL of oligonucleotide (100 pmol/µL) and 
500 µL of EDC-HCl solution was added. Coupling was performed for 5 h at 
50°C shaking at 800 rpm. Temperature of 37°C and shorter incubation time for 
2 h was tested as well together with the described standard protocol with a 
bead slurry volume of 5 µL using oligo. For coupling tests, 20 mers of oligodA 
with a Cy5 label at its 5’end and a primary Amine at its 3’end were used. 
Coupling performance for the test protocol was controlled by fluorescence 
measurement and for the standard protocol coupling efficiency was controlled 
via NanoDrop measurement. For NanoDrop measurement around half of the 
nucleotide amount was depleted from the supernatant after coupling. After 
coupling the beads were washed two times with PBS and residual carboxyl 
residues were inactivated by incubating the beads with 200 mM Ethanolamine 
ph 8 for 1h at 37°C. Beads were finally washed three times with 1 M NaCl and 
stored in PBS supplemented with 0.1% Tween. 
5.2.7 Oligonucleotide coupling to magnetic Epoxy beads 
For the coupling procedure, DNA/RNA LoBind tubes (Eppendorf) were used to 
reduce the loss of oligonucleotide to the tube surface. During the coupling 
process the oligonucleotide was coupled to the epoxy activated surface of the 
magnetic beads (Perkin Elmer MPVA E01) via its 3’ Aminomodifier. For the 
coupling efficiency tests, coupling was performed in 5 µL bead slurry portions 
(50 mg/mL). First, beads were washed three times in 0.1 M sodiumphosphate 
buffer pH 8. For coupling tests 20mers of oligodA with a Cy5 label at its 5’end 
and a primary Amine at its 3’end were used. The coupling was performed in a 
volume of 100 µL buffered with 0.1 M sodiumphosphate buffer pH 8 for 48 h at 
25°C or 37°C  respectively. The beads were continuously shaking at 800 rpm 
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during the coupling. Coupling performance was controlled via Fluorescence 
measurement. After coupling the beads were washed two times with PBS and 
residual epoxy residues were inactivated by incubating the beads with 200 mM 
Ethanolamine ph 8 for 1 h at 37°C. Beads were finally washed two times with 1 
M NaCl and stored in PBS supplemented with 0.1% Tween-20. 
5.2.8 Fluorescence measurements for oligonucleotide coupling and 
hybridization tests 
Fluorescence was measured in a TECAN Safire II microplate reader, using the 
following parameters: Cy5: the optimal excitation and emission are 630 nm and 
670 nm; Cy3: the optimal excitation and emission are 520 nm and 590 nm. In all 
cases bandwidth was restricted to 5 nm and gain was set using a well of the 
prepared standard. A standard was prepared for the fluorescence 
oligonucleotide in beads and in buffer. Measurements were prepared in 
triplicates for coupling and hybridization conditions. Fluorescent 
oligonucleotides were synthesized by MWG. For coupling tests 20mers of 
oligodA with a Cy5 label at its 5’end and a primary Amine at its 3’end were 
used. For hybridization tests 20mers of oligodT with a Cy3 label at its 3’end 
were used. Hybridization was performed in 100 µL volume in the lysis buffer 
used in interactome capture for 1 h at 4°C rotating. Washings after the 
hybridization were performed two times with buffers of the interactome capture 
with a volume of 750 µL per wash. The hybridized oligonucleotide was not 
released but measured on the bead by fluorescence measurement. Non-
hybridized oligonucleotide was measured in the supernatant. 
5.2.9  Cell culture  
Adherent HeLa cells (American type culture collection (ATCC), cat. no. CCL-2) 
were cultured in Dulbecco’s Modified Eagle’s Medium (Sigma-Aldrich) with 4.5 
mg/L D-glucose (Sigma-Aldrich) supplemented with 10% heat inactivated fetal 
bovine serum (Gold, GE Healtcare), 2 mM L-glutamine (Sigma-Aldrich) and 10 
mL/L penicillin/streptomycin mix (Sigma-Aldrich; P4333) at 37°C in 5% CO2. 
Cells were seeded in 500 cm2 dishes (Corning) and grown till 70-90% 
confluency.  
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5.2.10 RNA interactome captures 
The methods used and the buffers for lysis and the washings were based on a 
published protocol (Castello et al. 2012; Castello et al. 2013). 
5.2.10.1 HeLa RNA interactome capture 
HeLa cells with a confluency of 80-90% on a 500 cm2 dish were washed two 
times with 30 mL of PBS. Afterwards all the liquid was removed and the cells 
were irradiated on ice with an energy of 150 mJ/cm2 at 254 nm in a Stratalinker. 
For the non-crosslinked control the cells were processed in parallel with the 
same washings and incubation on ice. HeLa cells from 1x500 cm2 dish were 
harvested and lysed in 4 mL of lysis buffer supplemented with protease inhibitor 
(complete EDTAfree, Roche) and RNase Inhibitor (RNAsIn produced in house), 
and homogenized with five strokes using a narrow gauge needle (0.4 mm 
diameter). After an Input sample was taken, Poly(A)+ mRNAs and crosslinked 
proteins were captured with oligo(dT)25 magnetic beads (NE Biolabs). 
Subsequently, oligo(dT)25 beads were washed two times with 1.9 mL of buffers 
containing decreasing concentrations of LiCl and LiDS (Buffer 1; Buffer2; Buffer 
3). RNAs and crosslinked proteins were eluted with RNase free H2O at 90°C. 
For RNA analysis, samples were digested with proteinase K in proteinase K 
buffer at 55°C for 1h. RNA from Input and eluates was isolated from a 10µL 
aliquot with RNA Microprep Kit (Zymo Research). For protein analysis, samples 
were treated for 1 h at 37°C with 0.5 µL RNAse T1 (1 mg/mL; Sigma) and 0.5 
µL RNase A (2 mg/mL; Sigma), and released proteins were analyzed by silver 
staining or Mass Spectrometry. 
5.2.10.2 Specific RNP capture in HeLa translational active extracts 
Single RNP capture was performed using 3 mL of cleared HeLa cytoplasmic 
extracts (Cilbiotech) in which translational assays of 7.5 mL total volume with 
heat denatured 65 µg Rluc reporter RNA ( RNA with wt = BREF or mut Sxl 
binding sites BmR(EF)m, see plasmid construction) and 4xmolar excess of 
recombinant N-terminal GST-tagged Sxl RNA binding domains (a generous gift 
from Medenbach lab) were performed at 25°C for 1 h. Afterwards translational 
extracts were evenly spread on 500 cm2 cell culture dishes and irradiated with 
an energy dose of 300 mJ/cm2 at 254 nm. 5x lysis buffer supplemented with 
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protease inhibitor and RNasIn (complete EDTAfree, Roche) was added to the 
extracts. An input sample was taken from the processed lysate. 250 µl 
LNA/DNA mixmer oligonucleotide coupled magnetic beads targeting the Rluc 
reporter sequence of the RNA were 3x washed with TE buffer and then blocked 
with 200 µg yeast tRNA for 15 min at 30°C. Subsequently, beads were washed 
in lysis buffer and heat denatured for 3’ at 95°C. The crosslinked lysate was 
added to the beads and hybridization was performed for 2 h at 41°C in a 
waterbath with intermittent shaking for a pulldown with LNA beads and for 2 h at 
25°C for a pulldown with oligodT beads.  Afterwards, beads were washed two 
times with buffers containing decreasing concentrations of LiCl and LiDS (Buffer 
1; Buffer 2; Buffer 3) as described previously (Castello et al. 2012; Castello et 
al. 2013). RNAs and crosslinked proteins were eluted with TE buffer at 90°C for 
3’. Three rounds of pull down were performed. For RNA analysis, samples were 
digested with proteinase K in proteinase K buffer at 55°C for 1h. RNA from Input 
and eluates was isolated from a 10µL aliquot with RNA Microprep Kit (Zymo 
Research). For protein analysis, samples were treated for 1 h at 37°C with 0.5 
µL RNAse T1 (1 mg/mL; Sigma) and 0.5 µL RNase A (2 mg/mL; Sigma), and 
released proteins were analyzed by silver staining and Western Blotting. 
5.2.10.3 Specific RNP capture in Drosophila melanogaster embryo 
extracts 
10 µg (32 pmol) in vitro transcribed reporter RNA was heat denatured at 95°C 
for 3 min in LoBind tubes (Eppendorf). Then 2 mL Drosophila melanogaster 
embryo extract was added to the cooled down RNA and incubated for 30 min at 
25°C in a waterbath. Afterwards, the extract was evenly spread on a 15 cm cell 
culture dish on ice and irradiated with an energy dose of 300 mJ/cm2 at 254 nm. 
After crosslinking, 2 mL of a 2x lysis buffer supplemented with RNase Inhibitor 
(RNAsIn produced in house) and protease inhibitor (complete, Roche) was 
added. After snap freezing the lysate in liquid nitrogen, the beads were 
prepared for the pulldown. 200 µL with LNA/DNA mixmer oligonucleotide 
coupled magnetic beads were 3x washed with TE buffer and then blocked with 
200 µg yeast tRNA for 15 min shaking at 30°C. Subsequently, beads were 
washed in 1x lysis buffer and heat denatured for 3’ at 95°C. The crosslinked 
lysate was added to the beads and hybridization was performed for 2 h at 41°C 
in a waterbath with intermittent shaking. Afterwards beads were washed two 
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times with buffers containing decreasing concentrations of LiCl and LiDS (Buffer 
1; Buffer 2; Buffer 3) as described previously.   RNAs and crosslinked proteins 
were eluted with TE Buffer pH 7.5 for 3’ at 90°C. The pulldown was performed 
in four replicates and in three different set ups. LNA1 was targeting the wild type 
or the mutant in vitro transcribed Rluc reporter, whereas LNAscr control was 
used for the wild type Rluc reporter. For RNA analysis, samples were digested 
with proteinase K in proteinase K buffer at 55°C for 1h. RNA from Input and 
eluates was isolated from a 10 µL aliquot with RNA Microprep Kit (Zymo 
Research). For protein analysis via Mass Spectrometry, the eluates were 
concentrated to 100 µL on a Amicon filter column with a cut off of 3 kDa. At the 
proteomics core facility RNase digest with Benzonase was performed before 
starting the sample preparation (see Mass Spectrometry sample preparation). 
5.2.10.4 Specific RNP capture of 18S and 28S rRNA in HeLa cells  
HeLa cells with a confluency of 70% on a 500 cm2 dish were washed two times 
with 30 mL of PBS. Afterwards, all the liquid was removed and the cells were 
irradiated on ice with an energy dose of 150 mJ/cm2 at 254 nm in a Stratalinker. 
For the non-crosslinked control the cells were processed in parallel with the 
same washings and incubation on ice. HeLa cells from 1x500 cm2 dish were 
harvested and lysed in 4 mL of lysis buffer supplemented with protease inhibitor 
(complete EDTAfree, Roche) and RNase Inhibitor (RNAsIn produced in house), 
and homogenized with five strokes using a narrow gauge needle (0.4 mm 
diameter). 4x 500 cm2 plates were prepared per sample to get a final volume of 
16 mL lysate. After snap freezing in liquid nitrogen, lysate was thawed, an Input 
was taken and the lysate was pre-warmed in the waterbath to 60°C. Then 15% 
v/v Ethylenecarbonate was added to the lysate as hybridization enhancer. 300 
µL LNA/DNA mixmer oligonucleotide coupled magnetic beads were three times 
washed with TE buffer and then blocked with 300 µg yeast tRNA for 15 min at 
30°C. Subsequently, beads were washed in lysis buffer and heat denatured for 
3’ at 95°C. The beads were added to 16 mL of lysate (coming from 4x 500cm2 
dishes) and hybridization was performed for 2 h at 41°C in a waterbath with 
intermittent shaking. For each experiment three samples were prepared, one 
with the specific 18S or 28S LNA with crosslinked lysate, one with the specific 
18S or 28S LNA with non-crosslinked lysate and one with a scramble LNA 
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control on crosslinked lysate. After hybridization, beads were washed three 
times in 1.9 mL of lysis buffer and then twice in 1.9mL of buffers with 
decreasing amount of LiDS and LiCl (Buffer 1, Buffer 2 and Buffer 3). 
Afterwards captured RNA was eluted with 150 µL RNase free H2O for 3’ at 
90°C. Six pulldown rounds were performed. Each eluate was checked on 
Bioanalyzer (Agilent) for specific enrichment of the respective ribosomal RNA, 
then the six elution rounds were pooled. For RNA analysis RNA from input and 
eluates was isolated with RNA Microprep Kit (Zymo Research) after proteinase 
K treatment from a 10 µL aliquot. For Mass Spectrometry, samples were treated 
for 1 h at 37°C with Benzonase and then alkaline hydrolysis was performed to 
remove any residual RNA. For alkaline hydrolysis the sample was incubated at 
pH 12 (adjusted with NaOH) for 1 h at 60°C. Afterwards the pH was neutralized 
again with HCl. The sample was buffered by adding HEPES buffer to get final 
50 mM HEPES pH 7.5. The protein sample was then submitted for Mass 
Spectrometry to the proteomics core facility. 
5.2.10.5 18S rRNA capture after Nuclear-Cytoplasmic Fractionation from 
HeLa cells 
HeLa cells from 1x 500 cm2 dish were washed and crosslinked as mentioned 
above in specific capture of 18S rRNA. The cell pellet was re-suspended in 
three volumes of nuclear lysis buffer (Nuclear buffer + 0.5% NP40). After 
pipetting 5 times up and down the lysate was incubated for 5’ on ice. Then the 
lysate was centrifuged for 3’ at 3000 rpm at 4°C. The supernatant (cytoplasmic 
fraction) was taken and again spun for 3’ at 3000 rpm to remove any residual 
nuclei. The supernatant was then taken and mixed with 2x LiDS lysis buffer. 
The Nuclei were washed three times with Nuclear Buffer that does not include 
NP40. Then two volumes of Nuclear Buffer with 0.5% NP40 was added to the 
Nuclei and incubated with the Nuclei for 10’ on ice. The Nuclear fraction was 
sonicated with three cycles of 10’’ (3 cycles of 10 ‘’, 50% duty, level4, 15’’ 
pause). After sonication 200x DNAse Buffer and 1µL DNaseI (Ambion) and 1µL 
TurboDNAse (Ambion) were added and incubated for 10’ at 37°C. After 
digestion the Nuclear fraction was mixed with 2x LiDS lysis buffer (added 5 mM 
more EDTA to chelate Mg Ions). Inputs from the Nuclear and Cytoplasmic 
fractions were taken to confirm clean fractionation on Western Blot by using 
antibodies raised against the nuclear marker Ki67 and the cytoplasmic marker 
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Tubulin. 18S rRNA was performed as described before with 100 µL beads and 
2 rounds of hybridization. For RNA analysis RNA from input and eluates was 
isolated after proteinase K treatment from a 10µL aliquot with RNA Microprep 
Kit (Zymo Research). 
 
5.2.11 Sample Preparation for Mass Spectrometry  
5.2.11.1 Sample Preparation for Mass Spectrometry (specific RNP 
capture in Drosophila melanogaster embryo extracts) 
Samples were submitted to EMBL Proteomics Core Facility in TE Buffer. 1x 
Protease Inhibitor Cocktail (Roche) and 1 µl Benzonase (Novagen, 25 U/µl) was 
added to the samples and incubated at 37°C for 1 h. Cysteines were reduced 
with 1 µl of 200 mM DTT (Biomol) in 50 mM HEPES (Biomol) for 30 min. at 57 
°C. The sample was cooled to 24 °C and 2 μL of 400 mM IAA (Merck) dissolved 
in 50 mM HEPES was added and incubated in dark for 30 min. at 24 °C. A 
novel protocol using paramagnetic beads, termed Single-Pot Solid-Phase-
enhanced Sample Preparation (SP3) (Hughes et al. 2014) was used to prepare 
the samples for LC-MS/MS. The proteins were digested using trypsin 
(Promega) with an enzyme to protein ratio 1:50 at 37°C overnight. Peptides 
were labeled on magnetic rack using 1% formaldehyde (CH2O, CD2O, 
13CD2O) and 0.2 M sodium cyanoborohydride solution (NaBH3CN, NaBD3CN) 
for 1 hour at room temperature.  
5.2.11.2 Sample Preparation for Mass Spectrometry (human rRNA 
interactome) 
~1 mL RNAse treated samples were submitted to EMBL Proteomics Core 
Facility in 50 mM HEPES buffer pH 7.5. Proteins were precipitated by adding 
ice cold trichloractetic acid (TCA) to 4 parts of protein sample. Then the sample 
was left on ice for 20-30 min. Samples were spun for 20 min at 4°C at 20k g. 
TCA supernatant was removed and the protein pellet was washed with 1 mL of 
10% TCA, vortexed and spun again for 20 min at 4°C at 20k g. The washing 
step was repeated twice with 1 mL of acetone and spun for 30 min at 4°C at 20k 
g. Afterwards the pellet was air dried and solubilized in 60 µL of 50 mM HEPES. 
Cysteines were reduced with 1 µl of 200 mM DTT (Biomol) in 50 mM HEPES 
(Biomol) for 30 min. at 57 °C. The sample was cooled to 24 °C and 2 μL of 400 
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mM IAA (Merck) dissolved in 50 mM HEPES was added and incubated in dark 
for 30 min at 24 °C. Proteins were then digested with 800 ng Trypsin (Promega) 
at 37°C overnight. Peptides were desalted and labeled with high, medium and 
low dimethyl-labeling reagent using OASIS 96 well plate (Waters). Afterwards 
the labeled peptides were eluted from the plate with Buffer B (60% methanol, 
1% formaldehyde in water). 
5.2.12 LC-MS/MS 
Measurements were performed by the EMBL proteomics core facility. Peptides 
were separated using the nanoAcquity ultra performance liquid chromatography 
(UPLC) system (Waters) fitted with a trapping (nanoAcquity Symmetry C18, 5 
μm, 180 μm x 20 mm) and an analytical column (nanoAcquity BEH C18, 1.7 
μm, 75 μm x 200 mm). The outlet of the analytical column was coupled directly 
to a LTQ Orbitrap Velos Pro (Thermo Fisher Scientific) using the Proxeon 
nanospray source. The samples were loaded with a constant flow of solvent A 
(0.1% formic acid) at 5 μL/min onto the trapping column. Trapping time was 6 
min. Peptides were eluted via the analytical column with a constant flow of 0.3 
μL/min. During the elution step, the percentage of solvent B (acetonitril, 0.1% 
formic acid) increased in a linear fashion from 3% to 7% within 10 min., then 
increased to 25% within 100 min (60 min for human ribosomal rna interactome) 
and finally to 40% within a further 10 min (5 min for human ribosomal rna 
interactome). The peptides were introduced into the mass spectrometer 
(Orbitrap Velos, Thermo Fisher Scientific) via a Pico-Tip Emitter 360 μm OD x 
20 μm ID; 10 μm tip (New Objective) and a spray voltage of 2.2 kV was applied. 
The capillary temperature was set at 300°C. Full scan MS spectra with mass 
range 300-1700 m/z were acquired in profile mode in the FT with resolution of 
30000. The filling time was set at maximum of 500 ms with limitation of 1.0 x 
106 ions. The most intense ions (up to 15) from the full scan MS were selected 
for sequencing in the LTQ. Normalized collision energy of 40% was used, and 
the fragmentation was performed after accumulation of 3.0 x104 ions or after 
filling time of 100 ms for each precursor ion (whichever occurred first). MS/MS 
data was acquired in centroid mode. Only multiply charged (2+, 3+, 4+) 
precursor ions were selected for MS/MS. The dynamic exclusion list was 
restricted to 500 entries with maximum retention period of 30 s and relative 
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mass window of 10 ppm. In order to improve the mass accuracy, a lock mass 
correction using the ion (m/z 445.12003) was applied. 
5.2.13 Proteomic Data Analyses 
Analysis was performed by the EMBL proteomic core facility.All data-dependent 
data were analyzed using MaxQuant (v 1.4.1.2). Carbamidomethylation of 
cysteine was specified as a fixed modification, acetylation of the protein N-
terminus and oxidation of methionine as variable. More variable modifications of 
the N-terminus and lysine were specified for masses of +28.0313 (light 
dimethyl), +32.0564 (medium dimethyl), +36.0757 (heavy dimethyl) and 
oxidation of methionine in all searches. The data were searched against the 
Uniprot_Drosophila_20140519 database. For all searches, trypsin was specified 
with 2 missed cleavage allowed.  
5.2.14 Bioinformatic Analyses 
Performed by Bernd Fischer 
5.2.14.1 Bioinformatic Analysis for RNP capture in Drosophila 
melanogaster embryo extracts 
Peptides were mapped back to the Uniprot protein database (Version 2014_06). 
Peptides uniquely mapping to one gene model and to the largest protein 
translation of this gene model were used for subsequent analysis. Protein log2-
intensity ratios were computed by averaging the peptide log2-intensity ratios per 
protein. Protein ratios were divided by the median deviation to compensate for 
scaling effects. For comparison of wild type to mutant proteins, the median ratio 
was subtracted to center the ratios around zero. 
Protein ratios were tested against the hypothesis that the ratio is zero by a 
moderated t-test (Lönnstedt & Speed 2002) implemented in the R/Bioconductor 
package limma (Gordon K Smyth 2004). The method of Benjamini-Hochberg 
(Benjamini & Hochberg 1995) that controls for the false discovery rate was used 
to adjust the p-values for multiple testing. 
5.2.14.2 Bioinformatic Analysis for RNP capture of human ribosomal 
RNA 
Peptides were mapped back to the Uniprot protein database (Version 2014_06). 
Peptides uniquely mapping to one gene model and to the largest protein 
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translation of this gene model are used for subsequent analysis. To compare 
the conventional cross-linking fraction to the non-cross linking fraction a semi-
quantitative approach was chosen. For each sample and each protein, it was 
assessed, if the protein was identied for at least one protein. Then it was 
counted in how many samples each protein is quantied for CCL samples 
(nCCL), for NoCL samples (nNoCL) and for Scr samples (nScr). We counted 
and list all genes that are quantified in at least two more CCL samples than in 
NoCL samples. The false discovery rate was estimated by the reverse events 
(at least two more quantifications in the NoCL samples). 1 was added to the 
estimated number of false discoveries to reduce the chance of an 
underestimation of the false-discovery rate due to small numbers.  
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6 Abbreviations 
 
4SU 4-thiouridine 
6SG 6-thioguanosine 
ARE AU rich element 
bcd bicoid 
bp Basepairs 
C Celsius 
CAS CRISPR associated protein 
cCl Conventional Crosslink (254nm) 
cDNA complementary/copy DNA 
CDS Coding sequence 
CHIP chromatin immunoprecipitation 
CIP calf intestine phosphatase  
circRNA circular RNA 
CLIP cross-linking immunoprecipitation 
CLIP-seq cross-linking immunoprecipitation-high-throughput sequencing 
CRISPR clustered interspaced short palindromic repeats 
Da Dalton 
DNA Desoxyribonucleic acid 
DMEM Dulbecco's Modified Eagle Medium 
dsRBM double stranded RNA binding motif 
dsRNA Double stranded RNA 
DTT Dithiothreitol 
E. coli Escherichia coli 
ECL Enhanced Chemoluminscence 
eCLIP enhanced CLIP 
EDC 1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide 
EDTA Ethylenediaminetetraacetic acid 
eEF eukaryotic elongation factor 
eIF eukaryotic translation initiation factor 
eRF eukaryotic release factor 
ES ribosomal expansion segment 
ES cells embryonic stem cells 
ETS External transcribed spacer 
FA Xlink Formaldehyde crosslinking 
FBS Fetal Bovine Serum 
Fluc Firefly Luciferase 
GAPDH Glyceraldehyde phosphate Dehydrogenase 
GO Gene Ontology 
grk gurken 
GTP guanosinetriphosphate 
h Hour(s) 
HEPES 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid 
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HRP Horseradish peroxidase 
iCLIP individual-nucleotide resolution CLIP 
IFNy Interferon γ 
IRE Iron responsive element 
IRES Internal ribosomal entry site 
IRP1 Iron regulatory protein 1 
ITC Isothermal Calorimetry 
ITS Internal transcribed spacer 
J Joule 
k kilo 
KH hnrnp K homology motif 
LC-MS/MS Liquid chromoatography coupled with tandem mass spectrometry 
LiDS Lithium Dodecyl Sulfate 
LNA Locked Nucleic Acid(s) 
lncRNA long non coding RNA 
m7G 7-methylguanosin 
MCP MS2 coat protein 
Met Methionine 
min Minute(s) 
miRNA microRNA 
mm Millimeter 
mRNA Messenger RNA 
MS Mass spectrometry 
msl2 male specific lethal 2 
mut mutant 
Ncl Nucleolin 
NGD “No go” decay 
NMR Nuclear magnetic resonance 
nos nanos 
NRD non-functional rRNA decay 
nt Nucleotides 
oligodT oligonucleotide consisting of deoxy Thymidin 
ORF Open reading frame 
osk oskar 
PABP Poly-(A) binding protein  
PAIR PNA assisted identification of RBPs 
PAM protospacer adjacent motif 
PAR-CL Photoactivatable Ribonucleoside Crosslink 
PAR-CLIP PAR-Crosslinking and Immunoprecipitation 
PBS Phosphate Buffered Saline 
PCR Polymerase Chain Reaction 
piRNA piwi interacting RNA 
PNA peptide nucleic acid 
Pol Polymerase 
qPCR qunatitative Polymerase Chain Reaction 
Abbreviations  
 
109 
 
RBD RNA Binding Domain 
RBP RNA Binding Protein 
REM RNA, enzme, metabolite 
RIP RNA immunoprecipitation 
Rluc Renilla Luciferase 
RNA Ribonucleic Acid 
RNP Ribonucleoprotein 
Rpl large subunit ribosomal protein 
rpm Rotations per minute 
Rps small subunit ribosomal protein 
RRM RNA Recognition Motif 
rRNA Ribosomal RNA 
RT room temperature (25°C) 
RT-PCR Reverse transcription polymerase chain reaction 
s Second(s) 
scr scramble(d) 
SDS Sodium dodecyl sulfate 
SDS-PAGE Sodium dodecyl sulfate polyacrylamide gel electrophoresis 
SILAC Stable isotope labeling amino acid in cell culture 
snRNP small nuclear recognition particle  
SP3 Single-Pot Solid-Phase-enhanced Sample Preparation 
Ssx Sister of Sex lethal 
Sxl Sex lethal 
tra transformer 
Tris Tris(hydroxymethyl)aminomethane 
tRNA Transfer RNA 
U2AF U2 auxiliary factor 
UNR Upstream of N-ras 
UPLC ultra performance liquid chromatography 
UTR Untranslated Region 
UV Ultraviolet 
V Volt 
wt wildtype 
Znf Zinc finger motif 
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7 Supplemental Data 
 
 
Figure S 7.1 Volcano plot comparing sample enrichments. Enrichments in the mut sample over the 
scramble sample in 4 biological replicates. Mass spectrometry measurements were performed by the 
EMBL proteomics core facility Statistical analysis and plot was created by Bernd Fischer The axes display 
the log2-fold changes (orange: 5% FDR, red: 1% FDR). 
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Figure S 7.2; Comparison of the protein sequences of Sxl and Ssx. (A) Alignment of the protein 
sequences. There is a strong conservation in the two RRMs and part of the N-terminus. (B)  Domain 
architecture s of Sxl  and Ssx displayed via SMART (http://smart.embl-heidelberg.de/). 
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Table S 7.1; log2 fold enrichments from wt/mut RNA in the four biological replicates. Log2FC 
column gives the mean of the enrichments in the different replicates. **  1% FDR; * = 5% FDR.   
Symbol WT.MT.rep
 
WT.MT.rep
 
WT.MT.rep
 
WT.MT.rep
 
log2FC p.value p.adj si
 ssx 4,28 NA NA 2,16 3,22083
 
0,0000
 
0,0078
 
** 
bic 2,11 NA NA NA 2,11027
 
0,0592
 
0,6454
  Hrb98DE 0,43 1,07 5,33 1,13 1,99239
 
0,0004
 
0,0254
 
* 
Hrb87F 1,74 1,34 2,52 1,22 1,70213
 
0,0026
 
0,0951
  lin-28 1,62 NA NA NA 1,62453
 
0,1452
 
0,9402
  RpS27A 0,21 NA 2,52 NA 1,36351
 
0,0843
 
0,7662
  RpS7 0,21 NA 2,71 0,75 1,22690
 
0,0574
 
0,6454
  elav 1,44 NA NA 0,85 1,14650
 
0,1459
 
0,9402
  rump 0,83 2,62 NA -0,03 1,14280
 
0,0765
 
0,7585
  RpS15 -0,31 -2,08 6,42 0,39 1,10330
 
0,0486
 
0,6454
  rig 0,98 NA NA NA 0,98168
 
0,3774
 
0,9402
  RpL32 0,91 NA NA NA 0,91407
 
0,4110
 
0,9402
  sqd 0,56 1,16 1,02 0,90 0,90845
 
0,1036
 
0,8692
  bnb -0,43 0,42 2,70 0,80 0,87284
 
0,1177
 
0,9169
  sp:P21187 1,11 NA NA 0,56 0,83831
 
0,2868
 
0,9402
  RpL4 0,65 NA NA NA 0,65186
 
0,5574
 
0,9402
  Pabp2 0,61 NA NA NA 0,61405
 
0,5805
 
0,9402
  larp 0,61 NA NA NA 0,61223
 
0,5816
 
0,9402
  CG30122 0,80 0,37 NA NA 0,58123
 
0,4596
 
0,9402
  eIF3-S10 0,52 NA NA NA 0,52264
 
0,6380
 
0,9402
  Ars2 0,48 NA NA NA 0,47666
 
0,6678
 
0,9402
  vig2 0,60 0,01 0,74 0,37 0,43091
 
0,4382
 
0,9402
  Df31 2,51 -0,69 -0,70 0,59 0,42798
 
0,4413
 
0,9402
  B52 -0,33 NA NA 1,16 0,41404
 
0,5981
 
0,9402
  vig 0,74 NA 0,06 NA 0,39838
 
0,6120
 
0,9402
  nonA 0,39 NA NA NA 0,39391
 
0,7228
 
0,9402
  RpL30 1,27 0,56 -0,78 NA 0,34773
 
0,5877
 
0,9402
  RpS24 1,56 -2,35 2,07 0,03 0,32873
 
0,5540
 
0,9402
  CG9915 0,73 0,41 0,25 -0,08 0,32607
 
0,5572
 
0,9402
  Imp 0,33 NA NA NA 0,32566
 
0,7693
 
0,9402
  La 0,33 NA NA NA 0,32500
 
0,7698
 
0,9402
  RpL15 1,23 0,00 0,32 -0,25 0,32454
 
0,5591
 
0,9402
  RpL13 0,32 NA NA NA 0,31890
 
0,7740
 
0,9402
  RpS12 3,09 0,12 -0,01 -1,94 0,31721
 
0,5680
 
0,9402
  lost -0,37 1,41 -1,06 1,23 0,30241
 
0,5862
 
0,9402
  RpS3 -0,02 0,11 NA 0,81 0,30192
 
0,6378
 
0,9402
  Nlp NA NA NA 0,29 0,29263
 
0,7921
 
0,9402
  Dp1 0,23 NA NA NA 0,23383
 
0,8332
 
0,9426
  CG3800 -0,51 1,20 -0,49 0,69 0,22092
 
0,6908
 
0,9402
  RpL3 0,21 NA NA NA 0,20871
 
0,8509
 
0,9464
  RpS17 1,09 NA -0,15 -0,38 0,18552
 
0,7723
 
0,9402
  sp:Q9V3T8 1,32 0,72 -1,59 0,28 0,17983
 
0,7460
 
0,9402
  RpS2 0,57 -1,30 1,18 0,14 0,14526
 
0,7936
 
0,9402
  CG9894 0,21 -0,68 2,77 -1,74 0,13890
 
0,8024
 
0,9405
  CG8636 0,10 NA NA NA 0,10364
 
0,9256
 
0,9836
  RpS4 0,09 NA NA NA 0,08584
 
0,9383
 
0,9836
  rin 0,16 -0,04 0,31 -0,21 0,05593
 
0,9197
 
0,9836
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RpS27 0,04 NA NA NA 0,04057
 
0,9708
 
0,9878
  Hrb27C 0,95 -0,17 0,01 -0,70 0,02122
 
0,9695
 
0,9878
  RpS6 -0,44 NA NA 0,46 0,01190
 
0,9878
 
0,9878
  RpS14a 0,71 NA NA -0,74 -
 
0,9852
 
0,9878
  Ef2b -0,07 NA NA NA -
 
0,9475
 
0,9836
  RpS16 -0,08 NA NA NA -
 
0,9438
 
0,9836
  x16 -0,12 NA NA NA -
 
0,9165
 
0,9836
  CG42351 0,68 -0,06 -1,00 -0,11 -
 
0,8243
 
0,9426
  eIF-3p66 -0,13 NA NA NA -
 
0,9094
 
0,9836
  Tudor-SN 0,55 NA -0,56 -0,38 -
 
0,8388
 
0,9426
  Dek -0,26 0,91 -0,33 -0,93 -
 
0,7822
 
0,9402
  CG1677 0,55 -0,08 -0,90 -0,37 -
 
0,7171
 
0,9402
  tral -0,09 -0,08 NA -0,48 -
 
0,7354
 
0,9402
  yps -0,81 0,67 -0,51 -0,27 -
 
0,6809
 
0,9402
  SF2 -0,24 NA NA NA -
 
0,8312
 
0,9426
  Pep -1,33 1,13 -0,39 -0,43 -
 
0,6454
 
0,9402
  RpS11 -0,64 0,32 0,44 -1,20 -
 
0,6286
 
0,9402
  lig 0,11 NA NA -0,71 -
 
0,7034
 
0,9402
  RpS10b 0,48 -1,14 NA NA -
 
0,6738
 
0,9402
  glo -0,34 NA NA NA -
 
0,7622
 
0,9402
  lark -0,36 NA NA NA -
 
0,7485
 
0,9402
  bel -0,36 NA NA NA -
 
0,7460
 
0,9402
  eIF3-S8 -0,24 NA -0,49 NA -
 
0,6395
 
0,9402
  Rox8 -0,38 NA NA NA -
 
0,7340
 
0,9402
  Fmr1 0,86 -1,45 -0,48 -0,46 -
 
0,4933
 
0,9402
  nito -0,43 NA NA NA -
 
0,6987
 
0,9402
  fne -0,44 NA NA NA -
 
0,6919
 
0,9402
  bl -0,45 NA NA NA -
 
0,6859
 
0,9402
  RpL5 -0,46 NA NA NA -
 
0,6791
 
0,9402
  asp -0,46 NA NA NA -
 
0,6758
 
0,9402
  CG31813 -0,73 -0,29 -0,65 -0,22 -
 
0,3959
 
0,9402
  RpS13 -0,18 -0,80 NA NA -
 
0,5345
 
0,9402
  RpS25 -0,50 NA NA NA -
 
0,6558
 
0,9402
  RpS19a -0,42 NA 0,31 -1,42 -
 
0,4269
 
0,9402
  RpS20 0,04 NA -0,78 -0,83 -
 
0,4157
 
0,9402
  RpL24 1,24 -2,39 0,03 -0,97 -
 
0,3462
 
0,9402
  CG5787 -0,57 NA NA NA -
 
0,6049
 
0,9402
  RpS9 0,02 -0,10 -1,24 -1,00 -
 
0,2973
 
0,9402
  RpS18 0,66 -0,55 -1,72 -0,80 -
 
0,2795
 
0,9402
  mod -0,63 NA NA NA -
 
0,5738
 
0,9402
  RpS3A -0,72 NA NA NA -
 
0,5180
 
0,9402
  Capr -0,82 NA NA NA -
 
0,4594
 
0,9402
  nonA-l -0,84 NA NA NA -
 
0,4495
 
0,9402
  RpS26 -0,85 NA NA NA -
 
0,4458
 
0,9402
  RpS8 -0,86 NA NA NA -
 
0,4375
 
0,9402
  RpL18 -0,88 NA NA NA -
 
0,4309
 
0,9402
  Rack1 -0,91 NA NA NA -
 
0,4121
 
0,9402
  RpL18A -0,93 NA NA NA -
 
0,4043
 
0,9402
  RpL36 -0,93 NA NA NA -
 
0,4034
 
0,9402
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sta 1,45 NA NA -3,49 -
 
0,1971
 
0,9402
  RpL14 -2,39 NA NA 0,20 -
 
0,1640
 
0,9402
  RpL19 -1,11 NA NA NA -
 
0,3199
 
0,9402
  Psi -1,20 NA NA NA -
 
0,2829
 
0,9402
  RpL6 -1,21 NA NA NA -
 
0,2759
 
0,9402
  RpL13A -1,24 NA NA NA -
 
0,2661
 
0,9402
  Ref1 -1,10 -0,68 -2,63 -0,64 -
 
0,0247
 
0,5384
  CG9775 -1,33 NA NA NA -
 
0,2320
 
0,9402
  RpL7 -1,44 NA NA NA -
 
0,1949
 
0,9402
  Pdcd4 -1,47 NA NA NA -
 
0,1869
 
0,9402
  RpL22 -2,14 NA NA NA -
 
0,0559
 
0,6454
  RpL8 -2,30 NA NA NA -
 
0,0402
 
0,6454
  CG8108 -2,68 NA NA NA -
 
0,0170
 
0,4647
  CG30118 NA NA NA NA NA NA NA 
 CG13114 NA NA NA NA NA NA NA 
 CoRest NA NA NA NA NA NA NA 
 tko NA NA NA NA NA NA NA 
 RpS15Aa NA NA NA NA NA NA NA 
 RpL27A NA NA NA NA NA NA NA 
 U2af38 NA NA NA NA NA NA NA 
 RpS21 NA NA NA NA NA NA NA 
 RpL37a NA NA NA NA NA NA NA 
 cib NA NA NA NA NA NA NA 
 sp:P02283 NA NA NA NA NA NA NA 
 Yp1 NA NA NA NA NA NA NA 
 Yp2 NA NA NA NA NA NA NA 
 Cp36 NA NA NA NA NA NA NA 
 Cp15 NA NA NA NA NA NA NA 
 Ef1alpha48D NA NA NA NA NA NA NA 
 dec-1 NA NA NA NA NA NA NA 
 Rm62 NA NA NA NA NA NA NA 
 bap NA NA NA NA NA NA NA 
 RpL7A NA NA NA NA NA NA NA 
 Cam NA NA NA NA NA NA NA 
 wibg NA NA NA NA NA NA NA 
 RpS5a NA NA NA NA NA NA NA 
 SmF NA NA NA NA NA NA NA 
 CG14756 NA NA NA NA NA NA NA 
 trsn NA NA NA NA NA NA NA 
 CG8635 NA NA NA NA NA NA NA 
 CG13326 NA NA NA NA NA NA NA 
 CG13083 NA NA NA NA NA NA NA 
 Zn72D NA NA NA NA NA NA NA 
 CG32017 NA NA NA NA NA NA NA 
 CG31064 NA NA NA NA NA NA NA 
 CG3508 NA NA NA NA NA NA NA 
 CG32720 NA NA NA NA NA NA NA 
 Jafrac1 NA NA NA NA NA NA NA 
 Sucb NA NA NA NA NA NA NA 
 Pur-alpha NA NA NA NA NA NA NA 
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CG7911 NA NA NA NA NA NA NA 
 CG6255 NA NA NA NA NA NA NA 
 eIF-1A NA NA NA NA NA NA NA 
 Bin1 NA NA NA NA NA NA NA 
 RpS5b NA NA NA NA NA NA NA 
 CG9684 NA NA NA NA NA NA NA 
 eIF4AIII NA NA NA NA NA NA NA 
 CG13084 NA NA NA NA NA NA NA 
 CG10341 NA NA NA NA NA NA NA 
 ncm NA NA NA NA NA NA NA 
 CG17768 NA NA NA NA NA NA NA 
 CG13096 NA NA NA NA NA NA NA 
 CG10418 NA NA NA NA NA NA NA 
 SRm160 NA NA NA NA NA NA NA 
 SmG NA NA NA NA NA NA NA 
 Pkcdelta NA NA NA NA NA NA NA 
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Figure S 7.3; RNA analysis after specific RNP capture with and without ethylenecarbonate (EC) 
inclusion during hybridization. (A) After specific RNP capture of 18S rRNA RNA was analyzed using a 
6000 Pico bioanalyzer. The 2 peaks from the Input samples come from 18S (runs at 2000 nt) and 28S 
(runs at 4000 nt). The y-axes display the fluorescence intensity coming from a dye labeling the RNA 
quantitatively. (B) After specific RNP capture of oskar mRNA (Osk) in Drosophila embryo extract, RNA was 
analyzed by qPCR; Levels of pulled out oskar mRNA and control RLuc RNA were quantified in relation to 
the Input in %. Error bars display standard deviation coming from 3 replicates. 
 
 
Figure S 7.4; RNA analysis after ribosomal specific RNP capture. (A) After specific RNP capture of 
18S rRNA, RNA was analyzed by qPCR; Levels of pulled out18S rRNA and28S rRNA were quantified in 
relation to the Input in %. Error bars display standard deviation coming from 3 replicates. (B) After specific 
RNP capture of 28S rRNA, RNA was analyzed by qPCR; Levels of pulled out18S rRNA and28S rRNA 
were quantified in relation to the Input in %. Error bars display standard deviation coming from 3 replicates. 
Supplemental Data  
 
117 
 
Table S 7.2; Proteins enriched from 18S rRNA after specific RNP capture. Mass spectrometry 
measurements were performed by the EMBL proteomics core facility; Bernd Fischer did the semi-
quantitative analysis of the three replicates. The amount of enrichments (n) in crosslinked sample (cCl) 
was compared to the non crosslinked (NocCl) and scrambled control (Scr). The estimated false discovery 
rate was calculated with following formula: (0+1)/n; being 6.2% (enriched over NocCl), being 7.1% 
(enriched over Scr) for the listed proteins;  
Symbol nCCL nNoCL nScr sigNoCL sigScr 
YBX3 2 0 0 * * 
ELAVL1 2 0 0 * * 
EIF3J 2 0 0 * * 
NCL 3 0 1 * * 
RPS15 3 0 1 * * 
RPL22 3 0 0 * * 
HNRNPA1 2 0 0 * * 
LRPPRC 2 0 0 * * 
RPS24 3 0 0 * * 
SERBP1 3 0 1 * * 
RPL8 3 0 0 * * 
RPSA 2 0 0 * * 
HNRNPH1 2 0 0 * * 
HNRNPF 3 0 0 * * 
YBX1 3 0 3 *   
RPS2 2 0 2 *   
RPL31 0 0 0     
ZFYVE26 0 0 0     
P2RY10 1 1 1     
TNPO1 0 0 0     
XRN2 0 0 0     
HNRNPC 0 0 0     
HSP90AB1 0 0 0     
HNRNPH3 0 0 0     
HNRNPM 0 0 0     
HCFC1R1 0 0 0     
CASP14 0 0 0     
SSBP1 0 0 1     
COL1A1 0 0 0     
CPE 0 1 0     
FOLR3 0 0 0     
ATP5B 0 0 0     
ARHGDIB 1 1 1     
RPL24 1 0 0     
TAF1B 1 0 0     
SFPQ 0 0 0     
KMT2A 1 1 1     
FKBP15 1 1 1     
CSTA 1 0 0     
RPL5 0 0 0     
HNRNPA2B1 1 0 0     
H2BFWT 0 0 0     
ATG14 1 1 1     
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ZSCAN5A 0 0 0     
DSG1 0 0 0     
HNRNPD 1 0 0     
BTF3 0 0 0     
NONO 0 0 0     
RPL7 0 0 0     
MKI67 0 0 0     
OLAH 0 0 0     
HNRNPDL 0 0 0     
TMEM87B 1 1 1     
MCOLN2 0 0 0     
MAGED4 0 0 0     
AFAP1L1 1 1 1     
HIST1H4H 0 0 0     
ATP6V0D1 2 2 2     
TRAPPC10 0 0 0     
LCN1 2 1 1     
SRSF2 0 0 0     
DCD 0 0 0     
FMNL3 0 0 1     
CCDC78 1 1 1     
RPL29 0 0 0     
CFAP221 0 0 0     
SPTA1 0 0 0     
GTPBP8 0 0 0     
HNRNPK 0 0 0     
C19orf33 1 0 0     
PLIN4 1 0 0     
KRT1 3 3 3     
SRRM2 1 0 0     
PA2G4 1 0 0     
JUP 0 0 0     
RPL4 0 0 0     
TUBB6 1 0 0     
COX5A 0 0 0     
CCDC89 0 0 0     
RESP18 0 0 0     
NAA38 0 1 0     
ABAT 1 1 1     
ARAP1 0 0 0     
KCNJ11 1 1 1     
NCOR2 0 0 0     
HNRNPAB 0 0 0     
TGM2 1 1 1     
CFAP44 0 0 0     
PPME1 0 0 0     
C21orf140 0 0 0     
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Table S 7.3 Proteins enriched from 28S rRNA after specific RNP capture. Mass spectrometry 
measurements were performed by the EMBL proteomics core facility; Bernd Fischer did the semi-
quantitative analysis of the three replicates. The amount of enrichments (n) in crosslinked sample (cCl) 
was compared to the non crosslinked (NocCl) and scrambled control (Scr). The estimated false discovery 
rate was calculated with following formula: (0+1)/n; being 4.3% (enriched over NocCl), being 5.3% 
(enriched over Scr) for the listed proteins;  
Symbol nCCL nNoCL nScr sigNoCL sigScr 
YBX3 3 0 0 * * 
ELAVL1 2 0 0 * * 
RPL31 2 0 0 * * 
HNRNPC 2 0 0 * * 
HNRNPM 2 0 0 * * 
NCL 3 0 0 * * 
RPL22 3 0 0 * * 
RPL5 3 0 0 * * 
HNRNPA2B1 2 0 0 * * 
DSG1 2 0 0 * * 
HNRNPA1 3 0 0 * * 
HNRNPD 2 0 0 * * 
BTF3 2 0 0 * * 
RPL29 2 0 0 * * 
PLIN4 2 0 0 * * 
HNRNPH1 2 0 0 * * 
HNRNPF 3 0 0 * * 
PA2G4 3 0 0 * * 
RPL4 2 0 0 * * 
YBX1 3 0 2 *   
RPS2 3 0 2 *   
SERBP1 3 1 2 *   
RPL8 3 1 2 *   
ZFYVE26 1 1 1     
P2RY10 0 0 0     
TNPO1 0 0 0     
XRN2 0 0 0     
HSP90AB1 1 0 0     
HNRNPH3 1 0 0     
HCFC1R1 0 0 0     
EIF3J 0 0 0     
CASP14 2 2 2     
SSBP1 0 0 0     
COL1A1 1 1 1     
CPE 0 0 0     
FOLR3 0 0 0     
ATP5B 1 1 1     
ARHGDIB 3 3 3     
RPL24 0 0 0     
RPS15 0 0 1     
TAF1B 0 0 0     
SFPQ 1 0 0     
KMT2A 0 0 0     
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FKBP15 0 0 0     
CSTA 2 1 1     
H2BFWT 0 0 0     
ATG14 0 0 0     
ZSCAN5A 3 3 3     
LRPPRC 1 0 0     
RPS24 0 0 0     
NONO 1 0 0     
RPL7 1 0 0     
MKI67 0 0 0     
OLAH 2 2 2     
HNRNPDL 1 0 0     
TMEM87B 0 0 0     
MCOLN2 0 0 0     
MAGED4 0 0 0     
AFAP1L1 0 0 0     
HIST1H4H 1 0 0     
ATP6V0D1 0 0 0     
TRAPPC10 3 3 3     
LCN1 2 1 1     
SRSF2 1 0 0     
DCD 1 1 1     
FMNL3 0 0 0     
CCDC78 3 3 3     
CFAP221 0 1 0     
SPTA1 2 2 2     
GTPBP8 0 0 0     
HNRNPK 0 0 0     
C19orf33 0 0 0     
KRT1 3 3 3     
SRRM2 1 0 0     
RPSA 0 0 0     
JUP 1 0 1     
TUBB6 0 0 0     
COX5A 0 0 0     
CCDC89 0 0 0     
RESP18 3 3 3     
NAA38 0 0 0     
ABAT 1 1 1     
ARAP1 2 2 2     
KCNJ11 1 1 1     
NCOR2 1 1 0     
HNRNPAB 1 0 0     
TGM2 0 0 0     
CFAP44 0 0 0     
PPME1 0 0 0     
C21orf140 0 0 0     
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